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Abstract 
 
A low vitamin D status (determined by 25(OH)D concentration) has been 
identified as an association risk factor in the aetiology of numerous chronic 
diseases, with older adults identified as generally more deficient than younger 
populations. Accumulating data is suggestive that physical activity and 
exercise may influence 25(OH)D and vitamin D metabolites downstream in the 
complex metabolic pathway. Specifically, exercise has been shown to act as 
a direct and indirect stimulus on the intracellular vitamin D receptor (VDR), 
which mediates the effects of vitamin D and initiates genomic and non-
genomic signalling responses. The role of physical activity and exercise on 
25(OH)D concentration and VDR expression is not yet recognised in a healthy 
human population.  
This thesis aimed to establish whether there is a link between physical activity 
status and 25(OH)D concentration, and if there is a role of age and exercise 
on 25(OH)D concentration and VDR expression (as quantified in circulating 
systemic T lymphocytes).  
The main results demonstrate that 25(OH)D concentration is not influenced by 
age or cardiorespiratory fitness (CRF), however VDR expression declines with 
older age and a higher CRF predicts a greater expression of the VDR. It was 
found that a single bout of exercise acutely increases VDR expression in 
circulating T lymphocytes, with exercise modality appearing to influence the 
response. There was a more pronounced response observed following an 
endurance compared to a resistance exercise bout. The impact of the 
exercise-induced lymphocyte response on the observed changes in T cell VDR 
expression was explored, however they appear to be independent.  
In conclusion, the findings of this thesis support the notion that exercise could 
be used as a short-term strategy to increase cellular VDR expression in a 
human population.  
Keywords: vitamin D, 25(OH)D, vitamin D receptor (VDR), physical activity, 
exercise, age.   
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Chapter 1: Introduction 
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Vitamin D is the major regulator of calcium homeostasis in the body (Sheikh et 
al., 1988) and is critical in the maintenance of bone mineral density (BMD) 
(Cauley et al., 2008). As well as this classical role of vitamin D in bone health, 
it has become evident that vitamin D exerts many additional effects 
contributing to good health functioning via both genomic and non-genomic 
pathways. The two main sources of vitamin D: sunlight exposure and dietary 
sources, contribute to whole-body vitamin D status (Holick, 2002, 2007). A low 
vitamin D level has been identified as a risk factor in the aetiology of numerous 
chronic diseases, such as diabetes (Calvo-Romero & Ramiro-Lozano, 2015; 
Mauss, Jarczok, Hoffmann, Thomas, & Fischer, 2015; Pittas, Lau, Hu, & 
Dawson-Hughes, 2007) and cardiovascular disease (Dobnig et al., 2008; T. J. 
Wang et al., 2008), with older adults identified as generally more vitamin D 
deficient than younger populations (Jacques et al., 1997; Laird et al., 2014; 
Touvier et al., 2015). Although a sufficient vitamin D status is important and 
linked to good health, it is through the cellular ligand-dependent receptor, 
vitamin D receptor (VDR), which receives the converted active form of vitamin 
D (as a ligand), that modulates the main function of vitamin D metabolism 
(Haussler, Jurutka, Mizwicki, & Norman, 2011; Haussler et al., 2013). The VDR 
is a ligand-inducible transcription factor that effectively alters gene 
transcription and thus protein synthesis (Bischoff et al., 2001; R. U. Simpson, 
Thomas, & Arnold, 1985). The upregulation or suppression of proteins at a 
particular time and in a specific quantity plays a role in the pathophysiology of 
diseases and conditions. Therefore, the bioavailability and functional capacity 
of the VDR is important when investigating vitamin D metabolism and health.  
Scotland can be defined as a vitamin D deficient nation according to outputs 
from both large and small scale studies evaluating the vitamin D status of 
residents of Scotland (Gallacher et al., 2005; Holick, 2008; Rhein, 2008; Weiss 
et al., 2016; Zgaga et al., 2011). Since a low vitamin D status is linked to ill-
health (Autier, Gandini, & Mullie, 2012), strategies are required to address the 
issue. However, vitamin D deficiency may not just be a problem at the 
circulatory level, but also on a cellular level. Therefore, strategies employed 
need to address the main mediators of the vitamin D metabolic pathway in 
order to improve efficiency and effectiveness of vitamin D metabolism, 
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presenting a solution to acquire the health-protective role vitamin D appears to 
provide. In addition, vitamin D supplementation, although an easy route to 
increase vitamin D status, is costly (around £50 per year per person) if all 
residents in Scotland were prescribed them. In addition, recommending 
increased sunlight exposure carries health risks itself: skin cancer induced by 
ultraviolet (UV) A radiation exposure from the sun (Armstrong & Kricker, 2001; 
Brash et al., 1991), and not feasible due to weather and seasonal influence 
(Rhodes et al., 2010). Therefore, alternative strategies are required that are 
low risk, plausible and low expense.  
In recent studies it has been reported that mechanical stress, physical activity, 
and exercise may influence vitamin D metabolism at the surface and cellular 
level (Aly, Abdou, Rashad, & Nassef, 2016; Maimoun et al., 2005; Makanae et 
al., 2015; Sun, Cao, Taniguchi, Tanisawa, & Higuchi, 2017). However, there is 
limited research in humans, with the majority of studies conducted in murine 
models and not translated into the human population. According to The 
Scottish Healthy Survey 2016, the physical activity status of Scotland is poor, 
with reports that 36 % of the adult population, around 1.6 million people, are 
physically inactive (The Scottish Health Survey, 2017). The survey reports also 
that men are more likely to meet the recommended physical activity guidelines 
compared to women. If exercise is found to beneficially influence vitamin D 
metabolism, it could pose as a cost-effective and low risk strategy to combat 
the deficiency epidemic in Scotland.  
Another concern surrounding vitamin D status and it’s link with health, is the 
influence of age, with older populations exhibiting low 25(OH)D concentrations 
(Chapuy, Durr, & Chapuy, 1983; Jacques et al., 1997) and a reduced 
expression of VDR (Bischoff-Ferrari, Borchers, et al., 2004). However, it is 
elusive whether 25(OH)D concentration declines with age independent of 
other characteristics and environmental factors. Furthermore, adding to this 
concern, ageing is associated with a decline in physical activity levels (Sallis, 
2000) and aerobic fitness (Buskirk & Hodgson, 1987; Fitzgerald, Tanaka, Tran, 
& Seals, 1997). Interestingly, it has been reported that higher self-reported 
physical activity is associated with higher circulating concentrations of vitamin 
D (Jacques et al., 1997; Scragg & Camargo, 2008). However, the effect of 
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cardiorespiratory fitness (CRF) and exercise itself on key vitamin D 
metabolites has not yet been investigated in a human population.  
The overall aim of this thesis is to investigate the role of physical 
activity/exercise and age on vitamin D metabolism: primarily systemic 
25(OH)D concentration, identified as vitamin D status, and circulating cellular 
VDR expression. The intention is to identify whether exercise could be 
proposed and utilised as a strategy to optimise vitamin D metabolism and 
potentially improve health.  
To realise this aim, the following specific objectives will be addressed:  
I. To evaluate the vitamin D status of older adults in Scotland and 
determine whether there is a link with physical activity levels.  
II. Investigate whether vitamin D status is influenced by age and 
associated with CRF.  
III. Determine whether there is a relationship between vitamin D status 
and baseline VDR expression, and investigate the role of age and 
CRF on VDR expression.  
IV. Explore the effects of an acute bout of exercise on VDR expression, 
and identify if this response is influenced by age.  
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Chapter 2: Literature Review 
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2.1 Introduction 
This literature review will cover the current main research in the areas of 
physical activity and exercise on vitamin D status and metabolism, specifically 
the vitamin D receptor (VDR), of which the function and activity will be 
reviewed. Both murine and human research will be reviewed, with focus on 
translation of the investigations into a human population. The role that the 
inevitable ageing process has on these areas will also be addressed, with the 
influence of age being a main outcome of the thesis.  
 
2.2 Background of vitamin D 
Vitamins are organic compounds, primarily obtained through the diet from 
dietary food sources or supplements. Vitamin D may not be a vitamin in the 
truest sense since it has been classified as a fat-soluble secosteroid hormone 
(Vieth, 2004), classically responsible for increasing intestinal absorption of 
calcium (Christakos, Dhawan, Porta, Mady, & Seth, 2011). More recently, non-
classic roles of vitamin D have emerged in the prevention of chronic disease, 
assisting the immune system, and regulating the endocrine system (Holick & 
Chen, 2008). Vitamin D metabolism involves a substantially long and 
complicated pathway, exerting its effects via genomic and non-genomic 
mechanisms, ultimately affecting health, or more specifically preventing ill 
health (Autier, Boniol, Pizot, & Mullie, 2014). Studies have generally 
documented that vitamin D plays a crucial role in the development and 
maintenance of skeletal and extraskeletal health (Cauley et al., 2008; Holick, 
1996; Hossein-nezhad & Holick, 2013; Wacker & Holick, 2013). Vitamin D 
deficiency is also linked to the prevalence of cardiovascular disease, diabetes, 
and autoimmune diseases (Holick, 2004a, 2004b; Hypponen, Laara, 
Reunanen, Jarvelin, & Virtanen, 2001; Hypponen & Power, 2007; Pittas, Lau, 
et al., 2007), such as multiple sclerosis (Munger et al., 2004) and Crohn’s 
disease (Simmons, Mullighan, Welsh, & Jewell, 2000).  
The two primary sources of vitamin D are dietary intake, ideally contributing to 
approximately 20 % of total intake (although in very minimal doses), and direct 
ultraviolet (UV) B radiation exposure from sunlight, optimally contributing the 
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other 80 % (Holick, 2002). There are two main forms of vitamin D: 
ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3), which should not 
be used interchangeably as they do not have equal nutritional values. Both 
forms contribute to a person’s vitamin D status, identified as plasma or serum 
25(OH)D concentration, determining whether a person is vitamin D deficient 
or sufficient (Dawson-Hughes et al., 2005). Vitamin D2 is derived from plants 
and thus is consumed through the diet in relatively small quantities, whereas 
vitamin D3 can be obtained from a variety of exogenous sources, such as oily 
fish, eggs, and green leafy vegetables, and produced endogenously by the 
exposure of skin to UV rays (G. Jones, Strugnell, & DeLuca, 1998). There is 
evidence that supplementation with vitamin D3 is more effective at increasing 
overall vitamin D status than D2 (Nimitphong, Saetung, Chanprasertyotin, 
Chailurkit, & Ongphiphadhanakul, 2013; Trang et al., 1998). Through the 
metabolic pathway, vitamin D2 needs to be converted to vitamin D3 in order to 
be further metabolised into calcidiol (25-hydroxy-vitamin D or 25(OH)D) and 
thus it is usually 25(OH)D (both forms combined) or 25(OH)D3 concentration 
that is reported in the majority of research studies. However, vitamin D status 
is not only determined by the input but also the efficiency of storing and 
releasing 25(OH)D. Many cell types, such as skeletal muscle cells and fat cells 
(Abboud et al., 2014; Abboud et al., 2013), have been reported to uptake 
25(OH)D for storage. However, the release of the protein hormone is 
dependent on the cell type: adipose tissue cells sequester and store 25(OH)D 
(Wortsman, Matsuoka, Chen, Lu, & Holick, 2000), whereas skeletal muscle 
cells store but also readily release 25(OH)D (Abboud et al., 2013) to contribute 
to circulating 25(OH)D concentration when required. It is suggested that this is 
due to the strong lipophilic properties of 25(OH)D. Compared to other 
constituents of blood, 25(OH)D has a relatively long half-life that varies 
between 15-45 days (Abboud et al., 2013; Zehnder et al., 2001; Zerwekh, 
2008), although its residence is remarkably longer than its binding protein, 
vitamin D binding protein (DBP), which is 1-3 days. Therefore, the 
maintenance of vitamin D status may be attributed to more than just UV 
exposure, dietary intake, and lifestyle influences.  
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The concentration of total systemic 25(OH)D3 has been identified as the most 
reliant biomarker when determining the overall vitamin D status of a person in 
both a clinical and research capacity (Holick, 2009). However, an observed 
elevation in 25(OH)D3 does not necessarily reflect the efficiency or success of 
the metabolic pathway as a whole. Despite reported links between vitamin D 
status and health conditions, there is minimal proof of concept that vitamin D 
induced-health benefits are gained if the only metabolite that is measured and 
reported is 25(OH)D3. Plasma or serum 25(OH)D may not be representative 
of vitamin D status, but a critical intermediary in the utilisation of vitamin D by 
the body, since the action is mediated by intracellular metabolites and 
receptors towards the end of the pathway. In addition, the current marker to 
determine vitamin D status does not take into account the distribution of 
25(OH)D3 in other stores as opposed to plasma or serum: fat cells, muscle 
cells and various other tissues (Heaney, Horst, Cullen, & Armas, 2009). 
Circulating 25(OH)D concentration may not be a reliable indicator of whole 
body vitamin D status, and therefore it is important to consider all key 
metabolites involved in the entire metabolic pathway when determining a 
person’s vitamin D status and their capacity to effectively utilise 25(OH)D at a 
cellular level.  
 
2.3 Vitamin D metabolism 
2.3.1 The vitamin D pathway 
Classified as an active hormone in the body, 25(OH)D is metabolised from the 
active pre-cursor 7-dehydrocholesterol located within the epidermis of the skin 
(Kumar, 1984). The basic vitamin D metabolic pathway is shown in Figure 1. 
Upon photo-activation by UVB rays from direct sunlight exposure, 7-
dehydrocholesterol undergoes photo-conversion into vitamin D. This is 
dissimilar to oral ingestion, whereby the ingested supplement or dietary source 
of vitamin D is absorbed through the intestinal wall. The vitamin D from either 
source then circulates in the blood bound to the DBP, its carrier protein, then 
undergoes two consecutive hydroxylation reactions, the first in the liver and 
the second in the kidney (Girgis, Clifton-Bligh, Hamrick, Holick, & Gunton, 
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2013; Kitson & Roberts, 2012). The DBP is the primary vitamin D carrier 
protein, binding 80-95 % of total 25(OH)D, with the remaining 25(OH)D bound 
to albumin, and less than 1 % of total circulating 25(OH)D in the free form 
(Bikle et al., 1986). The first step in the bioactivation of vitamin D is by the 
hydroxylation of carbon 25, which occurs primarily in the liver by 25-
hydroxylases, specific cytochrome P450 enzymes such as CYP27A (sterol 27-
hydroxylase), converting vitamin D to 25-hydroxyvitamin D3 (25(OH)D3). This 
is then further metabolised by CYP27B1 (1α-hydroxylase) in the kidney to the 
bioactive form of vitamin D: 1,25-hydroxyvitamin D3 (1,25(OH)2D3). This active 
form is then secreted into the bloodstream for systemic delivery to the target 
tissue/cells. Although, the kidney is not unique in its ability to convert 25(OH)D3 
to 1,25(OH)2D3, as numerous cells and tissues have demonstrated the 
capacity for local metabolism of vitamin D.  
 
 
Figure 1 Vitamin D metabolic pathway adapted from Girgis et al. (2013) and 
Kitson and Roberts (2012).  
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2.3.2 The vitamin D receptor (VDR) 
Located in the cytoplasm and nucleus of many cells, the VDR is a ligand-
inducible transcription factor (Klopot, Hance, Peleg, Barsony, & Fleet, 2007), 
that was first discovered in 1974 by Brumbaugh and Haussler in animal 
intestines (Brumbaugh & Haussler, 1974). The target genes of VDR play a key 
role in cellular metabolism, bone health, mediating inflammation and muscle 
protein synthesis (Carlberg & Seuter, 2009). It has been reported that target 
genes of the VDR are associated with an individual’s vitamin D status, whereby 
changes of their messenger ribonucleic acid (mRNA) expression significantly 
correlates with alterations of 25(OH)D3 levels (Vukic et al., 2015). Although, 
the metabolic pathway is closely linked and dependent upon the bioavailability 
of specific metabolites, vitamin D functions through the cellular action of the 
VDR. It is suggested that 1,25(OH)2D3 acts via the VDR to have a direct effect 
on enzymatic activity, establishing the main control mechanism for vitamin D 
metabolism (Tiosano, Weisman, & Hochberg, 2001). The VDR has been found 
to regulate the expression of more than 900 genes involved in numerous 
physiological functions and pathological conditions, with more than 36 types of 
human tissue identified to express the VDR, including skeletal muscle 
(Norman, 2008). The primary role of VDR is to induce mRNA transcription and 
thus regulate protein synthesis (Bischoff et al., 2001; R. U. Simpson et al., 
1985).  
The intracellular pathway of vitamin D metabolites is displayed in Figure 2. 
The circulating unbound 1,25(OH)2D3 crosses the cellular membrane of the 
target cell and subsequently binds to the cytoplasmic or nuclear VDR with high 
affinity (Pike, Meyer, & Bishop, 2012). The ligand 1,25(OH)2D3 promotes 
heterodimerisation of VDR with retinoid X receptor (RXR), a nuclear receptor 
that is activated by 9-cis retinoic acid, a metabolically active form of vitamin A. 
Ligand binding to VDR may induce translocation of the complex to the nucleus 
(MacDonald et al., 1993). The VDR-RXR complex subsequently binds with 
high affinity to vitamin D response elements (VDRE) in the promoter region of 
target genes on the deoxyribonucleic acid (DNA) strand (Haussler et al., 1998). 
It is this binding mechanism that leads to the genomic activity of vitamin D. 
Once bound, VDR is then positioned such that it may recruit co-regulatory RNA 
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polymerase II transcriptional machinery to the target site to induce or suppress 
transcription of target genes (Girgis et al., 2013). These data imply a 
mechanism by which the VDR-RXR complex expresses promotor specificity 
permitting differential effects on numerous vitamin D related genes (J. Zhang 
et al., 2011). This ultimately induces translation of mRNA leading to de novo 
protein synthesis. Thus, vitamin D action depends on the delivery or metabolic 
production of sufficient concentrations of the 1,25(OH)2D3 ligand to the target 
cell, and adequate intracellular expression of VDR and RXR proteins (Haussler 
et al., 2013).  
 
Figure 2 Intracellular vitamin D metabolic pathway adapted from Pike et al. 
(2012).  
 
As with all members of the super family of steroid/thyroid hormone/retinoid 
nuclear receptors, the VDR is comprised of two well-conserved core domains, 
the ligand-binding domain, and the DNA-binding domain (Orlov, Rochel, 
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Moras, & Klaholz, 2012). The structure of the VDR is shown in Figure 3. The 
hinge region connecting the two active domains allows for flexibility within the 
structure of the receptor, allowing the receptor to bind to various DNA response 
elements in the DNA strand. The intricacies of the VDR structure have been 
well discussed and outlined by Haussler et al. (1998).  
  
Figure 3 Structure of the VDR adapted from Orlov et al. (2012).  
 
The positive interaction between VDR and RXR on the promotor region on a 
DNA strand is cyclic in nature with regards to the kinetics of receptor 
association (C. Zhang et al., 2003). The receptor action correlates with timely 
recruitment of many co-regulators, such as VDREs and the basic elements of 
the transcriptional machinery required for gene transcription. Following 
treatment with 1,25(OH)2D3, binding of the VDR-RXR dimer complex has been 
assessed over 15 minute (min) intervals for a period of 3 hours (h) and also 
over longer term exposures up to 24 h (Kim, Shevde, & Pike, 2005). It 
appeared that VDR binding activity increased following 1,25(OH)2D3 
stimulation, with a peak at 45-60 min and a second wave at 135 min. Treatment 
with 1,25(OH)2D3 also induced strong VDR and modest RXR protein 
upregulation, with the increase maintained to the 24 h time point. These 
findings support the idea that localisation of the VDR-RXR complex to the 
promotor region is ligand-dependent requiring the bioavailability of 
1,25(OH)2D3 (Pike & Meyer, 2010).  
In numerous health conditions it is imperative that the functional products of a 
gene, primarily proteins, are consistently or intermittently expressed at a 
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specific concentration, for example: sufficient release of insulin to 
downregulate elevated glucose levels in order to achieve euglycaemia and 
prevent the onset of chronic hyperglycaemia: the initial pathophysiological 
event in the development of diabetes (Kahn, 2003). Vitamin D metabolism, 
specifically the VDR has been reported to regulate or induce gene expression, 
therefore altering protein synthesis (Haussler et al., 1998; Pike & Meyer, 
2010).  
 
2.3.3 Regulation of active vitamin D 
In plasma and serum, the majority of 25(OH)D3 is bound to the DBP (85-90 
%), with a small minority (10-15 %) bound to albumin, and less than 1 % of 
25(OH)D3 circulating in the free form (Bikle, Siiteri, Ryzen, & Haddad, 1985; 
Chun et al., 2014). However, since the affinity of albumin to 25(OH)D is weaker 
than that of DBP to 25(OH)D, when bound to albumin the 25(OH)D becomes 
a bioavailable form, which also includes free circulating 25(OH)D (Bikle et al., 
1986). Although DBP may not be directly associated with the risk of vitamin D-
induced disease or health complications, the protein indirectly modulates 
circulating free and bioavailable 25(OH)D concentration, ultimately delivering 
the ligand 1,25(OH)2D3 to the target cell and VDR. Thus the concentration of 
bioavailable 25(OH)D depends on both the total 25(OH)D and levels of DBP 
and albumin. Although total 25(OH)D is recognised as the biomarker of vitamin 
D status (Chun et al., 2014), free or bioavailable 25(OH)D may be more 
relevant to determine vitamin D deficiency and the association with health 
complications (C. Li et al., 2017).  
There is an optimal level of 1,25(OH)2D3, which requires a mechanism to 
promote or attenuate its activity. This physiologically active metabolite has a 
relatively shorter half-life (4-15 h) (Zehnder et al., 2001) than 25(OH)D3 (15 
days) (K. S. Jones et al., 2014). Although sufficient delivery of the ligand to 
target cells is required to have vitamin D-induced cellular transcriptional 
actions, a high potency of 1,25(OH)2D3 may have toxic effects. The efficacy of 
tissues expressing VDR positive cells to metabolise vitamin D and exert its 
biological effects will be dependent upon the ability of the cell to internalise the 
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1,25(OH)2D3-DBP complex. Cells express membrane-bound proteins that 
facilitate the uptake of the complex to the cytoplasm. For example, skeletal 
muscle tissue cells express megalin, which has been identified to play a role 
in mediating endocytosis of the 1,25(OH)2D3 ligand (Abboud et al., 2013).  
A feedback regulation by 1,25(OH)2D3 has been identified, which mediates the 
circulating levels of 24-hydroxylase and CYP27B1, limiting an unnecessarily 
high abundance of the enzymes and thus strives to maintain optimal levels of 
the ligand. The protein 24-hydroxylase (encoded by the CYP24A1 gene) 
initiates the degradation of 25(OH)D3 and 1,25(OH)2D3 at the C-24 position to 
produce 24,25(OH)2D3 and 1,24,25(OH)2D3, respective. Thus 24-hydroxylase 
works alongside CYP27B1 to control the systemic concentration of the non-
active and active forms (Dusso, Brown, & Slatopolsky, 2005; Ohyama, 
Noshiro, & Okuda, 1991). It has been shown that 1,25(OH)2D3 does not 
regulate CYP27B1 mRNA or protein expression, suggesting that 1,25(OH)2D3 
levels are controlled via 24-hydroylase-induced degradation of 1,25(OH)2D3 
(Xie et al., 2002). Thus the 1,25(OH)2D3 feedback mechanism relies on 
1,25(OH)2D3 catabolism rather than inhibition of 1,25(OH)2D3 production. For 
vitamin D metabolism to operate effectively, all the components and co-
regulators must be orchestrated optimally. Therefore when investigating key 
components of the vitamin D metabolic pathway, consideration must be paid 
to the impact of metabolites and their potential mediating effect on protein 
expression and availability.  
 
2.3.4 Physiological roles of the ligand-VDR complex 
Vitamin D is not only known for its classic role in bone health and calcium 
regulation, but also in other non-genomic and genomic actions, such as cell 
proliferation and differentiation, as well as inducing and supressing gene 
transcription and mRNA translation leading to the synthesis and secretion of a 
variety of proteins. Since the VDR is identified as the controlling mechanisms 
of such actions, it is important to consider what ultimate outcome these VDR-
induced actions have with regards to therapeutic use in human health.  
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2.3.4.1 Calcium regulation and bone health 
A primary function of the vitamin D endocrine system is to maintain calcium 
homeostasis, with intestinal calcium absorption dependent on the availability 
of vitamin D metabolites: 1,25(OH)2D3 and VDR (Sheikh et al., 1988). Intestinal 
calcium absorption efficiency has also been found to be attributed to a fall in 
circulating 1,25(OH)2D3 concentration, as well as intestinal resistance to the 
action of 1,25(OH)2D3 (Pattanaungkul et al., 2000). 1,25(OH)2D3 is reported as 
the major hormone actively involved in the absorption of calcium from the small 
intestine and reabsorption in the kidney and bone. On a cellular level, 
1,25(OH)2D3 and VDR induce the expression of membrane calcium channels 
thus facilitating calcium entry into the cell, with VDR expression necessary for 
normal calcium homeostasis (Christakos et al., 2011; Christakos, Dhawan, 
Verstuyf, Verlinden, & Carmeliet, 2016). The ligand and receptor also exert 
control in the intestine on calcium binding once calcium enters the cell, and 
preventing cellular calcium concentrations from reaching toxicity (Christakos, 
2012). If calcium homeostasis cannot be achieved through absorption from the 
intestine alone, then 1,25(OH)2D3 cooperates with parathyroid hormone (PTH) 
to induce calcium reabsorption from the kidney and the bone, contributing to 
circulating calcium levels.  
During the ageing process there is a decline in the intestinal absorption of 
calcium, which may be predetermined by 1,25(OH)2D3 bioavailability 
(Veldurthy et al., 2016). This disturbed calcium balance is often accompanied 
with secondary hyperparathyroidism as a result of an overcompensated 
production of PTH in the presence of less 1,25(OH)2D3. Hyperparathyroidism 
is also triggered by low concentrations of calcium in the blood, prompting the 
parathyroid gland to secrete more hormone (G. Jones et al., 1998), thus 
lowered combined action of 1,25(OH)2D3 and PTH to release calcium from 
renal tubule or bone. Ageing has been associated with disturbed vitamin D 
metabolism (Chapuy et al., 1983; Jacques et al., 1997), therefore exposing 
older populations to calcium deficient issues, such as decreased BMD, 
osteoporosis and age-related bone loss (Cauley et al., 2008).  
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2.3.4.2 Muscle mass and strength 
Vitamin D appears to have a role on several tissues in the body including 
skeletal muscle (Ceglia & Harris, 2013), with vitamin D deficiency associated 
with muscle weakness, muscle mass loss, and increased risk of falls in older 
populations. Fewer falls have been reported in persons who supplement with 
vitamin D combined with calcium verses calcium alone (Bischoff et al., 2003; 
Flicker et al., 2005). The risk of falls increases with changes in skeletal muscle 
mass, fibre type, and strength. Sarcopenia is a skeletal muscle-related 
syndrome characterised by low muscle mass, strength and function, which 
becomes increasingly prevalent as age advances (Cruz-Jentoft et al., 2010) 
and is linked to lower vitamin D status (Verlaan et al., 2015). Muscle mass and 
strength generally peak in early adult life and gradually decline with the ageing 
process (Frontera, Hughes, Lutz, & Evans, 1991; Hughes et al., 2001; Keller 
& Engelhardt, 2013), therefore maintenance of muscle mass and strength are 
key to promote conservation of independence and exercise capacity. 
Inadequate intake of vitamin D has been identified as a potentially modifiable 
risk factor in the development of sarcopenia (Mithal et al., 2013). It has been 
reported that higher baseline serum 25(OH)D concentrations have been 
associated with a greater muscle mass gain in sarcopenic adults (Verlaan et 
al., 2017). The authors suggested that sufficient baseline vitamin D status may 
be required for muscle mass gain or maintenance. Potential mechanisms for 
the action of vitamin D may be via the bioactive 1,25(OH)2D3, which stimulates 
calcium influx into cells, phosphate transport, and muscle fibre differentiation 
(Garcia, King, Ferrini, Norris, & Artaza, 2011). Investigations in vitro have 
reported 1,25(OH)2D3 to stimulate key cellular pathways of muscle growth and 
differentiation, acting primarily through the action of the VDR, to induce 
myogenesis (Garcia et al., 2011). VDR expression and genetic variation 
appears to impact human skeletal muscle strength and mass (Ceglia et al., 
2013; Walsh, Ludlow, Metter, Ferrucci, & Roth, 2016). Since there is a decline 
in VDR expression in skeletal muscle cells with ageing (Bischoff-Ferrari, 
Borchers, et al., 2004), the key vitamin D-mediated molecular pathways 
introduce possible mechanisms for vitamin D to influence muscle mass and 
strength regulation. 
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Supplementation with 25(OH)D3 can increase intracellular VDR concentration 
and muscle fibre size after a 4 month period (Ceglia et al., 2013), although 
research is limited within a human population. Mice with global body knockout 
of VDR exhibit impaired gut absorption and abnormal serum calcium levels, 
and differences in the phenotype of their muscles, with reduced muscle mass 
and smaller muscle fibres (Endo et al., 2003; Girgis et al., 2015). In addition, 
in skeletal muscle-specific VDR knockout mice there is a reduction in type II 
fibre type size (Chen, Villalta, & Agrawal, 2016). These data may suggest a 
vitamin D-speciﬁc eﬀect on muscle ﬁbre size, although the murine model 
studies should be explored in humans to establish whether it is a transferable 
finding between species.  
 
2.3.4.3 Diabetes 
Epidemiological studies have shown that vitamin D deficiency is associated 
with a higher prevalence of diabetes (Pittas et al., 2006; Pittas et al., 2012) and 
the development of metabolic syndrome (Barchetta et al., 2013). Insulin 
resistance and beta cell dysfunction are the main pathophysiological events in 
the development of diabetes (Kahn, 2003). There are several mechanisms 
underpinning the insulin-sensitising actions of vitamin D. Ligand bound-VDR 
has been identified in beta cells, where it activated intracellular signalling 
pathways involved in the transcription of the human insulin gene, subsequently 
upregulating insulin production and secretion destined to control systemic 
glycaemia (Guo et al., 2013; Maestro, Molero, Bajo, Davila, & Calle, 2002). 
1,25(OH)2D3 has also been reported to mediate glucose transporter type 4 
(GLUT4) translocation and thus cellular glucose uptake, therefore reducing the 
risk of developing chronic hyperglycaemia, a pre-disposed physiological state 
of diabetes (Manna & Jain, 2012).  
 
2.3.4.4 Inflammation and autoimmune diseases 
Vitamin D deficiency has been linked to altered inflammatory responses and 
chronic low-grade inflammation, leading to inflammatory and autoimmune 
diseases, such as diabetes, Crohns’ disease, asthma, and multiple sclerosis 
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(Yin & Agrawal, 2014). Although investigations into the potential mechanisms 
involved in this association are still in their infancy, it has been proposed that 
the ligand binding of 1,25(OH)2D3-VDR complex to VDREs alters the rate of 
transcription of a variety of cytokines, such as tumour necrosis factor (TNF)-α, 
interferon-γ, and interleukin (IL)-1 (Di Rosa, Malaguarnera, Nicoletti, & 
Malaguarnera, 2011). Although, in vivo studies have reported associations 
between vitamin D supplementation and a reduction in proinflammatory 
cytokines in patients with osteoporosis (Inanir, Ozoran, Tutkak, & Mermerci, 
2004) and heart failure (Schleithoff et al., 2006), but not in healthy individuals 
(Gannage-Yared et al., 2003). Similarly, data from the Framingham Offspring 
Study, which included a healthy older population, reports no association 
between vitamin D and overall inflammation (Shea et al., 2008). In an in vitro 
investigation, it was demonstrated that 1,25(OH)2D3 supressed the production 
of pro-inflammatory cytokines, which modulate the immune response and 
decreased overall inflammation (Colin et al., 2010). However, supplementation 
with vitamin D for a 3 year period reported no change on systemic inflammatory 
markers: plasma C-reactive protein (CRP) and IL-6 (Pittas, Harris, Stark, & 
Dawson-Hughes, 2007). It appears that currently the data surrounding the link 
between vitamin D and acute and chronic inflammation is elusive with further 
research required.  
 
2.3.4.5 Immune health 
Vitamin D and its metabolites are actively involved in the regulation of the 
innate and adaptive immune system (Aranow, 2011; Cantorna, 2000; 
Cantorna, Zhu, Froicu, & Wittke, 2004). It is known that the VDR and CYP27B1 
are expressed in peripheral blood mononuclear cells (PBMCs), specifically 
immune cells, including: B cells, T cells, and antigen presenting cells, and that 
1,25(OH)2D3 signalling modulates both innate and adaptive immune 
responses (Baeke, Korf, et al., 2010; Baeke, Takiishi, Korf, Gysemans, & 
Mathieu, 2010; Bhalla, Amento, Clemens, Holick, & Krane, 1983; Brennan et 
al., 1987; Provvedini, Tsoukas, Deftos, & Manolagas, 1983; Vukic et al., 2015). 
These immune cells are also capable of internally converting 25(OH)D to 
1,25(OH)2D3, demonstrating the ability of immune cells to internally metabolise 
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25(OH)D (Kongsbak, von Essen, Levring, et al., 2014). In addition, immune 
cells are responsive to 1,25(OH)2D3, however the route by which 1,25(OH)2D3 
regulates adaptive immunity utilising these cells remains unclear. The immune 
system plays the role of protector in the body, defending against invading 
organisms, and building immunity to foreign bodies. In a state of vitamin D 
deficiency there appears to be a compromised immune defence, which 
increases susceptibility to infection and increased autoimmunity (White, 2008). 
In addition to vitamin D’s more classic endocrine role, it can also act in a 
paracrine or autocrine manner in an immune environment.  
Traditionally vitamin D was prescribed in the form of cod liver oil, a rich source, 
to prevent upper respiratory tract infections (Ginde, Mansbach, & Camargo, 
2009; Laaksi et al., 2007), influenza, and as a treatment for tuberculosis. 
Studies date back to the 80’s and 90’s, whereby vitamin D deficiency was 
associated with increased risk of infection, even after adjusting for seasonal 
variations and age. This has also been found more recently in epidemiology 
research (Cannell et al., 2006).  
Vitamin D also has numerous effects on the immune cells within the adaptive 
immune system: B cells, T cell subsets (Thelper and Tcytotoxic cells) (Cantorna, 
Snyder, Lin, & Yang, 2015), and natural killer cells. Primarily vitamin D 
supresses or promotes immune cell proliferation or differentiation, mediating 
control over the T cell response (Jeffery et al., 2009; Jeffery et al., 2012). The 
effects of which induce the production of inflammatory and anti-inflammatory 
cytokines, which modulate the function of the immune system. As a result this 
enhanced control of the immune systems function can prevent the 
development of autoimmune diseases.  
However, the mechanisms and direct influence of vitamin D within these 
infectious and autoimmune diseases is not clear and at present the 
relationship is unsubstantiated. The in vivo effects of vitamin D on immune 
function also depend on the immunological challenge presented (Cantorna et 
al., 2004), therefore, further investigations are required to identify the cellular 
and molecular targets of active vitamin D within the immune system, and the 
mechanisms involved and recruited.  
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2.3.4.6 Cancer 
Epidemiological observations have reported an association between 
inadequate concentrations of 25(OH)D and increased risk of different types of 
cancers, such as colon, prostate, and breast cancer, shown through in vivo an 
in vitro systems (Deeb, Trump, & Johnson, 2007). Potential mechanisms of 
action include genomic activity through the VDR, apoptosis, cell signalling, 
angiogenesis, and cell-cell interactions (Deeb et al., 2007), although the 
mechanisms have not extensively been explored.  
 
2.4 Vitamin D status in Scotland 
In regions of low UVB radiation, such as Scotland, individuals are at risk of 
vitamin D deficiency as the primary source of vitamin D that should contribute 
80 % of our total intake is via skin synthesis following UVB exposure (Holick, 
2002). The high northern latitude of Scotland (55°-59° North) and the prevalent 
cloud cover and poor weather conditions, does not facilitate sufficient vitamin 
D skin synthesis (Rhodes et al., 2010) to increase or maintain a sufficient 
vitamin D status. In addition to these limiting factors, the UVB radiation must 
be of a specific wavelength (290-315 nm) to promote dermatologic vitamin D 
metabolism to then contribute to the body’s overall vitamin D pool (Chapuy et 
al., 1997). The classifications for vitamin D status are displayed in Table 1. 
The Institute of Medicine (IOM) has defined vitamin D deficiency as <20 ng·ml-
1, insufficiency as 20-30 ng·ml-1, and sufficiency as ≥30 ng·ml-1 (A. C. Ross et 
al., 2011).   
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Table 1 Current classifications of vitamin D status and equivalences of units 
(Bischoff-Ferrari, Giovannucci, Willett, Dietrich, & Dawson-Hughes, 2006; 
Holick, 2009; Holick et al., 2011; A. C. Ross et al., 2011).  
Serum/plasma 25(OH)D concentration Classification 
< 12 ng·ml-1 < 30 nmol·L-1 Severely deficient 
13-20 ng·ml-1 31 - 50 nmol·L-1 Deficient 
21-29 ng·ml-1 51- 75 nmol·L-1 Insufficient 
> 30 ng·ml-1 > 75 nmol·L-1 Sufficient 
> 100 ng·ml-1 > 250 nmol·L-1 Toxicity 
Equivalences: 1 ng·ml-1 = 2.5 nmol·L-1.  
 
In countries of a high latitude the provision of sunlight exposure to daily vitamin 
D uptake is significantly reduced or diminished. When considering the overall 
vitamin D status of Scotland, it has been reported that during all seasons’ 
vitamin D insufficiency and deficiency is common (Hypponen & Power, 2007; 
Kelly et al., 2015; Zgaga et al., 2011). The prevalence of vitamin D deficiency 
has been reported to be high, particularly in the winter and spring months, in 
the UK (Hirani, 2013; Hypponen & Power, 2007). The investigation by 
Hypponen and Power (2007) included men and women from the 1958 British 
birth cohort, all aged 45 years old and born in England, Scotland or Wales, and 
resided in the UK at time of data collection. Almost all of the participants (87.1 
% of n=7437) were vitamin D deficient or insufficient despite the seasonal 
effect, with a mean serum 25(OH)D concentration of 16.5 ng·ml-1 in the winter 
and spring months, and 24.2 ng·ml-1 in the summer and autumn months, the 
lowest reported concentrations were prevalent in February. Interestingly, in the 
latter investigation Scotland had a significantly lower vitamin D status 
compared to other areas of Britain: South England, Midlands and Wales, and 
North England, with a mean 25(OH)D of 14.2 ng·ml-1 compared to 16.3-17.1 
ng·ml-1 in the summer and autumn months and 20.4 ng·ml-1 compared to 24.2-
25.0 ng·ml-1 in the winter and spring months. Hirani et al. (2013) reported the 
prevalence of vitamin D insufficiency and deficiency in men and women 
(n=2070) aged 65 years and older in England to be 33.8 % and 51.7 %, 
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indicating only 14.5 % of this population exhibited a sufficient status. Similarly, 
an adult population including older adults (n=222; 48-94 years) living in 
sheltered housing in East London, England, also reported a high prevalence 
of vitamin D deficiency, with a mean 25(OH)D3 concentration of 17.2 ng·ml-1 
(Jolliffe et al., 2016). They highlighted a seasonal variation on 25(OH)D3 
concentration, where vitamin D status was reported to peak in July to 
September and trough in January to March, consistent with reports from other 
studies in the UK (Hypponen & Power, 2007; Zgaga et al., 2011) and out-with 
the UK (K. Brock et al., 2010).  
A study evaluating the vitamin D status of men and women (n=2235, 61.3 ± 
10.7 years) in Scotland reported a high prevalence of severe deficiency (34.5 
%) and deficiency (28.9 %), with a mean 25(OH)D3 concentration of 14.4 
ng·ml-1 (Zgaga et al., 2011). The same research group also conducted an 
investigation comparing vitamin D status of mainland Scotland to the Northern 
Scottish Isle Orkney, establishing the main determinants of vitamin D status in 
Orkney (Weiss et al., 2016). The mean 25(OH)D3 concentration (n=1453, 16.5-
100.2 years) in Orkney was 14.5 ng·ml-1, which was similar to that reported in 
mainland Scotland. However, when observing age-matched data, Orkney had 
a significantly higher status (14.1 ng·ml-1) than mainland Scotland (12.7 ng·ml-
1), with mean 25(OH)D3 higher in every month of the year except for August. It 
was reported that older age, farming occupations and going on foreign 
holidays (holiday outside of the UK at least once per year) were associated 
with higher 25(OH)D3 concentrations. It should be noted that the status in 
Orkney was classified as deficient despite the influence of any of the lifestyle 
determinants.  
Despite a small sample size (n=99) to be reported from a medical practice, a 
General Practitioner in Scotland has reported findings that vitamin D deficiency 
was high in patients aged 15-85 years, with only 2 % reporting levels of 
sufficiency (Rhein, 2008). Severe deficiency was reported at 47 % of the 
cohort. Similarly in Scotland, results of a hospital based study in 548 older 
adult patients (94 % were aged over 60 and 74 % were aged over 75 years) 
reports universal vitamin D inadequacy, with a mean concentration of 9.9 
ng·ml-1, with no seasonal influence (Gallacher et al., 2005). Another hospital 
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based group in Scotland reported low vitamin D levels of older patients (n=102, 
79.6 ± 7.3 years), at 16.6 ng·ml-1 (Burleigh & Potter, 2006). These data support 
findings that vitamin D deficiency is grossly high in the UK, in particular in 
Scotland, throughout the calendar year, with low levels observed in older 
adults.  
 
2.4.1 Determinants of vitamin D status 
The prevalence of a low vitamin D status or the risk of developing vitamin D 
deficiency can be attributed to the contribution of numerous environmental, 
physiological and lifestyle characteristics (Ginde, Liu, & Camargo, 2009; 
Thuesen et al., 2012). Since an estimated 80 % of the contribution to vitamin 
D status is ideally meant to come from UVB radiation from sunlight exposure, 
it must be considered that in countries lacking prevalent sunlight, such as 
Scotland, strategies to reduce vitamin D deficiency must focus on other 
modifiable determinants of vitamin D status. The recommendation to increase 
sunlight exposure, is not only not possible during winter months, but may carry 
dangers, such as increased risk of skin cancer. Therefore, it is important to 
identify determinants that can potentially be modified in order to reduce 
deficiency, especially in countries of high latitude with drastic seasonal 
variations. Identifying other potential determinants of vitamin D status can also 
assist in suitable recommendations to increase vitamin D levels. Many 
determinants of vitamin D status are (or can be) modifiable factors, such as 
UVB exposure, diet, physical activity levels, and body composition, therefore 
there is scope for altering lifestyle or behaviour in order to preserve or increase 
vitamin D status and metabolism.  
 
2.4.1.1 Supplementation with vitamin D 
It has been demonstrated through numerous studies, systematically reviewed, 
that oral vitamin D supplementation successfully increases systemic 25(OH)D3 
concentration (Autier et al., 2012). This is a result also found in our own 
laboratory (Lithgow, Florida-James, & Leggate, 2018). Contributing to dietary 
intake with vitamin D supplements, most commonly cholecalciferol, is an 
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effective strategy to increase vitamin D status. Depending on the dose, 
25(OH)D3 concentration can rise to the level associated with sufficiency. 
Vitamin D can be supplemented in two forms: vitamin D2 or vitamin D3, 
although it has been reported that vitamin D3 supplementation increases 
serum 25(OH)D concentration more effectively than vitamin D2, by as much as 
70 % more (Nimitphong et al., 2013; Trang et al., 1998). However, although 
sufficiency is associated with the health benefits discussed at the beginning of 
this review, simply raising vitamin D status does not necessarily directly 
influence the driving force for health benefits.  
Cashman et al. (2008) have proposed a vitamin D intake of 7.2-41.1 µg/day to 
ensure maintenance of vitamin D status in adults (aged 20-40 years). The 
current intake of vitamin D in adults in Europe is 2.3-7.1 µg/day, therefore 
below requirements and recommendations (Spiro & Buttriss, 2014). Data 
solely on the intake of vitamin D supplements of the population is not known, 
although it is reported that 34.6 (male) – 46.9 % (female) of the UK population 
consume dietary supplements (including all vitamins, minerals, and oil-based 
supplements) (Skeie et al., 2009). The Endocrine Society suggest that a daily 
dose of 1500-2000 IU/day or more may be required to elevate blood 25(OH)D 
concentration above 30 ng·ml-1 (Holick et al., 2011). The IOM have 
recommended an upper level tolerable intake of 4000 IU/day to prevent any 
associated harm or risk from potentially excessive or high vitamin D 
consumption (G. Jones, 2008). A serious risk of vitamin D toxicity is 
hypercalcaemia, which can lead to vascular and tissue calcification and 
subsequent damage to blood vessels, the heart, and the kidneys (Tebben, 
Singh, & Kumar, 2016). Several systematic reviews have been published 
concerning and evaluating the influence of vitamin D supplementation on 
circulating 25(OH)D levels (Autier et al., 2012; Zittermann, Ernst, Gummert, & 
Borgermann, 2014). Although supplementation is effective at achieving an 
elevated 25(OH)D concentration, the absolute between-study variation in 
circulating concentration induced by similar doses, demonstrates the inter-
individual variation in absorption and metabolism of cholecalciferol. As 
discussed in this review, the orchestration of the metabolic pathway that 
supersedes the established circulating 25(OH)D level, is complicated and 
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dependent on many factors, therefore the scope for inter-individual and inter-
study variation is high. As a result, a ‘one size fits all’ approach for 
recommending or prescribing a supplementation dose may not be a practical 
method to guarantee a vitamin D status in the adequate range for all 
individuals.  
 
2.4.1.2 Physical activity status 
It is widely recognised that regular physical activity can provide health benefits 
in all ages. Living an active lifestyle predominantly reduces the healthcare 
burden and promotes healthy ageing, primarily through preventing or delaying 
the onset of non-communicable diseases and maintaining musculoskeletal 
health. The current physical activity guidelines set by the UK Government 
Department of Health ("Physical activity guidelines for adults (19-64 years)," 
2011), recommend a minimum of 150 mins/week of moderate intensity 
exercise, or 75 mins/week of vigorous exercise, in combination with resistance 
exercises (recruiting each major muscle group) on 2-3 days/week, and 
flexibility and strength exercise training on 2-3 days/week, in order to maintain 
or achieve optimal cardiorespiratory and musculoskeletal health. It should be 
noted that the more specific recommendations for exercise prescription are 
dependent on age, and not all intricacies of optimal frequency and intensity 
have been determined yet. However, data from the World Health Organisation 
(WHO) global health observatory data repository in 2012 estimates that 
worldwide, 31.1 % of adults are physically inactive, determined from self-
reported and monitored physical activity data, and thus are not meeting the 
recommended guidelines (Hallal et al., 2012). In Scotland, 36 % of the adult 
population are not meeting the recommended physical activity guidelines (The 
Scottish Health Survey, 2017). Furthermore, physical activity levels have been 
reported to decline with age, assessed through objectively measured physical 
activity (hip-worn accelerometers), with only 85-90 % of older adults aged 70 
years and above in Scotland achieving the recommended activity 
requirements (Jefferis et al., 2014). Although it is ideal to measure physical 
activity levels with both subjective (self-reported) and objective (monitored via 
accelerometers) measures, the cut off points used to define moderate to 
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vigorous physical activity can differ between studies. Some studies use age-
appropriate cut off points, which will influence the reported percentage of the 
population that achieve the guidelines.  
Physical activity is related to circulating plasma/serum 25(OH)D, with higher 
self-reported activity linked with higher concentrations of 25(OH)D, reported in 
the established third National Health and Nutrition Examination Survey 
(NHANES III), as well as in other studies (Jacques et al., 1997; Lucas et al., 
2005; Scragg & Camargo, 2008; Scragg, Holdaway, Jackson, & Lim, 1992; 
Scragg et al., 1995). Physical inactivity has also been reported to be a 
modifiable predictor of low vitamin D status in healthy middle-aged men and 
women in the United States of America (USA) (K. Brock et al., 2010). This has 
been attributed to increased sunlight exposure due to the nature of physical 
activity often occurring outdoors (Kluczynski et al., 2011). However, an 
investigation in the USA measuring both indoor and outdoor activity 
demonstrated that the relationship with vitamin D status is not stronger for self-
reported outdoor activity compared to indoor activity (Wanner, Richard, Martin, 
Linseisen, & Rohrmann, 2015). Moreover, it was hypothesised that active 
people are usually active both indoors and outdoors. In support of this, 
investigations in the USA, Finland, and France where both exposure to UV 
radiation and physical activity were measured, it has been reported that the 
relationship between vigorous activity and vitamin D status persists when 
adjusting for UV exposure (K. Brock et al., 2010; K. E. Brock et al., 2010; 
Touvier et al., 2015). Similarly, age- and UV exposure-adjusted 25(OH)D 
concentrations in a USA population are associated with recreational physical 
activity, with season accounting for much of the observed activity-25(OH)D 
associations (Kluczynski et al., 2011). Taken together, these data suggest that 
physical activity and exercise may play a role in vitamin D metabolism 
regulation independent of sunlight exposure. However, self-reported physical 
activity measures should be interpreted with caution, as the scope for error is 
usually higher than objective measures, particularly for physical activity. This 
may disrupt the true association between physical activity status and vitamin 
D concentrations.  
27 
 
Low serum 25(OH)D has also been associated with poorer physical 
performance, particularly among an older population (Wicherts et al., 2007). 
This may suggest that either physical performance is linked to outdoor activity 
behaviours and thus an increase in potential UVB radiation, or that vitamin D 
has a role in the musculoskeletal system, therefore potential to improve 
physical capacity.  
However, there is conflicting evidence surrounding the link between physical 
activity levels and the influence on vitamin D status. Serum vitamin D levels 
have been reported not to differ between physically active and inactive female 
health care workers (Lehnert et al., 2018). Although baseline 25(OH)D 
concentrations were relatively low (n=67, median of 20 ng·ml-1), they were 
unaffected by activity level, but were affected by season (Germany - 50°N 
latitude, therefore similar to Scotland: 55°-59° North). Therefore, the direct 
relationship between physical activity levels and vitamin D status may not 
stand when adjusted for confounding factors such as latitude and season.  
 
2.4.1.2.1 Influence of seasonality on physical activity levels 
Natural environmental factors, such as seasonality (Leger-Guist'hau et al., 
2016) and weather conditions, have been shown to influence physical activity 
behaviours, specifically day length, precipitation level, and temperature. The 
unpredictable weather in Scotland, marks it as a country for unpredictable 
physical activity engagement, especially if the particular activity is outdoors-
specific or associated with outdoors, i.e. hiking. If the winter months restrict 
outdoor activity, activities may be less accessible and thus require facilities 
such as a gym. Therefore, physical activity status becomes dependent on 
available funds to access such facilities. In addition, it was found that after 
controlling for individual characteristics, closer proximity and more accessible 
exercise facilities were associated with increased frequency of physical activity 
and exercise (Sallis et al., 1990). Furthermore, day length plays a similar role 
in that it can restrict outdoor activity, influenced by seasonality.  
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2.4.1.3 Body composition 
Total body fat percentage and body mass index (BMI) has been inversely 
associated with serum 25(OH)D concentrations in older persons aged 55-74 
years (K. Brock et al., 2010) and 65 years and older (Oliai Araghi et al., 2015), 
suggesting obesity is a risk factor for vitamin D deficiency. The association 
between vitamin D concentration and fat mass is attributable to the fat-soluble 
property of Vitamin D. If adipocytes sequester systemic vitamin D at a rate that 
exceeds the rate of synthesis of vitamin D, this renders the body as a whole 
deprived of vitamin D (Bolland, Grey, Ames, Mason, et al., 2007; Wortsman et 
al., 2000). It has been proposed that there is an increase in catabolism of 
vitamin D in adipose tissue (Wortsman et al., 2000). Another mechanism by 
which high body mass is associated with lower 25(OH)D concentration, is a 
greater tissue volume within which vitamin D metabolites are distributed, 
successively affecting measured systemic concentrations: suggesting a 
dilutional model (Drincic, Armas, Van Diest, & Heaney, 2012). The latter 
investigation demonstrated that the type of adiposity accounts for the 
relationship between body mass and 25(OH)D concentration, specifically 
visceral adiposity. A higher body fat percentage has been inversely associated 
with vitamin D status in an older population aged 70.5 ± 5.9 years (Vitezova et 
al., 2016). This was reported from data taken from the Rotterdam study: an 
ongoing prospective population-based follow-up study comprising of people 
aged ≥ 45 years in the Netherlands. They found an association between 
25(OH)D and android fat but not with gynoid fat, even though it was not 
independent of BMI. This coincides with findings of another investigation into 
the relationship between vitamin D status and fat distribution, where 25(OH)D 
was inversely associated with all regions of fat mass, but positively associated 
with fat-free mass (Moschonis et al., 2009). Although, this represents the 
findings of an overweight postmenopausal health study, and thus differs to the 
ageing population in the Rotterdam Study.  
Adipocytes have been found to express the VDR and CYP27B1, which is 
needed for the production of 1,25(OH)2D3, suggesting a contribution of fat 
mass to vitamin D metabolism (Wamberg et al., 2013). In addition, 
1,25(OH)2D3 has been linked to the inhibition of the expression of genes 
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involved in the genesis of adipocytes (Kong & Li, 2006). Although these were 
reported from in vitro studies, it suggests a negative feedback loop is 
associated with excess fat mass accumulation.  
Lean mass also contributes to vitamin D status and metabolism, with growing 
evidence demonstrating the prevalence of the VDR in skeletal muscle tissue 
thus mediating the vitamin D endocrine system (Bischoff et al., 2001). Despite 
the contribution of fat mass to overall BMI, which is known to sequester 
25(OH)D3, the quantity of lean mass may be just as important when 
considering the effects of body composition on vitamin D metabolism. 
Myocytes have a role in the orchestration of vitamin D bioavailability since 
myocytes have been found to store and protect vitamin D (Abboud et al., 2014; 
Abboud et al., 2013). Murine skeletal muscle cells have been found to act as 
a functional extravascular store of 25(OH)D that can uptake and release it back 
into the circulation, thereby preventing it from degradation (Abboud et al., 
2013). Muscle tissue/mass loss is reported as a prominent feature of the 
clinical syndrome of vitamin D deficiency, with age-related decline in muscle 
mass, known as dynapenia, also associated with reduced VDR expression 
(Bischoff-Ferrari, Borchers, et al., 2004). The rate of loss of muscle mass with 
age has been summarised from literature and reported as 4.7 % in men and 
3.7 % in women per decade (Mitchell et al., 2012). Therefore, a loss of muscle 
mass can directly impact the myocyte stores of vitamin D, and thus the 
capacity of extravascular stores to contribute to vitamin D status.  
Low concentrations of 25(OH)D3 have also been associated with numerous 
obesity-related disorders, such as diabetes, cardiovascular disease, and 
metabolic syndrome (Chowdhury et al., 2014; Holick, 2007). Although, the 
more classic role of vitamin D is in maintaining bone health, with an elevated 
vitamin D status linked to improvements in BMD and muscle mass and 
strength (Bartoszewska, Kamboj, & Patel, 2010). BMD is associated with 
numerous metabolic bone disorders, such as osteoporosis, and is dependent 
on the presence of adequate vitamin D to avoid depletion (Mezquita-Raya et 
al., 2001). A positive association between 25(OH)D concentration and (hip) 
BMD was observed in both young (34.8 ± 8.1 years) and older (69.0 ± 10.9 
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years) white adults (Bischoff-Ferrari, Dietrich, Orav, & Dawson-Hughes, 2004). 
This finding was found regardless of ethnicity/race and sex.  
It has been reported that vitamin D insufficiency is associated with reduced 
spinal BMD but not with lower limb BMD (Mezquita-Raya et al., 2001), 
hypothesising that lower limb BMD is also maintained through other factors 
such as higher mechanical use (physical activity and exercise) of lower limbs. 
If physical activity status influences BMD, with premise that it may be through 
the vitamin D metabolic pathway, improvements in bone health may be 
stimulated via mechanical stress, i.e. an exercise bout.  
 
2.4.1.4 Race and ethnicity 
Race/ethnicity has been found to influence vitamin D metabolism, with a lower 
vitamin D status in black people than white people (Ginde, Liu, et al., 2009; 
Holick et al., 2011; Powe et al., 2013). Skin colour and pigmentation may 
explain the variation in vitamin D status, due to differential UV exposure and 
cultural behaviours. Melanin in the skin acts as a natural barrier to the UV light, 
affecting the cutaneous production of vitamin D3 (Holick, MacLaughlin, & 
Doppelt, 1981). An investigation by Powe et al. (2013) also reported a lower 
concentration of circulating vitamin DBP in black people compared to white 
people, suggesting a reduced capacity to transport vitamin D in the circulation. 
Additionally, combined with previous data (Powe et al., 2011), they also 
reported black people to exhibit a higher BMD than white people, however, 
vitamin D status did not differ between races. These data suggest that low total 
25(OH)D concentrations do not uniformly indicate vitamin D deficiency, 
supporting the notion that the entire metabolic pathway from 25(OH)D to 
cellular action should be considered.  
 
2.5 The role of ageing 
2.5.1 Ageing and physical activity status 
It is well established that physical activity and exercise are key components in 
the management of many chronic disease associated with ageing. Activity 
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levels decline with advancing age (Sallis, 2000), reported to be attributable to 
a variety of factors and barriers to engagement in exercise: possibly 
environmental, psychological, or biological factors (Schutzer & Graves, 2004). 
Participation in leisure time activities in Scotland declines with increasing age 
with many deterrents identified, such as lack of interest and physical symptoms 
(Crombie et al., 2004). Given the extending life expectancy in the UK, thus 
expanding the proportion of older adults, the suboptimal physical activity status 
of all adults presents a public health concern. Maintaining sufficient physical 
activity levels throughout life, particularly when entering older adult age and 
onwards (60 + y) may attenuate or delay the onset of chronic diseases and 
health complications. Physical inactivity may also shorten life expectancy, 
suggesting a substantial impact of a physically inactive lifestyle on the 
development of the world’s major non-communicable diseases, such as 
cardiovascular disease, coronary heart disease, and diabetes. The Lancet 
Physical activity Working Group reported that physical inactivity is responsible 
for between 6 % and 10 % of the burden of these diseases, varying between 
countries, and increasing activity status could extend life expectancy (Lee et 
al., 2013). It is therefore crucial to maintain a healthy active lifestyle as age 
advances in order to prevent or delay the onset of health issues. In addition, 
an active lifestyle helps to preserve functional ability across the lifespan, 
improving quality of life and independence, particularly amongst the older adult 
population (McPhee et al., 2016).  
An investigation in a large older adult population (n=2621; 55-74 y) across the 
USA has found that a low vitamin D status is correlated with a low physical 
activity status, a higher BMI, and poor dietary vitamin D and calcium intake (K. 
Brock et al., 2010). Consistent with other studies, vigorous physical activity has 
been identified as a modifiable predictor of 25(OH)D concentration in 
numerous countries (K. Brock et al., 2010; K. E. Brock et al., 2010; Scragg & 
Camargo, 2008; van Dam et al., 2007). The relationship between physical 
activity status and vitamin D status has been attributed to UV exposure, since 
many physical activities and sports are outdoors. However, there has also 
been reports that mechanical stress alters vitamin D metabolites and vitamin 
D cell signalling pathways (Aly et al., 2016; Makanae et al., 2015), therefore 
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physical activity may influence vitamin D status through multiple routes as 
opposed to solely UV exposure.  
If regular physical activity is associated with vitamin D status, and ageing is 
linked to a decline in both physical activity status and vitamin D status, it can 
be hypothesised that maintaining a physically active lifestyle may influence 
25(OH)D concentrations. Therefore, identifying predictors of reduced vitamin 
D status, such as physical inactivity or lack of mechanical stress, is important 
to develop health interventions to potentially increase 25(OH)D3 or augment 
the efficiency of the metabolic pathway.  
 
2.5.2 Ageing and vitamin D metabolism 
Vitamin D concentrations are inversely associated with advancing age 
(Chapuy et al., 1983; Chapuy et al., 1997; Jacques et al., 1997), this is largely 
due to low UVB exposure (Thomas et al., 1998) and low dietary vitamin D 
intake (Lips, 2010). In an older population there also appears to be a decline 
in cutaneous synthesis of pre-vitamin D (Holick & Chen, 2008; MacLaughlin & 
Holick, 1985). Advancing age has been reported to inversely affect the 
concentration of the pre-cursor 7-dehydrocholesterol in the epidermis, with 
exposure to UV radiation increasing 7-dehydrocholesterol and pre-vitamin D3 
in the epidermis and dermis, respectively, largely dependent on age 
(MacLaughlin & Holick, 1985). This suggests that age affects the cutaneous 
capacity for the initial metabolic conversion in the vitamin D pathway: 7-
dehydrocholesterol into pre-vitamin D. In addition, the ability of the gut to 
absorb cholecalciferol declines with age (Barragry et al., 1978).  
It appears that the relationship between stimulation of a cell and alterations in 
vitamin D metabolism may be tissue specific, which would coincide with the 
local processing of vitamin D metabolites that has been demonstrated in 
several studies. Likewise, specific cells may participate in vitamin D 
metabolism in response to stimulations. For example, it has been 
demonstrated that T cells are targets of 1,25(OH)2D3 and accommodate 
vitamin D metabolism (Baeke, Korf, et al., 2010; Cantorna, 2011). It has also 
been discovered that in addition to immune cells, other cells such as human 
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marrow stromal cells, have the molecular machinery and capacity to 
enzymatically convert 25(OH)D3 to 1,25(OH)2D3 by the action of CYP27B1 
(Zhou, LeBoff, & Glowacki, 2010). Skeletal muscle cells express VDR, with 
alterations in the concentration of VDR after administration of 1,25(OH)2D3 
(Garcia et al., 2011), although the exact mechanisms and signalling of VDR-
mediated vitamin D action in human skeletal muscle is not well established. 
The level of expression of CYP27B1 also correlated to the vitamin D status of 
the clinical deficient population group. This may suggest that cell-localised 
metabolism may influence whole body metabolism, or that an elevated vitamin 
D status is associated with or mediates cellular metabolism. The previous 
study was unpowered and thus age-related changes were not assessed. 
However, in a follow up study, the research group investigated the effect of 
age (young, n=12: ≤ 50 y; older, n=15: ≥ 55 y) on the expression and activity 
of CYP27B1 in this cell type and reported an inverse correlation between 
CYP27B1 expression and age (Geng, Zhou, & Glowacki, 2011). However, they 
also observed a similar expression of the VDR in the young and older cells, 
contrasting with other findings in different cell types, including skeletal muscle 
tissue (Bischoff-Ferrari, Borchers, et al., 2004). Therefore, the responsiveness 
of cells to vitamin D or stimulation to then alter vitamin D metabolism may be 
dependent on age, although there is not a consensus based on current 
published literature.  
Expression of the VDR in skeletal muscle tissue has been reported to decline 
with age (Bischoff-Ferrari, Borchers, et al., 2004; R. U. Simpson et al., 1985). 
In the investigation by Bischoff-Ferrari et al. (2004), circulating blood and 
skeletal muscle tissue samples were taken from female patients undergoing 
hip and spinal surgery (71.6 ± 14.5 y verses 55.2 ± 19.6 y, respectively): serum 
samples were analysed for 25(OH)D3 and 1,25(OH)2D3 concentration, and the 
myocytes were cultured and subsequently analysed for VDR-positive nuclei. 
They reported that younger cultured myocytes expressed more VDR than 
older myocytes, possibly attributable to a reduction in the functional response 
of cells to 1,25(OH)2D3 in an older cohort, or the observed decrease in 
25(OH)D3, reported with age (Jacques et al., 1997; Lips, 2010). This may lead 
to a decrease in the expression of the VDR due to reduced stimulation of the 
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receptor by 1,25(OH)2D3 and thus an ultimate down-regulation of the VDR 
present intracellularly. However, no relationship between 25(OH)D and 
1,25(OH)2D3 and VDR expression was shown.  
Conversely, other reports have demonstrated no age-dependent change in 
peripheral cell VDR gene expression, through correlation and linear regression 
analysis (Coleman et al., 2016). However, this study was restricted to an older 
age range (50-69 y and ≥70 y, n=20 in each group) and thus not comparing 
relatively young to relatively old. The contradicting findings between studies 
may be because regulation of expression of VDR is tissue or cell specific, or 
how intracellular VDR was quantified. In the study by Bischoff et al. (2004), 
VDR protein concentration was measured, whereas Coleman et al. (2016) 
analysed VDR mRNA expression, which may not be representative of protein 
expression. Within a cell, the concentrations of proteins is not proportional to 
the levels of corresponding mRNA, although the mRNA expression indicates 
the rate at which proteins may be produced. Therefore, measuring mRNA 
expression of VDR will provide insight into the rate of production of VDR, but 
not specifically the available receptors to receive the ligand 1,25(OH)2D3 and 
subsequently feed VDR-induced transcription and translation of other proteins 
associated with disease. Although, VDR mRNA may not be increased just 
because there are receptor-ligand complexes acting on the VDRE. It may be 
the case that the transcriptional machinery induces gene expression of other 
proteins and not those required to produce VDR proteins. It has also been 
hypothesised that this post-transcriptional regulation of expression can be 
affected by ageing (Coleman et al., 2016).  
All components of the vitamin D pathway can be affected by age, including the 
availability of the DBP and the availability and activation status of the nuclear 
co-regulators. There is little evidence of the expression of the DBP with 
advanced age, however the limited current reports are controversial, either 
demonstrating the expression to be compromised by ageing or showing no 
significant relationship (Bolland, Grey, Ames, Horne, et al., 2007).  
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2.6 The role of exercise on vitamin D metabolism 
2.6.1 Exercise and vitamin D 
Recent research has focussed on the effect of vitamin D supplementation on 
physical performance and/or in combination with exercise interventions (Close 
et al., 2013; Lithgow et al., 2018; Owens et al., 2015), in athletes, overweight 
individuals, and in clinical populations at risk of falls and fractures (Latham et 
al., 2003). Owens et al. (2015) reported 6 weeks of supplemental vitamin D3 
(4,000 IU/day) to increase serum 25(OH)D and improve skeletal muscle 
regeneration post-exercise in human males (n=20). Close et al. (2013) 
documented that 6 and 12 weeks of weekly vitamin D3 supplementation 
(20,000 or 40,000 IU/day) increased serum 25(OH)D concentrations in all club-
level athletes (n=30) but did not induce any alterations in measures of muscle 
function and physical performance (bench press, leg press, and vertical jump 
height). Similarly, our previous investigations (Lithgow et al., 2018) 
demonstrated that supplementing with vitamin D3 (4,000 IU/day) over a 6 week 
period elevates 25(OH)D concentrations (n=20). However, the supplemental 
course in combination with high intensity intermittent training (HIIT) did not 
provide any additional improvements in measures of performance (V̇O2max 
test) compared to the consumption of a placebo. Alongside these mixed 
findings, other investigation have reported that 24 weeks of vitamin D 
supplementation (800 IU per day) does not affect physical performance in 
older persons (n=59) (Vaes et al., 2018), and vitamin D deficiency is not linked 
to reduced performance in young persons (n=80) (Dubnov-Raz, Livne, Raz, 
Cohen, & Constantini, 2015). These data may suggest that a cross-over exists 
between vitamin D and physical activity and exercise, but the conclusions 
remain inconclusive.  
Studies have indicated that mechanical stress can alter the expression and 
action of key vitamin D metabolites: 25(OH)D3, 1,25(OH)2D3 and the VDR (Aly 
et al., 2016; M. Li, Li, Meikle, Islam, & Cao, 2013; Makanae et al., 2015; Sun 
et al., 2017). Key vitamin D metabolites have been reported to be present in 
skeletal muscle cells, with the capacity to locally metabolise 25(OH)D to 
1,25(OH)2D3 via CYP27B1. The ligand may then form a complex with VDR in 
the myocyte to elicit vitamin D-induced changes in transcription, or the 
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myocyte may release 1,25(OH)2D3 back into the circulation to be transported 
by DBP to a different type of cell, focussed on a different target outcome. There 
is data to support the uptake of 25(OH)D into skeletal muscle cells, murine 
model, where it is held by the DBP (Abboud et al., 2013). They suggest that 
although DBP is primarily a circulatory protein binding nearly all of 25(OH)D in 
blood, the DBP has a high affinity for actin in skeletal muscle. Following uptake, 
the 25(OH)D remains bound to DBP, which crosses the membrane via low 
density lipoprotein-related protein 2 (LRP2), known as megalin, and is retained 
by binding to actin. As a result, the residence time of 25(OH)D in the blood has 
been reported to differ based on physical activity status, with a higher half-life 
of 25(OH)D in exercised mice (25 days) compared to non-exercised mice (23 
days) (Abboud et al., 2013). This suggests that exercise may play a role in 
prolonging the maintenance of vitamin D status.  
It has been demonstrated that serum 25(OH)D concentrations can increase 
after a single bout of continuous aerobic exercise (30 min cycling at 70% 
V̇O2max) in a young adult cohort (Sun et al., 2017). Although, previous reports 
have also found no alterations of 25(OH)D concentrations in response to a 
single bout of exercise (a standard walking V̇O2max test) in young adults 
(Maimoun et al., 2009), and a slight, but significant, decrease in 25(OH)D 
concentration following a maximal walking incremental exercise test in an older 
adult population (Maimoun et al., 2005). The latter study reported disturbances 
in calcium homeostasis in active older males and females (73.3 ± 9.1 years). 
Since calcium and vitamin D are co-regulators, changes in calcium regulation 
can directly influence vitamin D metabolic intercellular signalling pathways. 
Concentrations of ionised serum calcium and 25(OH)D decreased after 
exercise compared to pre-exercise, however 1,25(OH)2D3 remained 
unchanged. If VDR expression is increased and no change in systemic 
1,25(OH)2D3 concentration is observed, it may be hypothesised that the renal 
conversion of 25(OH)D3 to 1,25(OH)2D3 increases simultaneous to an 
increased cellular uptake of 1,25(OH)2D3 and thus the efficiency of binding to 
VDR. This may result in no change in 1,25(OH)2D3, however this is speculative 
and must be explored in response to exercise.  
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Although circulating 25(OH)D concentration is used as the biomarker for 
vitamin D status, it is the VDR that provides the functional platform for vitamin 
D-induced alterations in gene transcription (Haussler et al., 1998). In a recent 
investigation, an acute bout of resistance exercise (isometric exercise – 5 sets 
of 10 x 3 second (s) contractions, with 7 s intervals between repetitions and 3 
min rest intervals between sets) has been reported to increase VDR protein 
expression in rat skeletal muscle, although there was no accompanying 
increase in 25(OH)D3 concentration (Makanae et al., 2015). This study 
compared two modes of exercise, resistance and endurance, although there 
was no reported change in VDR expression in response to the endurance 
exercise bout (60 min running at a speed corresponding approximately to 
lactate threshold). Interestingly, CYP27B1 expression also increased, again 
this was only following the resistance exercise bout and not the endurance 
exercise bout. However, a limitation of the study is that 1,25(OH)2D3 was not 
measured and thus restricts understanding of what phase of the metabolic 
pathway is less efficient in response to exercise. Furthermore, no change in 
VDR expression was observed following the endurance exercise bout, 
indicating that the response is specific to muscle fibre type recruitment and 
contraction and greater mechanical stress. Therefore, mechanical stress may 
affect skeletal muscle tissue metabolism in contracting muscles but not resting 
muscles. It was hypothesised that local metabolism occurred within skeletal 
muscle, which did not contribute to whole body 25(OH)D3 status. It should be 
noted that the resistance exercise bout involved maximal involuntary 
contractions in rats, and thus the outcome may not be comparable to voluntary 
contractions, which would be measured in humans.  
Recent investigative findings support the hypothesis that vitamin D has a direct 
positive effect on skeletal muscle metabolism. It has been found that skeletal 
myocytes express VDR (Bischoff et al., 2001), and moreover, vitamin D 
signalling has been found to alter muscle protein synthesis (Girgis et al., 2013; 
Girgis, Clifton-Bligh, Mokbel, Cheng, & Gunton, 2014). However, the vice 
versa relationship, that skeletal muscle contraction has a direct effect on 
vitamin D metabolism, has only been investigated in the rat model by Makanae 
et al. (2015).  
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In an investigation into the combined effect of vitamin D supplementation and 
regular resistance training for 12 weeks on skeletal muscle function, it was 
reported that vitamin D intake did not change VDR mRNA expression 
(Agergaard et al., 2015). This was regardless of age, with a comparison 
between young (20-30 y) and older (60-75 y) healthy untrained adults. 
Furthermore, the CYP27B1 expression was decreased in the older adult 
vitamin D supplementation group post-training intervention. Although an 
increase in this key enzyme may be beneficial, as it converts 25(OH)D3 to 
1,25(OH)2D3, a negative feedback mechanism may exist. In the presence of a 
high circulating concentration of the active form, there is a lessened 
requirement of the enzymatic activity of CYP27B1, and thus a reduction in the 
availability of the converting enzyme. In addition, the authors reported an 
improvement in muscle quality and fibre type morphology in the older adult 
cohort, suggesting an effect of vitamin D on skeletal muscle modelling. 
However, the mechanisms were not explored.  
It must be considered whether the relationship between exercise and vitamin 
D is association or causation. It has been hypothesised that possible 
explanations are: those with a high vitamin D status have a greater capacity 
for exercise, or that exercise can raise systemic 25(OH)D3 concentration 
(Birrell & Francis, 2008). There is an argument that regular exercise may 
increase 25(OH)D3 concentration because of the outdoor nature of many 
exercises and sports thus increasing potential opportunity for sunlight 
exposure. However, the investigations into the effects of exercise on vitamin 
D metabolism are usually performed indoors in laboratories with no exposure 
to UV light and thus eliminates the possible contribution of skin synthesis of 
vitamin D3. Therefore, the second explanation seems plausible based on the 
literature discussed, as the observed effects of exercise to alter vitamin D 
metabolism are stratified by the mechanical intervention or stimulation (Aly et 
al., 2016; Makanae et al., 2015; Sun et al., 2017). Moreover, the acute UV 
exposure from performing exercise outdoors will not immediately raise 
25(OH)D concentration, as this is a gradual elevation over time with regular 
exposure necessary. Therefore, investigations into the effect of acute exercise, 
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whether performed indoors or outdoors should be unaffected by the short-term 
exposure to UVB rays.  
Furthermore, the current literature involves rat model investigations and thus 
are not wholly applicable to the human physiological environment. There is a 
requirement for investigations into the effects of mechanical stress in the form 
of physical activity and/or exercise on vitamin D metabolites in a human 
population.  
 
2.6.2 Vitamin D metabolism in immune cells 
Expression of the VDR has been identified in a variety of cells of the immune 
system including macrophages, T lymphocytes, dendritic cells and monocytes 
(Laird et al., 2014). Naive T cells have the potential to orchestrate and 
determine the nature of immune and inflammatory responses, and with the 
presence of VDRs in activated T cells (Joseph et al., 2012), this proposes 
additional mechanisms for 1,25(OH)2D3 and VDR to directly regulate T cell 
responses (Cantorna, 2011). Moreover, activation of the VDR has the capacity 
to alter transcription, proliferation, and differentiation of immune cells (Adorini 
& Penna, 2008). This role in the immune system is linked to risk of infections 
and risk of developing autoimmune diseases, such as Crohn’s disease, 
Multiple Sclerosis, and diabetes mellitus (Yin & Agrawal, 2014). Vitamin D has 
been reported to have a potential protective effect on autoimmune diseases 
and immune suppression, with reports that 1,25(OH)2D3 triggers non-classical 
immunomodulatory responses (J. S. Adams & Hewison, 2008; Baeke, van 
Etten, Gysemans, Overbergh, & Mathieu, 2008). The literature reports 
contradictory results on the expression of the VDR in T cells, with some studies 
demonstrating that only stimulated T cells express VDR (Bhalla et al., 1983; 
Kongsbak, von Essen, Boding, et al., 2014), and others reporting unstimulated 
T cells express VDR (Veldman, Cantorna, & DeLuca, 2000) but at lower levels 
(Correale, Ysrraelit, & Gaitan, 2009). The latter investigation reported 
1,25(OH)2D3 to increase VDR expression in both inactive and activated T cells, 
indicating a role of vitamin D in T cell homeostasis independent of 
environment/stimuli. The contradictory findings may be explained by the 
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different subpopulations of T cells studied and the different methods for 
detection of the VDR: Western Blot, flow cytometry, or enzyme linked immune 
sorbent assay (ELISA), and the specific outcome reported: protein expression 
or mRNA expression.  
In a recent investigation into VDR expression in human T cells, it was reported 
that naïve CD4+ T cells do not express the VDR, however following stimulation, 
activated T cells start to express the VDR, independent of 1,25(OH)2D3 
concentration (Kongsbak, von Essen, Boding, et al., 2014). However, 
increased 1,25(OH)2D3 induced VDR protein expression in activated T cells, 
independent of 25(OH)D3 concentration. Furthermore, 1,25(OH)2D3 can also 
induce a substantial redistribution of intracellular VDR, with a shift in the 
percentage of VDR in the cytoplasm to the nucleus. This is beneficial for the 
formation of the VDR-RXR complex and binding to the VDRE to elicit an 
upregulation or suppression in gene transcription.  
It is well established that the vitamin D metabolic pathway involves two 
hydroxylation reactions, in the liver and kidney, to convert vitamin D into the 
active form. It has been reported that T cells express CYP27B1, the key 
enzyme for the conversion to 1,25(OH)2D3 (Baeke, Korf, et al., 2010; 
Kongsbak, von Essen, Boding, et al., 2014). However, there is debate as to 
whether T cells can convert 25(OH)D3 to 1,25(OH)2D3 in physiological 
environments. Human T cells have been identified as direct targets for 
1,25(OH)2D3, with activation of T cells inducing an increase in VDR expression 
(Baeke, Korf, et al., 2010; Cantorna et al., 2015). Moreover, Correale et al. 
(2009) found that 25(OH)D could be metabolised to 1,25(OH)2D3 in CD4+ T 
cells, representing local metabolism and production of active vitamin D. These 
data suggest there is a local processing of 1,25(OH)2D3, creating a localised 
metabolic mechanism to ultimately induce immunomodulatory actions. It was 
also demonstrated that the timing of delivery and the presence of 1,25(OH)2D3 
to T cells is critical for efficient activation of intracellular VDR signalling 
pathways. However, the latter investigation by Baeke et al. (2010) was an in 
vitro model and thus does not replicate physiological relevant concentrations 
in humans.  
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2.6.2.1 T lymphocytes 
Classically the immune system consists of two systems: innate and adaptive, 
which differ in their functional roles within the body (Rabb, 2002). Although 
born with both systems, the adaptive system comes into play later in life. The 
innate system is natural protection from disease and can be present at very 
short notice to protect from foreign invaders. Whereas the adaptive system has 
the capacity to mount a response to foreign bodies, but requires a change in 
the number or phenotype of B (bone) and T (thymic) cells in order to adapt and 
build an immune defence. The primary lymphocyte subpopulation express 
CD3+ molecules on their cell surface, and either CD4+ or CD8+ molecules, 
which define them as helper T cells (TH) or cytotoxic T cells (TC) cells, 
respectively. Furthermore, CD8+ T cells are affected by age, inducing the 
development of an inverted CD4:CD8 T cell ratio and thus contributing to 
immune incompetence (Effros, Cai, & Linton, 2003). Throughout life, the 
immune system gradually deteriorates causing impairment of its defence 
capability, known as immunosenescence. The innate and adaptive immune 
systems are differently affected by ageing, whereby innate immunity appears 
to be better preserved while adaptive immunity exhibits age-dependent 
depreciation. Age-dependent regression of the thymus, thymic atrophy, 
defined as the loss of thymic mass, induces a decline in the output of naïve T 
cells (Palmer, 2013). Therefore, as age advances fewer T cells are developed 
and exported into the vascular pool (Lazuardi et al., 2005), directly impacting 
on the peripheral naïve T cell repertoire and altering white blood cell subset 
diversity, and thus the cells that are circulated to the target tissues (Aw, Silva, 
& Palmer, 2010; Palmer, 2013). The age-related changes in lymphocyte 
subpopulations appear to have functional consequences. Therefore, 
comparing peripheral blood samples between young and older adults should 
consider the different T cell population and thus the altered expression of 
cellular components, such as metabolites and receptors. For example, a 
smaller peripheral blood T cell pool due to ageing, may transcend into a decline 
in the expression of the VDR.  
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2.6.3 Exercise and immunosenescence 
The beneficial effect of exercise became apparent in the early work of David 
Neiman in the 1990’s who demonstrated that individuals who exercise are at 
less risk of upper respiratory tract infections (URTI) (Nieman, 1994), which are 
a major cause of visits to and treatment from physicians. However, there is a 
hyperbolic relationship between intensity and volume of exercise and the risk 
of URTIs, suggesting that excessive or too intense exercise can be detrimental 
to effective immunity by supressing immune function (Malm, 2006). There are 
both acute and chronic effects of exercise on immune function. In response to 
an acute bout of exercise, one of the major changes that occurs is a change 
in the number of leukocytes (Gleeson & Bishop, 2005; Robson, Blannin, 
Walsh, Castell, & Gleeson, 1999), with a biphasic response induced (Nieman 
et al., 1991). The redeployment of lymphocytes from tissues or the blood 
vessel wall with exercise consists of an initial increase, known as is followed 
by a significant transient drop in lymphocyte number, known as 
lymphocytopenia. Immediately upon cessation of exercise the rise in 
lymphocyte and neutrophil number usually precedes a reduction to below 
baseline levels, creating a pocket period of reduced immune protection, known 
as exercise-induced immunosuppression. This is comprehensively reviewed 
by Gleeson and Bishop (2005).  
Each of the individual cell types respond differently to exercise as they all 
perform different tasks to achieve sound immune function, however it is the 
Natural Killer (NK) cells and the cytotoxic T cells that display the largest 
response (R. J. Simpson, Florida-James, Whyte, & Guy, 2006). Exercise-
induced immunosuppression can also be altered by cytokines, the signalling 
molecules of the immune system. Circulating concentrations of cytokines have 
numerous responsibilities and roles in the inflammatory profile and protection 
against pathogens, directly and indirectly.  
Ageing is recognised to strongly affect the redeployment of lymphocytes with 
particular subsets not mobilised in the bloodstream: although the relative 
numbers of T cells are similar between young and old, it is the absolute 
numbers that change. The process of age-associated deterioration of immune 
cells and thus the operation of the system, is referred to as 
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immunosenescence (Castle, 2000). This causes a rise in senescent T cells 
that are mobilised and thus circulate around the body unable to play an efficient 
role in immune function and protection (R. J. Simpson et al., 2012). This age-
related accumulation of senescent T cells lowers the naïve T cell stock and 
can increase host infection risk. This is also due to older individuals having 
less naïve and low differentiated cells in the circulation and peripheral tissues 
for redeployment (Provinciali, Moresi, Donnini, & Lisa, 2009). Exercise can 
potentially override the age-related impairments in T cell subset redeployment, 
specifically CD8+ T cells (Spielmann et al., 2014), as aerobic fitness level, 
achieved through regular exercise, is inversely associated with the proportion 
of senescent T cells, with the relationship withstanding adjustment for age 
(Spielmann et al., 2011). Regular exercise therefore appears to alleviate some 
of the deleterious effect of ageing on the immune system.  
Programmed cell death, or apoptosis, is an important mechanism in the 
mediation of the immune response, serving as a key role in the removal of 
damaged, infected, exhausted or redundant cells. This orchestrated system 
then allows for alterations in the proportion of cells that make up the 
bloodstream repertoire of T cells. Acute bouts of exercise have been shown to 
induce increases in both senescent and naïve T cells and elevate apoptotic 
lymphocytes (Mooren & Kruger, 2015). Since ageing induces an accumulation 
of senescent T cells, it is imperative for effective immune function to induce 
apoptosis in specific cell types, preferentially the older less functional cells, to 
allow for naïve T cells to be exported into the circulation, favourably altering 
the bloodstream repertoire. Exercise has been associated with an increase in 
apoptotic cells, although the mechanisms are not yet fully understood. In 
addition, despite the modality of exercise, there is no evidence to suggest that 
lymphocyte-apoptosis contributes to exercise-induced lymphocytopenia (R. J. 
Simpson, Florida-James, Whyte, et al., 2007).  
In summary, immunosenescence contributes to increased susceptibility to 
acute and chronic conditions placing the ageing population at a disadvantage. 
However, exercise can orchestrate a protective effect on immune function 
through phenotypic and functional changes in the T cell component of the 
immune profile.  
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2.6.4 VDR-induced cellular signalling 
There are genomic and non-genomic roles of the secosteroid hormone vitamin 
D and it’s metabolism, specifically through the action of the VDR (Haussler et 
al., 2011). The genomic role in the endocrine system is predominantly through 
the classic binding of the ligand, 1,25(OH)2D3, to its receiving receptor, VDR, 
modulating the transcriptions of genes, which has been discussed earlier in 
this literature review. The non-genomic effects are mediated through 
1,25(OH)2D3, which initiates many biological responses via the VDR, through 
cellular rapid response signalling pathways. This has been reviewed and 
outlined well by Haussler et al. (2011).  
In relation to the occurrence of VDR-mediated cellular signalling responses, 
this has been found to manifest in T cells. Recent data has shown that 
cytoplasmic VDR upregulation is a specific marker of T cell activation (Joseph 
et al., 2012), suggesting that a cooperative mechanistic relationship occurs 
between 1,25(OH)2D3 and T cells. A molecular mechanism proposed is 
through the intracellular extracellular signal-regulated kinase 1/2 (ERK1/2) and 
mitogen-activated protein kinase (MAPK) signalling pathway, with ERK1/2 
phosphorylation transiently induced following activation. Joseph et al. (2012) 
found an association between VDR upregulation and ERK1/2 phosphorylation. 
This relationship was examined given the importance of MAPK signalling in 
human T cell activation. It was suggested that the ERK1/2 pathway plays a 
role in the regulation of VDR, based on the finding that phosphorylation of 
ERK1/2 preceded VDR expression, but only on phospho-ERK1/2 positive 
cells: the T cells had induced phospho-ERK1/2, which was followed by a 
gradual rise in the expression of VDR.  
Another form of stimulation on the ERK/MAPK pathway and the signalling 
proteins is muscle contraction (Kramer & Goodyear, 2007), which may then 
link into vitamin D metabolism. In response to exercise, the ERK/MAPK 
relationship has been shown to be dependent on either exercise intensity, 
muscle fibre type recruitment or rate of contraction. Resistance training but not 
endurance aerobic training has been demonstrated to increase ERK1/2 
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phosphorylation immediately post-exercise, although the effect was 
attenuated at 1 h post-exercise (Makanae et al., 2015). There also appears to 
be different mechanisms underlying the skeletal muscle adaptations to 
exercise with regards to age, with MAPK proteins differentially activated at rest 
and in response to exercise in the skeletal muscle of young and old men 
(Williamson, Gallagher, Harber, Hollon, & Trappe, 2003). Subsequently, this 
may affect intracellular VDR expression and thus key cellular processes, such 
as transcription and translation and thus gene expression.  
There appears to be an exercise modality-dependent relationship between 
muscle contraction and upregulation of intracellular VDR expression, primarily 
demonstrated in skeletal muscle tissue (Makanae et al., 2015; Widegren, 
Wretman, Lionikas, Hedin, & Henriksson, 2000). It has not yet been 
investigated whether this is attributed to exercise intensity or recruitment of 
specific fibre type and metabolic system: aerobic or anaerobic, and thus 
endurance and resistance exercise. In a study investigating the effect of 
25(OH)D supplementation on VDR expression in the two muscle fibre types, it 
was found that an increase in VDR was only observed in type II fibres and not 
type 1 (Ceglia et al., 2013). Therefore, the changes in vitamin metabolism 
response to a stimuli or intervention could be type II specific.  
 
2.7 Summary 
In summary, upon review of the current literature it appears that both the 
vitamin D status and physical activity status of the UK, in particular Scotland, 
is poor and requires attention and action. However, the relationship between 
environment- and behaviour-related measures has not been extensively 
explored, with a particular gap regarding the influence of the ageing process. 
The development of appropriate strategies to correct vitamin D deficiency 
and/or improve the efficiency of vitamin D metabolism are particularly 
important considering the links between low vitamin D levels and the 
prevalence of numerous chronic diseases. Although exercise has been linked 
to alterations in vitamin D status (25(OH)D concentration), active vitamin D 
(1,25(OH)2D3) and cellular VDR expression, the current investigations are 
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limited to murine models or the inclusion solely of the inactive metabolite: 
25(OH)D. Therefore, it is of interest to investigate whether these findings are 
applicable to a human population. If this is the case, as hypothesised, the 
findings could support exercise as a strategic intervention to adopt in order to 
beneficially manipulate vitamin D metabolism.  
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Chapter 3: General Materials and Methods 
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3.1 Ethical approval 
Ethical approval for each study was granted by the School of Applied Sciences 
Research Integrity Approvals Group at Edinburgh Napier University. All 
samples and data were treated and stored in line with the Declaration of 
Helsinki and according to the ‘Edinburgh Napier University Code of Practice 
on Research Integrity October 2013’.  
 
3.2 Study participants 
3.2.1 Vitamin D Status (VDS) study  
The study population comprised of healthy Caucasian males and females, 
aged 60-80 y with a BMI between 18.5-35 kg·m-2 that resided in Scotland at 
the time of testing and had done so for the 6 months prior to initial contact with 
the researcher regarding the study. Participant recruitment numbers and 
methods are displayed in Figure 4. Participants were recruited via posters, 
flyers, magazine advertisement (Konect Magazine), Gumtree, and the use of 
social media (Facebook and Twitter). Edinburgh based groups/committees 
were contacted regarding recruitment, including: Rotary Clubs, the University 
of the Third Age (U3A), Edinburgh Leisure (Ageing Well), the Eric Liddell 
Centre, and the NHS Retirement Fellowship.  
The exclusion criteria excluded persons who regularly use tanning beds or 
undergo UV light therapy, had been on a ‘sun holiday’ in the past 8 weeks, or 
consume vitamin D tablets or any multivitamins containing vitamin D 
(concentration > 10 µg·day-1).  
Six volunteers were excluded based on their assessment of eligibility, due to: 
BMI < 18.5 kg·m-2 (n=1), BMI > 35 kg·m-2 (n=1), and regular consumption of 
vitamin D supplements (n=4).   
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Figure 4 Participant recruitment flow diagram for the Vitamin D Status (VDS) 
study.  
 
3.2.1.1 Power analysis calculation 
An a priori power analysis using GPower software 3.1.9.2 was performed for 
sample size estimation based on a multiple regression analysis (F test) to test 
whether physical activity (number of predictors = 5) predicted 25(OH)D 
concentration. Based off the data in the study by Jacques et al. (1997), it was 
estimated that there would be a small effect size (Cohen’s f - 0.15). The 
projected sample size required for the statistical test was n=89, to achieve 
statistical power >0.95 (α and β error probability – 0.05).  
 
3.2.2 Exercise and Vitamin D (ExVD) study  
The study population comprised of healthy Caucasian males, aged 18-45 and 
60-75 y with a BMI between 18.5-30 kg·m-2 that resided in Scotland at the time 
of testing and had done so for the 6 months prior to initial contact with the 
researcher regarding the study. The recruitment process of participants is 
outlined in Figure 5. Participants were included if they were recreationally 
active according to the moderate-to-vigorous physical activity (MVPA) 
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guidelines, as defined in the UK Physical Activity Guidelines: more than 150 
min of moderate activity per week, or 75 min of vigorous activity per week 
("Physical activity guidelines for adults (19-64 years)," 2011).  
The exclusion criteria excluded persons who have cardiovascular or 
respiratory diseases, autoimmune diseases, diagnosed diabetes, previous 
stroke or cardiac events, chronic or debilitating arthritis, hypertension, use 
tanning beds or undergo UV light therapy, had been on a ‘sun holiday’ in the 
past 8 weeks, or routinely take vitamin D supplements (dose >10 µg/day). If 
blood pressure (BP) was high, defined by the American Heart Association 
(AHA) as systolic BP >140 mmHg or diastolic BP >90 mmHg (Pickering et al., 
2005), participants were excluded from the study and informed to contact their 
General Practitioner (GP).  
Six volunteers were excluded based on their assessment of eligibility, due to: 
BMI > 35 kg·m-2 (n=1), hypertension (n=2), and regular consumption of vitamin 
D supplements (n=3).  
 
 
 
Figure 5 Participant recruitment flow diagram for the Exercise and Vitamin D 
(ExVD) study.  
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Upon inclusion, the participants were separated into three groups based on 
their age: young (18-30 y), young/mid (31-45 y), and older adults (60-75 y).  
 
3.2.2.1 Power analysis calculation 
An a priori power analysis using GPower software 3.1.9.2 was performed for 
sample size estimation based on an ANOVA: repeated measures, within-
between interaction statistical test (F test). The main outcome variable was 
CD3+ T cell VDR expression expressed as fold change. The number of groups 
equals 3 to represent the three age groups within each trial: young, young/mid, 
and older. Number of repeated measurements equals 4 to represent the 4 time 
points: pre-, 0 h, 1 h, and 3 h post-exercise/control. Based off the data in the 
studies by Makanae et al. (2015) and Aly et al. (2016), it was estimated that 
there would be a large effect size (Cohen’s f - 0.40). The projected sample size 
required for the statistical test was n=21, to achieve statistical power >0.95 (α 
and β error probability – 0.05).  
 
3.3 General screening of participants and inclusion criteria 
Participants who volunteered to take part in the investigations involved in this 
thesis provided verbal and written consent (Appendix 1) prior to participation. 
Participants were screened with relevant medical history questionnaires and 
physiology screening questionnaires prior to inclusion: physiology screening 
questionnaire (Appendix 2), the American College of Sports Medicine (ACSM) 
Physical Activity Readiness Questionnaire (PAR-Q) (Appendix 3), and the 
American Heart Association (AHA)/ACSM Health/Fitness Facility Pre-
participation Screening Questionnaire (Appendix 4).  
 
3.4 Anthropometric measurements 
Height and body mass were measured via a Stadiometer (Harpenden 
Portable, Holtain Limited, UK) and scales (Seca, 808, Germany), respectively. 
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Waist and hip circumference were measured using a standard measuring tape 
(Seca, Germany) with the participant standing in the upright neutral position. 
Waist circumference was measured at the mid-point between the iliac crest 
and the lowest palpable rib. Hip circumference was measured at the widest 
part of the hips (WHO, 2008).  
 
3.5 Blood pressure measurement 
Arterial BP was measured on the participant’s non-dominant arm using a 
digital automatic BP monitor (Nonin, Avant 2120, USA). Participants remained 
in a supine position on a laboratory bed for 5 min prior to the first measurement. 
Blood pressure was measured 3 times and an average of the second and third 
readings for systolic and diastolic BP was reported.  
 
3.6 Peak oxygen uptake test 
Peak oxygen uptake (V̇O2peak) was determined using an incremental step-
protocol exercise test on an electromagnetically-braked cycle ergometer 
(Lode, Corival CPET, Netherlands), performed to volitional exhaustion (Poole, 
Wilkerson, & Jones, 2008; Yoon, Kravitz, & Robergs, 2007). An on-line breath-
by-breath gas analysis system (Cortex, MetaLyzer 3B, Germany) was used to 
measure expired air continuously throughout the test. Calibration of the flow 
sensor and gas analysis device was performed 30 min prior to each use. Heart 
rate (HR) was continuously monitored throughout the test using a HR monitor 
(Polar, RS400, Finland) and the HR sensor linked to the gas analysis system. 
After a 5 min warm up at 80 W, the intensity was increased by 30 W every 2 
min until volitional exhaustion. Participants were instructed to maintain a 
minimum pedalling rate of 70 revolutions per min (rpm) and were verbally 
encouraged to perform to volitional exhaustion, at which point the test was 
terminated (rpm <60). A 5 min cool down at 50 W was then immediately 
commenced. Peak oxygen uptake was identified as the highest V̇O2 over a 30 
s period during the test.  
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3.7 Blood sampling 
Participants were in a semi-supine position on a laboratory bed for all blood 
sampling. Blood samples were collected in 4-6 ml capacity BD (BD 
Biosciences, Becton, Dickinson and Company, US) vacutainers: lavender-
topped vacutainers (4 ml) containing K3 ethylenediaminetetraacetic acid 
(EDTA) (approximately 1.0 mg) for plasma separation, grey-topped 
vacutainers (4 ml) containing sodium fluoride/potassium oxalate to obtain 
plasma for glucose determinations, pink-topped vacutainers (6 ml) containing 
K3 ethylenediaminetetraacetic acid (EDTA) (approximately 1.0 mg) to collect 
whole blood, and gold-topped vacutainers (5 ml) containing a clot activator and 
gel for serum separation. All vacutainers were inverted 8 times immediately 
after blood sampling.  
 
3.7.1 Venepuncture 
Peripheral venous blood samples were taken from an antecubital vein of the 
forearm via a 21-gauge needle and collection set with 7 inch tubing and a BD 
vacutainer Safety-LokTM Luer Adapter (BD Biosciences, USA).  
 
3.7.2 Cannulation 
Venous blood samples were taken from the antecubital vein in the forearm via 
cannulation using a 22-gauge BD VenflonTM Pro Safety I.V. Cannula (BD, 
USA). Connecta tubing (Nu-Care Products Limited, Bedfordshire, UK) was 
used to prevent movement of the positioning of the needle. The cannula and 
tubing were kept patent via syringe flushing between samples with 8 ml of 0.9 
(w/v) saline solution from pre-filled syringes (BD PosiFlushTM SP, BD, USA). 
After insertion and flushing of the cannula, at each time-point for blood 
collection, a 5 ml syringe (Terumo, Japan) was used to extract the first 3 ml of 
blood, which was discarded prior to sample collection.  
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3.7.3 Control measures 
Participants were asked to abstain from consuming caffeine and alcohol and 
engaging in strenuous exercise in the 24 h prior to blood sampling. Participants 
were asked to maintain their normal diet and activity during involvement in 
either study.  
 
3.7.4 Centrifugation of blood samples 
For plasma analysis, the whole blood was centrifuged (Satorius Universal, 
320R, Germany) at 1500 rpm for 15 min at 4 °C within 30 min of collection. To 
obtain serum, whole blood was incubated at room temperature for 30 min prior 
to centrifugation at 1000 x g for 10 min at 4 °C.  
The resulting plasma and serum was aliquoted into 1.5 ml Eppendorf tubes 
and stored at minus 80 °C for later analysis.  
 
3.8 Haematological parameters 
Whole blood was analysed for full blood cell count in vacutainers containing 
K3 EDTA using a haematology analyser (Sysmex Automated Haematology 
Analyser, XS 1000i, Sysmex, Japan). Samples were measured immediately 
following blood collection in triplicate and averaged. Quality control samples 
were used prior to each blood sample being quantified for differential white 
blood cell count (e-Check XS, Sysmex, Japan). Blood components measured 
were: white blood cell (WBC) count, red blood cell (RBC) count, haemoglobin 
(HGB) content, haematocrit (HCT) content, and WBC subsets: neutrophils, 
lymphocytes, monocytes, eosinophils, and basophils.  
 
3.9 Quantification of 25(OH)D3 concentration 
For the analysis of total serum 25(OH)D concentration, high-pressure liquid 
chromatography tandem mass spectrometry (LC-MS/MS) was implemented. 
The analysis was carried out by Mr Gary Duncan at The Rowett Institute in 
Aberdeen, Scotland, UK. The LC-MS/MS method of analysis has been 
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validated against other commercially available assays and is regarded as the 
most valid and reliable technique for the assessment of vitamin D metabolites 
(Snellman et al., 2010). Plasma samples from the ExVD study (n=35) were 
also analysed using enzyme immunoassay (EIA) (IDS-PLC, Tyne & Wear, 
UK). EIA has been reported to underestimate blood 25(OH)D3 concentrations 
in comparison to the gold standard LC-MS/MS. The coefficient of variation 
(CV) for the LC-MS/MS and EIA assays are displayed in Table 2.  
 
Table 2 Intra-assay coefficients of variance (CV) for 25(OH)D analysis.  
Study Analysis method Intra-assay CV (%) 
VDS LC-MS/MS 1.89 
ExVD EIA 2.65 
ExVD LC-MS/MS 3.04 
VDS; Vitamin D Status study (n=97). ExVD; Exercise and Vitamin D study (n=35).  
 
3.9.1 LC-MS/MS principle 
LC-MS/MS combines the capability of liquid chromatography with the mass 
analysis ability of mass spectrometry. Human serum must undergo preparation 
prior to injection in order to clean the sample, thus purifying the vitamins from 
the other components in serum. Following sample preparation, the process 
can be generally separated into three main steps: the separation step (step 1), 
ionization step (step 2), and mass analysis (step 3). In step 1 the cleaned up 
sample is forced at high pressure by a liquid (mobile phase) into a column 
(solid phase) to separate the analytes. In step 2, the sample is charged via 
atmospheric pressure chemical ionisation (APCI), whereby a solvent reagent 
ionizes the analyte. In the final step, the ions are separated according to their 
mass-to-charge ratio by electromagnetic fields in an analyser then detected by 
a quantitative method. The signal is then processed into mass spectra.  
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3.9.2 LC-MS/MS method 
Prior to injection into the mass spectrometer (Shimadzu Nexera X2 LC Binary 
Pump Model), 25(OH)D3 and deuterated internal standard (QMX Laboratories 
Ltd, UK) were extracted from serum samples via protein precipitation sample 
preparation. The internal standard (25-hydroxyvtamin D3-[d3]) was added to 
serum samples at a concentration of 400 pg·µl-1, then 300 µl of acetonitrile was 
added to 100 µl of spiked serum samples and vortexed. Solutions were 
incubated on ice for 30 min prior to centrifugation at 13,000 rpm for 15 min. 
The supernatant was removed via drying under a stream of nitrogen and dried 
extracts were reconstituted in the mobile phase (15% 5mM Ammonium 
Acetate + 0.1% Acetic Acid:85% Methanol) prior to injection (5 µl) into an LC-
MS/MS in the multiple reaction mode at a flow rate of 500 µl·min-1. The 
retention time of the injected sample in the column was 2.01 min. The accuracy 
of the assay is provided in Table 3.   
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Table 3 Accuracy of the LC-MS/MS assay.  
VDS study (n=97)    
Standards (pg∙µl-1) Concentration (pg∙µl-1) Accuracy (%) Intra-CV (%) 
1000 986.7 ± 10.3 98.67 0.70 
500 526.2 ± 1.2 105.23 0.68 
250 252.7 ± 1.0 101.07 0.52 
100 96.6 ± 0.8 96.67 0.56 
50 48.0 ± 01 95.93 0.45 
10 9.3 ± 0.3 92.50 3.92 
5 4.7 ± 0.2 94.57 4.19 
ExVD study (n=35)    
Standards (pg∙µl-1) Concentration (pg∙µl-1) Accuracy (%) Intra-CV (%) 
1000 984.4 ± 6.6 98.47 1.01 
500 529.4 ± 3.4 105.87 1.09 
250 255.0 ± 1.7 102.00 1.03 
100 96.9  ± 0.3 96.90 2.13 
50 49.3 ± 0.6 98.60 1.55 
10 9.5 ± 0.3 94.70 4.63 
5 4.8 ± 0.2 96.03 4.96 
The concentration data is presented as mean ± SD.   
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3.9.3 EIA 
Plasma 25(OH)D concentration was quantified using a 25-Hydroxy Vitamin D 
EIA kit (IDS-PLC, Tyne & Wear, UK). Low (10 ng·ml-1, measured at 10.1 ng·ml-
1) and high (45 ng·ml-1, measured at 44.8 ng·ml-1) controls were used and a 
standard calibration curve (R2=0.986) applied to the plotted concentrations of 
the standards. Absorbance was measured at the recommended 450 nm 
wavelength.  
 
3.9.4 Comparison of LC-MS/MS and EIA 
There is a diverse array of vitamin D testing methods routinely used in 
laboratories (Enko, Kriegshauser, Stolba, Worf, & Halwachs-Baumann, 2015). 
In comparative and reliability studies, LC-MS/MS is widely used as the 
reference method (Carter, 2012), and is a reliable diagnostic tool with the 
ability to distinguish between 25(OH)D2 and 25(OH)D3 (van den Ouweland, 
Beijers, Demacker, & van Daal, 2010). Although LC-MS/MS is classified as the 
gold standard measurement, other competitive assays have been developed 
that are less expensive and time-consuming compared to mass spectrometry. 
One such assay is EIA (or ELISA). Depending on the analysis method used, a 
clinical concern is the possible misdiagnosis of vitamin D concentration and 
thus classification. Therefore, it is important to determine whether methods 
that are not the gold standard have the presence of significant variance and/or 
proportional bias compared to the gold standard mass spectrometry.  
Within this PhD thesis methodology, the two clinical measurements: EIA and 
LC-MS/MS have been compared via a Bland-Altman plot and statistics have 
been performed on the comparison. The LC-MS/MS method was defined as 
the reference method. The CV between the LC-MS/MS and EIA assays (n=35) 
was 5.16 %.  
The null hypothesis was that there will be 0 difference (variance) between EIA 
and mass spectrometry analysis of serum sample for 25(OH)D3 concentration. 
Figure 6 shows the Bland Altman plot of the mean of the two measurements 
(x axis) and the difference between the two measurements (y axis). A one-
sample t-test was conducted on the difference between the measurements, 
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with the ‘test value’ set to 0 as it was hypothesised that there will be zero 
systematic difference between the two measurements. Results of the one-
sample t-test reported there was no significant difference (P=0.348) between 
0 and the mean difference (-0.1914) of our measurements. Therefore, there is 
agreement between the methods for analysis of serum 25(OH)D3 
concentration. Upper and lower confidence levels (95 %) have been added to 
the plot to show how well the data fits within the normal level of agreement.  
 
Figure 6 Bland-Altman difference plot for the proposed gold standard LC-
MS/MS and EIA. Each marker represents an individual’s data (n=35). 
Difference: the difference between the means for LC-MS/MS and EIA. Mean: 
mean 25(OH)D concentration (ng·ml-1).  
 
A linear regression analysis was then performed on the data to test the null 
hypothesis, presented in Figure 7. The results of the regression (F=0.573, t=-
0.757, P=0.454) report that the test is non-significant and we can accept the 
null hypothesis. Therefore, there is no proportional bias in the data and there 
appears to be a level of agreement.  
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Figure 7 Comparison between mean 25(OH)D concentration measurements 
assessed via LC-MS/MS and EIA. Each marker represents an individual’s data 
(n=35). 
 
It can be concluded that there is no trend in the data or proportional bias, and 
no variance between the two measurements: EIA and LC-MS/MS, that were 
used to analyse serum for 25(OH)D3 concentration. Therefore, EIA could be 
used as a reliable method to report 25(OH)D concentrations.  
However, upon inspection of the data, an interesting finding was the difference 
in individual diagnosis of vitamin D status classification (see Table 1) as a 
result of measured plasma/serum 25(OH)D concentration. As shown in Table 
4, the number of participants who would be diagnosed as severely deficient, 
deficient and insufficient is dependent on the method used to assess 25(OH)D 
concentration. This is clinically relevant, as this may impact upon classification 
and subsequent treatment.   
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Table 4 The number of participants in each vitamin D classification determined 
by LC-MS/MS and EIA (n=35).  
Classification 25(OH)D concentration LC-MS/MS EIA Diff 
 ng·ml-1 n n n 
Severely deficient < 12 14 12 -2 
Deficient 13-20 10 13 +3 
Insufficient 21-29 11 10 -1 
Sufficient > 30 0 0 0 
Diff, difference of EIA compared to gold standard LC-MS/MS.  
 
In light of these findings and for the purpose of this thesis, all 25(OH)D 
concentrations reported in the chapters are quantified by LC-MS/MS.  
 
3.10 Flow cytometry 
The flow cytometry protocol primarily followed a previously established 
protocol that is validated against confocal microscopy and has been reported 
to stain for both cytoplasmic and nuclear VDR (Bendix et al., 2015). Following 
PBMC isolation from whole blood, non-permeabilised and permeabilised cells 
were stained for VDR to analyse both cell surface and internalised VDR 
expression and analysed via a flow cytometer (BD FACSCelestaTM, San Jose, 
USA).  
 
3.10.1 PBMC isolation 
For PBMC isolation, 6 ml of peripheral blood was diluted 1:1 with sodium 
chloride (0.9 % NaCl) in a 50 ml centrifuge tube. The mixture was then layered 
on top of 12 ml of Ficoll-Paque (Amersham Biosciences, Uppsala, Sweden) in 
a 50 ml centrifuge tube, without disturbing the interface. The sample was then 
spun down at 700 x g for 30 min at 20 °C. Following centrifugation, the upper 
layer of plasma was carefully removed using a plastic pasture pastette and 
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discarded, leaving the lymphocyte layer undisturbed at the interface, which 
was aspirated and transferred to a new centrifuge tube. The cells were washed 
with 6 ml saline at 250 x g for 10 min at 20 °C, and the supernatant removed 
and the cell pellet washed again. The supernatant was decanted and the pellet 
re-suspended in 1 ml phosphate buffered saline (PBS) to create a PBMC 
suspension, stored at 4°C.  
 
3.10.2 Cell count 
The cooled PBMC suspension for each time point was counted for cells per µl, 
to calculate the volume of suspension to be added to each flow cytometry tube. 
Ten microliters of PBMC suspension were added to 50 µl Trypan Blue solution 
(Sigma-Aldrich, Missouri, USA) on Parafilm® (Bemis NA, Wisconsin, USA) and 
mixed thoroughly by drawing in and out of a pipette tip. Ten microliters of the 
stained solution was transferred onto a Neubauer counting chamber, and the 
4 corner squares were counted. Only the unstained cells were counted to avoid 
counting dead (stained) cells.  
 
Calculations: 
For the number of PBMCs in sample: 
PBMC count/ml = Mean of four squares x 105 x dilution factor (5) 
 
For 500,000 PBMCs:  
1000 ÷ [(PBMC count/ml) ÷ 500,000] 
 
3.10.3 VDR staining 
A control sample (PBMCs taken from the pre-trial time point and stained for 
CD3+, CD4+, and CD8+ T cells but not VDR) was analysed using both the 
permeabilised and non-permeabilised method.  
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3.10.3.1 Non-permeabilised method 
Based on the cell count, 500,000 cell suspension was added to each tube and 
stained with 2 µl of anti-CD3 antibody fluorescein isothiocyanate (FITC) (BD 
Bioscience), anti CD4 antibody Brilliant Violet 786 (BV786) (BD Bioscience), 
anti-CD8 antibody phycoerythrin with the cyanide dye Cy5 (PE-Cy5) (BD 
Bioscience), 1 µl anti-VDR antibody (VDR Polyclonal Antibody, ThermoFisher 
Scientific, Massachusetts, US) and 1 µl of the secondary antibody (PE) (BD 
Bioscience) were added to the VDR stained tubes only and cells were 
incubated at 4°C for 30 min. Following incubation, 1 ml PBS was added to all 
tubes and the cells were washed at 250 x g for 10 min at 20 °C. The cell pellet 
was re-suspended in 500 µl PBS via vortex and flow cytometry was performed 
within 1 h.  
 
3.10.3.2 Permeabilised method 
Based on the cell count, 500,000 PBMCs suspension was added to each tube 
and stained with 2 µl of anti-CD3 antibody FITC (BD Biosciences), anti CD4 
antibody BV786 (BD Biosciences), and anti-CD8 antibody PE-Cy5 (BD 
Biosciences), and incubated for 15 min at 4 °C. Following incubation, 250 µl of 
Fixation/Permeabilisation Solution (BD Biosciences) was added and incubated 
for 20 min at 4 °C. One millilitre of Perm/Wash Buffer (10x) (BD Biosciences) 
was added and the cells were washed at 250 x g for 10 min at 20 °C. Following 
centrifugation, the cell pellet was re-suspended in 500 µl Perm/Wash Buffer 
(10x) (BD Biosciences) via vortex, and 1 µl anti-VDR antibody and 1 µl of the 
secondary antibody PE was added to the VDR staining tubes only. All tubes 
were incubated for 30 min at 4 °C and flow cytometry was performed within 1 
h.  
 
3.10.3.3 VDR data analysis 
The VDR positive gate was set on the basis of the isotype PE control in each 
experiment: permeabilised and non-permeabilised method for each trial. VDR 
expression is reported as fold change, calculated from VDR geometric mean 
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(geomean). Absolute T cell number was calculated and quantified using the 
lymphocyte concentration obtained via haematological analysis (section 3.8).  
 
3.10.3.4 Flow cytometric gating 
The colour-dot plots of flow cytometric enumeration of T lymphocytes and the 
subsets: CD3+, CD4+, CD8+ T cells, and permeabilised and non-
permeabilised CD3+VDR+ T cells are shown in Figure 8.  
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Figure 8 Flow cytometric enumeration of T lymphocytes: (A) side scatter vs. 
forward scatter for identification of lymphocyte gate, (B) CD3+ gating of 
lymphocytes, (C) CD3+CD4+ and CD3+CD8+ gating of lymphocytes, (D) non-
permeabilised identification (CD3+VDR+), (E) permeabilised identification 
(CD3+VDR+).   
A 
B C 
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3.10.3.5 Cell surface and intracellular expression of VDR 
The T cells analysed for VDR expression were first analysed for cell surface 
expression and then the cells were permeabilised to analyse intracellular VDR 
expression. As shown in Figure 9, the percentage of cells (50,000 cells) 
expressing VDR internally was almost 100 % (CD3+: 98.0 ± 2.3 %, CD4+: 98.9 
± 1.3 %, CD8+:97.9 ± 2.0 %), whereas the cells expressing VDR on the cell 
surface was less than 3 % for all T cell subsets. The difference between the 
percentage of cells expressing VDR for non-permeabilised and permeabilised 
samples was significant (P<0.001) for the three T cell subsets. This data is 
based on the gating strategy and thus may identify false positives due to non-
specific binding or doublets. This demonstrates and confirms that the receptor 
is predominantly an intracellularly expressed and bioavailable protein, 
therefore only intracellular VDR geomean is presented in the results sections 
to follow.  
 
Figure 9 The percentage of T cell subsets expressing VDR, on the cell surface 
(non-permeabilised) and within the cell (permeabilised). * represents a 
significant difference between non-permeabilised and permeabilised 
(P<0.001). Data presented as mean ± SD.   
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3.11 Data analysis 
All statistical analysis was performed using SPSS 23.0 software (Statistical 
Package for the Social Sciences Inc., IBM Corporation, Chicago, Illinois, USA). 
The Shapiro Wilk test was used to test for normal distribution of all data prior 
to main analysis. If the data was not normally distributed, the data was 
transformed and the check for normality was repeated. For analysis involving 
more than 3 comparisons, Mauchly’s Test of Sphericity (P>0.05 sphericity 
assumed) was checked, with Greenhouse-Geisser correction applied where 
appropriate. Where significant main effect and interactions were present, the 
Bonferroni post-hoc pairwise comparisons test was used to detect where 
significances lay between paired comparisons, an analysis that includes 
correction for an ANOVA’s multiple comparisons. The data is presented as 
mean ± standard deviation (SD) or mean ± standard error mean (SEM). 
Statistical significance was accepted at P≤0.05. All figures were designed in 
Microsoft Excel v.2011. 
Independent samples t-tests were used to ascertain the difference between 
two independent variables, and one-way Analysis of Variance (ANOVA) were 
used when there were more than 2 groups in the comparison. Paired samples 
t-tests were used to ascertain difference between two paired variables.  
Regression models were used to analyse what independent variables predict 
the dependent variable. The multivariate model was used to provide the results 
of the ANOVA, correlation significance, adjusted regression coefficients 
(Beta), 95 % confident intervals, and adjusted R square (adjusted to account 
for sample size). Where regression models were not required, Pearson 
correlations were conducted to examine associations between two variables.  
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Chapter 4: Vitamin D Status and Physical 
Activity of Older Adults 
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4.1 Abstract 
Research shows that individuals residing in Scotland have a strikingly low 
vitamin D status, with an emerging association between physical activity levels 
and 25(OH)D concentrations. This association has not yet been investigated 
in older adults (60-80 years).  
A total of 98 (39 male, 59 female) older adults (age: 67 ± 5 y, body mass: 73.4 
± 14.9 kg, BMI: 26.1 ± 3.7 kg∙m-2) were included in the study. Participants 
provided 7-day self-reported (International Physical Activity Questionnaire, 
IPAQ) and objectively measured (accelerometer) physical activity levels, and 
fasted blood samples that were analysed for 25(OH)D concentration 
(measured by LC-MS/MS).  
The population was defined as vitamin D deficient, with a mean 25(OH)D 
concentration of 14.5 ± 3.9 ng·ml-1 and reported a high prevalence of severe 
deficiency (26 %), deficiency (64 %), and insufficiency (10 %). A seasonal 
influence was observed, although there was no influence of gender (P=0.063) 
on vitamin D status. In line with the literature, there was a decline in vigorous 
physical activity with age (P=0.004). However, only time spent engaged in 
vigorous activity was associated with 25(OH)D concentration (P=0.034), with 
a surprising negative correlation observed (r=-.203). Physical activity did not 
predict 25(OH)D concentration (P=0.542).  
In conclusion, the severely low 25(OH)D concentrations confirm that Scotland 
is a vitamin D deficient nation. The data suggests that 25(OH)D concentrations 
may be influenced by intense physical activity in older adults that reside in 
Scotland.  
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4.2 Introduction 
In an older population there appears to be a decline in skin synthesis of vitamin 
D (Holick & Chen, 2008; MacLaughlin & Holick, 1985), reported to be 
attributable to a decrease in the enzyme (CYP27B1) responsible for the initial 
conversion reaction in the skin following exposure. Moreover, recent 
systematic reviews and meta-analyses report an association between high 
levels of vitamin D and a lower prevalence of cardio-metabolic disorders 
(Parker et al., 2010), particularly in older adult populations (Pittas et al., 2010; 
Rendina et al., 2014). Therefore, ensuring an adequate vitamin D status, 
assessed by 25(OH)D concentration, is identified as important for older 
populations to slow or delay the decline in cardio-metabolic health that 
accelerates with the ageing process (Ford, Giles, & Dietz, 2002). The initial 
step towards achieving an adequate and/or sufficient status is to identify the 
mean baseline 25(OH)D concentration in Scotland and the potential lifestyle 
determinants that may influence this: sedentary behaviour and physical activity 
levels in older adults.  
Physical activity has been reported to decline with advancing age (Sallis, 
2000), however it is not known whether this is primarily attributed to 
environmental or biological factors. Participation in leisure time activities in 
Scotland decreases as age advances with many deterrents identified, such as 
lack of interest and physical symptoms (Crombie et al., 2004). Physical 
inactivity has been identified as a modifiable predictor of vitamin D status (K. 
Brock et al., 2010; K. E. Brock et al., 2010), although it has not been 
determined whether this is due to internal vitamin D metabolism or 
environmental factors, for example the outdoor nature of most physical activity 
and thus influence of UV exposure. 
Since there is a decline in physical activity with age, and a potential for 
decreased synthesis of vitamin D in older adults, the physical activity status 
and 25(OH)D concentration of older adults should be explored to identify 
whether these two lifestyle-induced factors are: (1) low, and (2) linked.  
Since Scotland has previously been reported as a vitamin D deficient nation 
across all ages (21-82 years old) (Zgaga et al., 2011), it is important to evaluate 
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the determinants in specific age groups such as older adults that may be at 
risk of lower vitamin D levels. In addition, this may provide insight into whether 
cause and effect relationships exist. Furthermore, physical activity levels 
remain low in Scotland (The Scottish Health Survey, 2017), presenting an 
avenue for behavioural change and thus a potentially modifiable route for 
intervention.  
The primary aim of this study is to determine the baseline vitamin D status 
(25(OH)D concentration), and evaluate the physical activity levels of older 
adults who live in Scotland. The association between 25(OH)D concentration 
and physical activity categories will then be explored.  
It is hypothesised that older adults will have a low baseline 25(OH)D 
concentration, which will inversely correlate with physical activity status. Due 
to the northern latitude and characteristic weather of Scotland, it is 
hypothesised that a seasonal influence on 25(OH)D concentrations will be 
observed.  
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4.3 Materials and methods 
4.3.1 Participants 
Ninety-eight male (n=39) and female (n=59) adults (aged 60-80 y) participated 
in this study (see section 3.2.1: age 67 ± 5 y, body mass 73.4 ± 14.9 kg, height 
1.67 ± 0.10 m, BMI 26.1 ± 3.7 kg·m-2).  
Participants were recruited on a rolling basis over the projected 12 month time 
frame for the VDS study to ensure that seasonal influence could be 
investigated. Based on the calculation determining that a sample size of n=85 
was required to achieve statistical power, the aim was to recruit a minimum of 
8 volunteers per month. However, this was not always possible due to the 
nature of volunteer-based recruitment, closure of the University over seasonal 
periods (such as Christmas/New Year), timing of participants’ holidays and 
thus a lag time before inclusion in the study, and screening deeming six 
recruited volunteers as ineligible to participate. The number of participants 
recruited per month for the 12 month study time frame is displayed in Figure 
10, with a mean of n=8 (8.17) per month. All participants attended the 
laboratory on two occasions: visit 1 and visit 2, as outlined below.  
 
Figure 10 Monthly recruitment of participants (n=98) in the VDS study.  
0
2
4
6
8
10
12
14
N
u
m
b
e
r 
o
f 
p
a
rt
ic
ip
a
n
ts
Month
Mean
73 
 
4.3.2 Visit 1 
Written and verbal consent were obtained on arrival to the laboratory and all 
participants completed the screening questionnaires (see section 3.3). 
Anthropometric measurements and BP were then taken (see section 3.4 and 
3.5). Each participant was issued with a wrist worn accelerometer 
(MotionWatch 8 (MW8), CamNTech Ltd and CamNTech Inc, UK) and 
instructed to wear it for 7 full days and nights to monitor their habitual activity. 
Seven days of objective monitoring has been identified as sufficient to reliably 
predict physical activity and sedentary behaviour of older adults (Hart, Swartz, 
Cashin, & Strath, 2011).  
 
4.3.3 Visit 2 
The second visit was scheduled 8-10 days after Visit 1 to allow 7 full days of 
data on the wrist worn accelerometer. Participants attended the laboratory 
between 7.30-9.30am following an overnight fast (10 h) and a fasted blood 
sample was collected via venepuncture (see section 3.7.1). Following blood 
sampling, the International Physical Activity Questionnaire (IPAQ) Long Form 
(Appendix 5) was completed.  
 
4.3.4 Blood sample analysis 
Whole blood was analysed for haematological parameters (see section 3.8). 
Serum 25(OH)D3 concentration was determined by LC-MS/MS (see section 
3.9.2).  
 
4.3.5 Accelerometer data analysis 
MotionWare Software was used for the set-up, download, and analysis of data 
captured with the accelerometer, and to quantify the intensity and duration of 
daily physical activity and night time activity (sleep duration). Recordings were 
for 7 days, 24 hours where possible. All activity counts were separated into 5 
categories: sleep, sedentary (SED) time, light intensity physical activity (LPA), 
moderate intensity physical activity (MPA), and vigorous intensity physical 
74 
 
activity (VPA), using the cut-off points outlined specific for older adults (Falck, 
Landry, Brazendale, & Liu-Ambrose, 2017; Landry, Falck, Beets, & Liu-
Ambrose, 2015).  
 
4.3.6 IPAQ 
The IPAQ (Appendix 5) was used to gather data on self-reported physical 
activity categories and sedentary time.  
 
4.3.7 Statistical analysis 
Data was analysed as outlined in section 3.11. A total of 98 participants (39 
males, 59 females) were included in the analysis for all variables aside from 
the MW8 physical activity data analysis, which included 82 participants (34 
males, 48 females) due to 16 corrupted data files.  
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4.4 Results 
4.4.1 Participant characteristics 
Full participant characteristics of all the participants and separated by sex are 
presented in Table 5. The post-hoc power calculation performed revealed that 
the study is statistically powered (P>0.95) based on a sample size of 98.  
There was no difference in age but there was a difference in height and mass 
between sexes, with males taller and heavier compared to females. Although 
there was no statistically significant difference in BMI, there is a tendency for 
males to have a higher BMI compared to females, with a close to significant P 
value (P=0.051). Waist circumference and hip circumference were both 
significantly lower in females compared to males, as was the waist-to-hip ratio. 
Diastolic BP was lower in females compared to males.  
 
Table 5 VDS study participant characteristics (n=98).  
 All (n=98) Males (n=39) Females (n=59) P value 
Age, y 67 ± 5 66 ± 4 68 ± 5 0.080 
Height, m 1.67 ± 0.10 1.77 ± 0.07 1.60 ± 0.05 * <0.001 
Body mass, kg 73.4 ± 14.9 85.0 ± 13.2 65.8 ± 10.3 * <0.001 
BMI, kg·m-2 26.1 ± 3.7 27.0 ± 3.4 25.5 ± 3.7 0.051 
Waist circ., cm 84.4 ± 12.4 93.3 ± 9.0 78.5 ± 10.7 * <0.001 
Hip circ., cm 98.5 ± 8.9 101.2 ± 7.0 96.8 ± 9.7 * 0.011 
Waist-to-hip ratio 0.86 ± 0.09 0.92 ± 0.06 0.81 ± 0.07 * <0.001 
Resting HR, bpm 67 ± 9 65 ± 8 67 ± 9 0.216 
Systolic BP, mmHg 135 ± 18 134 ± 14 136 ± 20 0.522 
Diastolic BP, mmHg 78 ± 9 81 ± 9 77 ± 9 * 0.040 
Data presented at means ± SD. * denotes a significant difference from males.   
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4.4.2 Vitamin D status 
We investigated baseline serum 25(OH)D3 concentrations in 97 healthy older 
males and females who live in Scotland. The mean 25(OH)D3 concentration of 
the population was 14.5 ± 3.9 ng·ml-1, which is classified as deficient according 
to the current classifications (Holick, 2009). There was no difference in 
25(OH)D3 concentration between males and females, as shown in Table 6.  
 
Table 6 Vitamin D status, as defined by systemic 25(OH)D3 concentration, of 
participants (n=97).  
 All (n=97) Males (n=39) Females (n=58) P value 
25(OH)D3, ng·ml-1 14.5 ± 3.9 13.6 ± 3.7 15.0 ± 3.9 0.063 
25(OH)D3, nmol·L-1 36.1 ± 9.7 33.9 ± 9.4 37.6 ± 9.6  
Data presented at means ± SD.  
 
The most striking finding was the very high prevalence of severe deficiency 
(26 %) and deficiency (64 %), see Table 7. The remaining 10 % of the cohort 
were at risk of deficiency, while there were no individuals determined as having 
a sufficient vitamin D level.  
 
Table 7 Categorical vitamin D status of participants (n=97).  
Classification 25(OH)D3 Concentration (ng·ml-1) N % 
Severely deficient <12 25 26 
Deficient 12-20 63 64 
Insufficient 20-30 10 10 
Sufficient >30 0 0 
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4.4.2.1 Season 
The distribution of vitamin D classifications for each month is presented in 
Figure 11. The number of the individuals who were severely deficient or 
deficient changes in summer compared to winter months, with winter more 
strongly associated with lower 25(OH)D3 concentrations.  
 
 
Figure 11 Monthly 25(OH)D3 distribution in older adults in Scotland (n=97).  
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4.4.2.2 Characteristics 
When investigating the difference in systemic 25(OH)D3 concentration below 
and above the mean of participant characteristics variables (age, body mass, 
BMI, waist-to-hip ratio, resting HR, systolic and diastolic BP), there was no 
observed differences, as shown in Table 8.  
 
Table 8 Descriptive analysis of 25(OH)D3 concentrations in relation to 
participant characteristics (n=97).  
Variable Mean N 25(OH)D3 (ng·ml-1) P value 
  <,> < mean > mean  
Age, y 67 61,37 14.1 ± 3.8 15.0 ± 4.0 0.270 
Body mass, kg 73.4 57,41 14.9 ± 3.9 13.8 ± 3.7 0.190 
BMI, kg·m-2 26.1 51,47 14.5 ± 3.6 14.4 ± 4.1 0.866 
Waist circ., cm 84.4 47, 51 15.0 ± 4.0 14.0 ± 3.7 0.209 
Hip circ., cm 98.5 47, 51 14.8 ± 3.9 14.1 ± 3.8 0.344 
Waist-to-hip ratio 0.86 50,48 14.8 ± 3.9 14.1 ± 3.4 0.343 
Resting HR, bpm 67 52,46 14.6 ± 3.9 14.3 ± 3.8 0.707 
Systolic BP, mmHg 135 52,46 14.2 ± 4.0 14.7 ± 3.7 0.502 
Diastolic BP, mmHg 78 47,51 15.1 ± 3.9 13.8 ± 3.7 0.087 
Data presented as mean ± SD. BP, blood pressure. For each test variable, the sample was 
split into two groups: above and below the mean.  
  
79 
 
4.4.2.3 Age 
Figure 12 shows there is no correlation relationship between baseline 
systemic serum 25(OH)D3 concentration and age from 60 to 80 years (n=98, 
r=.071, P=0.486).  
 
 
Figure 12 The relationship between baseline 25(OH)D3 concentration and age 
(n=97). Each marker represents an individual participants’ data.  
 
4.4.3 Physical activity and sedentary behaviour 
Of the 98 participants, 25.5 % did not meet the guidelines for moderate (150 
min/week) and vigorous physical activity (75 min/week).  
As shown in Table 9, there was a significant difference between self-reported 
and objectively measured sedentary time and LPA and MPA, both per day and 
per week. Participants were sedentary for 13 h per day compared to the 6 h 
self-reported sedentary time (sitting time + time spent in transportation) 
recorded in the IPAQ, concluding that participants underestimated their daily 
sedentary time by 7 h. Participants underestimated daily LPA by 1 h, and 
overestimated daily MPA by 37 min. VPA was not observed to be significantly 
different between the methods of assessment.  
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Table 9 The time spent sedentary or engaged in each category of physical 
activity per day and week.  
Category IPAQ (n=98) MW8 (n=82) P value 
Per day    
Sedentary, h 6.30 ± 2.12 13.22 ± 1.56 * <0.001 
LPA, h 1.61 ± 1.47 2.61 ± 1.40 * <0.001 
MPA, h 1.26 ± 1.45 0.65 ± 0.43 * <0.001 
VPA, h 0.34 ± 0.65 0.21 ± 0.19 0.078 
Per week    
Sedentary, h 44.09 ± 14.83 92.56 ± 10.93 * <0.001 
LPA, h 11.25 ± 10.28 18.26 ± 9.79 * <0.001 
MPA, h 8.81 ± 10.18 4.56 ± 3.04 * <0.001 
VPA, h 2.39 ± 4.56 1.44 ± 1.31 0.077 
IPAQ, International Physical Activity Questionnaire (self-reported data); MW8, MotionWatch8 
(objectively measured accelerometer data). Data presented as mean ± SD. * denotes a 
significant difference from the number of hours reported via the IPAQ.  
 
Since the self-reported data either overestimates or underestimates time 
engaged in each category of activity/behaviour (excluding VPA), the physical 
activity data reported in the following results is the objectively measured data 
collected from the MW8 accelerometers.  
The number of hours per week spent sleeping (6.71 ± 0.90 h per night), 
sedentary or engaged in LPA, MPA, and VPA, assessed via the MW8 
accelerometers, is presented in Figure 13. There were no differences between 
males and females for time spent in any category of activity: sleep (P=0.429), 
SED (P=0.328), LPA (P=0.898), MPA (P=0.393), VPA (P=0.910).  
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Figure 13 Hours spent in each category of daily behaviour for all participants 
(n=82) and males and females assessed via the MW8 accelerometer. Data 
presented a mean ± SD.  
 
4.4.3.1 Age 
Objective physical activity data collected from the MW8 accelerometer were 
used to analyse the relationship between age and physical activity levels. The 
results of the single linear regression models (Figure 14) indicated that age 
was a predictor of time spent engaged in VPA per week, explaining 10 % of 
the variance (R2=.100, F(1,80)=8.925, β=-.317, P=0.004). However, sedentary 
(R2=.015, F(1,80)=1.192, β=.121, P=0.278), LPA (R2=.035, F(1,80)=2.936, β=-
.188, P=0.090), and MPA (R2=.044, F(1,80)=3.704, β=-.210, P=0.058) were 
not correlated with age.   
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Figure 14 Time spent sedentary (A) or engaged in LPA (B), MPA (C), and 
VPA (D) correlated with age (n=82). Each marker represents an individual 
participants’ data.   
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4.4.4 Vitamin D and physical activity 
When comparing the 25(OH)D3 concentration below the mean to above the 
mean of each physical activity category, it was found that there were no 
differences (shown in Table 10).  
 
Table 10 Descriptive analysis of 25(OH)D3 concentrations in relation to sleep 
and daily activity characteristics (n=82).  
Variable N 25(OH)D3 concentration (ng·ml-1) P value 
 <,> < mean > mean  
Sleep, h 38,44 14.2 ± 4.2 14.5 ± 3.6 0.669 
SED, h 37,45 14.2 ± 3.8 14.5 ± 3.9 0.721 
LPA, h 49,33 14.3 ± 3.8 14.4 ± 3.9 0.879 
MPA, h 47,35 14.6 ± 3.6 14.1 ± 4.2 0.562 
VPA, h 50,32 14.3 ± 3.8 14.4 ± 3.9 0.913 
Data presented as mean ± SD. For each test variable, the sample was split into two groups: 
above and below the mean. SED, sedentary; LPA, light physical activity; MPA, moderate 
physical activity; VPA, vigorous physical activity.  
 
A regression model was implemented to analyse whether the five physical 
activity categories predicted 25(OH)D3 concentration. A non-significant 
regression equation was found (F(5,81)=0.817, R2=0.051, P=0.542). The 
correlation analysis for the five physical activity categories and 25(OH)D3 
concentration is shown in Table 11. There appears to be an inverse correlation 
between systemic 25(OH)D3 concentration and the number of hours per week 
spent engaged in VPA (r=-0.203, P=0.034) as shown in Figure 15. However, 
there was no association with the other categories.  
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Table 11 Correlation analysis of 25(OH)D3 concentration with sleeping, 
sedentary and physical activity behaviour (n=82).  
 Correlation with 25(OH)D3 concentration 
 r P value 
Sleep, h -.036 0.374 
SED, h .074 0.254 
LPA, h -.045 0.344 
MPA, h -.073 0.257 
VPA, h -.203 0.034 
SED, sedentary; LPA, light physical activity; MPA, moderate physical activity; VPA, vigorous 
physical activity. 
 
 
Figure 15 Association between 25(OH)D3 concentration and VPA (n=82).  
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4.5 Discussion 
The results of this study show that there is a high level of severe deficiency (26 
%) and deficiency (64 %), with only 10 % defined as insufficient in terms of 
vitamin D serum concentration in the current participant population. 
Importantly, no individuals were classified as having a sufficient vitamin D 
status. The mean 25(OH)D3 concentration was 14.5 ng·ml-1, which is similar 
to published findings in Scotland by Zgaga et al. (2011) (14.4 ng·ml-1) and 
Weiss et al. (2016) (12.7 ng·ml-1). This consolidates the finding that Scotland 
is largely a vitamin D deficient nation. Our data shows a higher percentage of 
deficiency compared to the other studies, however the eligibility criteria only 
included those that did not consume vitamin D supplements, therefore 
negating a proportion of the population who may alter the distribution of the 
sample population in each category of vitamin D status. Moreover, the current 
study only included older adults aged 60-80 years, whereas the previous 
mentioned studies included populations with a broader age span. Although, in 
line with our findings, there are no reports that age affects vitamin D status.  
In the current study, it was found that vitamin D status did not differ between 
males (13.6 ± 3.7 ng·ml-1) and females (15.0 ± 3.9 ng·ml-1) in an older adult 
cohort. However, a previous study that investigated the relationship between 
sex and vitamin D status reported that females have lower 25(OH)D3 
concentrations compared to males (14.5 ± 10.9 vs. 15.9 ± 9.5 ng·ml-1) (Verdoia 
et al., 2015). The age of the sample population (females: 71 ± 11 y, males: 66 
± 12 y) is similar to the current study (females: 68 ± 5 y, males: 66 ± 4 y), and 
although Verdoia et al. (2015) reported a difference in age between male and 
females, when adjusting for age the difference between sexes remained. In a 
study in a non-Caucasian population, males were consistently found to have 
lower 25(OH)D3 concentrations compared to females (11.1 ± 9.2 vs. 12.8 ± 
10.5 ng·ml-1) (Sanghera, Sapkota, Aston, & Blackett, 2017). In another study, 
obese males had a lower 25(OH)D3 concentration accompanied with a higher 
rate of vitamin D deficiency compared to obese females (20.0 ± 8.8 vs. 21.4 ± 
9.0 ng·ml-1) (Johnson et al., 2012). These inconsistent findings may be a result 
of sample size, since the variance in the measured concentrations are large in 
comparison to the current study, or attributed to the population characteristics, 
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such as body mass, age, and race. Investigations and reports on sex 
differences in vitamin D status should be specific to the characteristics of the 
cohort.  
When investigating the sample population as a whole, 25.5 % of the older 
adults did not meet the current physical activity guidelines set by the UK 
Government ("Physical activity guidelines for adults (19-64 years)," 2011). This 
finding is reported by numerous studies and has been identified as an issue in 
Scotland and globally (Hallal et al., 2012; The Scottish Health Survey, 2017). 
However, the percentage that is physically inactive (25.5 %) is lower than that 
reported by The Scottish Healthy Survey in 2016 (36 %). This may be 
explained by the volunteering nature of a research study: members of the 
public may be more inclined to volunteer for a study involving a physical activity 
assessment if they are currently active.  
An interesting observation from the data was that compared to objective, 
accelerometer-derived measures, participants’ self-reported activity measures 
via the IPAQ led to a substantial under or overestimation of time spent 
sedentary or physically active. This has previously been reported in males and 
females aged 18-73 years, however their data suggested a stronger 
correlation between methods for sedentary activity and a weak correlation for 
indices of physical activity (Celis-Morales et al., 2012). The current data set 
shows that individuals drastically under-estimate sedentary behaviour by as 
much as 7 hours per day, and over-estimate physical activity but to a lesser 
degree. Current epidemiological data shows that older adults are the most 
sedentary segment of the population, spending on average 70 % of their 
waking hours sedentary (Matthews et al., 2008; Stamatakis, Davis, Stathi, & 
Hamer, 2012). Sedentary behaviour refers to activities that do not increase 
energy expenditure substantially above the resting level and thus includes 
activities such as sitting and lying down (Pate, O'Neill, & Lobelo, 2008). 
According to the current cohort of older adults, 76 % of waking hours were 
spent sedentary (when assessed objectively), therefore similar to the larger 
scale epidemiological studies conducted in the US. The duration that 
participants believed they were sedentary per day was drastically 
underestimated by 7 hours, therefore perception of the time spent inactive 
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appears to be distorted. This may be due to social desirability whereby being 
physically active is a socially desirable behaviour and thus people may over-
report their activity inducing bias in order to gain social approval (S. A. Adams 
et al., 2005; Motl, McAuley, & DiStefano, 2005).  
Although studies have investigated the feasibility of interventions to reduce 
sedentary behaviour in older adults (Gardiner, Eakin, Healy, & Owen, 2011), if 
the general perception of time spent sedentary is distorted and vastly 
underestimated, there may not be awareness of the requirement for these 
physical or behavioural change interventions. Therefore, the problem may 
persist. This is an important finding, which may contribute to public health in 
light of reports that sedentary behaviour has a deleterious effect on a person’s 
health, independent of the amount of physical activity (Tremblay, Colley, 
Saunders, Healy, & Owen, 2010).  
Interestingly, LPA was underestimated by 1 hour and MPA was overestimated 
by 37 minutes daily, which then accumulates over the course of a week (7 
hours and 4.25 hours, respectively). However, VPA was reported as similar via 
both methods of assessment. It should be noted that the objective 
measurement includes 24 hours’ worth of activity accounted for and 
disseminated into a category, whereas the questionnaire asks specific 
questions with regards to sedentary time and time spent engaged in each 
physical activity category, therefore the IPAQ does not account for all hours of 
the day. As a result there may be gaps and sedentary or activity time 
unaccounted for throughout a day. This may explain the difference in 
sedentary time, however the under and overestimated of light and moderate 
activity, respectively, may be attributed to perception of intensity of an activity. 
The method of assessment appears to be the source of the controversial 
results regarding physical activity levels. There are numerous methods to 
assess physical activity, both subjective and objective (Ainsworth et al., 2000; 
Helmerhorst, Brage, Warren, Besson, & Ekelund, 2012), with the general 
conclusion that self-report methods (questionnaires) may provide an 
approximation of physical activity levels, however they may not determine 
whether an individual is meeting the physical activity guidelines (Loney, 
Standage, Thompson, Sebire, & Cumming, 2011). Although the IPAQ is the 
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most commonly used subjective tool for evaluating physical activity (Rangul, 
Holmen, Kurtze, Cuypers, & Midthjell, 2008), largely due to its cost 
effectiveness and relative ease of use, it may underestimate physical activity 
due to the greater level of variability. This may lead to false-negative and 
inconsistent results of absolute physical activity levels and the association with 
other factors/variables. The low level of agreement between the methods of 
assessment (Monyeki, Moss, Kemper, & Twisk, 2018) should be taken into 
consideration when digesting the results, with objective methods used where 
possible.  
Upon evaluation of the physical activity data, it was observed that there was 
no influence of sex on physical activity or sedentary behaviour. In addition, 
there was no impact of age on sedentary time, or the lower intensity categories 
of physical activity. Interestingly, the data revealed there to be a decline in the 
number of hours spent engaged in VPA with older age between 60-80 years. 
This may be attributed to the decline in functional and physical capacity due to 
the ageing process (Milanovic et al., 2013). Thereby disrupting the ability to 
carry out strenuous physical activities such as exercise, which constitutes the 
VPA as assessed and reported from the objectively measured accelerometer 
data.  
The current study also reports that age and sex did not influence baseline 
25(OH)D3 concentration of the cohort. These data suggest that it is perhaps 
environmental or behavioural factors, such as UVB exposure, diet and physical 
activity status that predict vitamin D status. Although the current study did not 
investigate UVB exposure and diet, the primary aim of the investigation was to 
evaluate the physical activity status of older adults, and to explore whether 
there is an association between 25(OH)D concentration and physical activity 
categories including sedentary behaviour. The main finding was that the time 
spent engaged in vigorous activity was a predictor of systemic 25(OH)D3 
concentration. However, this was an inverse correlation, with a decline in 
25(OH)D3 with increased hours per week of vigorous activity. Although this 
finding may appear to contradict previously published data reporting higher 
levels of activity are linked to higher 25(OH)D3 concentrations (Jacques et al., 
1997; Lucas et al., 2005; Scragg & Camargo, 2008; Scragg et al., 1992; 
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Scragg et al., 1995), the time engaged in vigorous activity does not represent 
a measure of overall physical activity. Therefore, the current finding is specific 
to vigorous activity and is not wholly comparable. Furthermore, it may be that 
vigorous activity, such as exercise and sports, are performed indoors and thus 
reduces UVB exposure. Although, it has been reported that physical activity 
often occurs outdoors and thus increases UVB exposure and subsequently 
25(OH)D concentrations (Kluczynski et al., 2011). However, this association is 
not supported by all reports, with the nature of activity reported not to influence 
UVB exposure (Wanner et al., 2015). Therefore, it may be that factors other 
than sun exposure may be responsible for a higher vitamin D status, requiring 
further investigation.  
Vitamin D status is known to be influenced by season due to the alterations in 
UVB radiation throughout the calendar year. Specifically in Scotland, there is 
impaired UVB exposure due to the high latitude of the country (Gies et al., 
2004), reducing the skin synthesis source that contributes to vitamin D status. 
The current data observed a seasonal influence on 25(OH)D3 with 
concentrations lower in winter compared to summer months, similar to other 
investigations conducted in Scotland and the UK (Hypponen & Power, 2007; 
Kelly et al., 2015; Zgaga et al., 2011). Therefore, since season is a determinant 
of vitamin D status and physical activity status (Tucker & Gilliland, 2007) 
independently, it may follow that a relationship occurs between the three 
factors, complicating the associations further.  
In conclusion, there is an association between VPA and 25(OH)D 
concentration, however the link is not observed with lower intensities or 
sedentary time. Contrary to the hypothesis, there was no influence of age on 
25(OH)D concentration within an older adult cohort (60-80 years). In order to 
investigate whether age influences 25(OH)D status and draw any conclusions, 
a broader age span must be investigated.  
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Chapter 5: Influence of Age and CRF on 25-
hydroxyvitamin D Concentration and VDR 
Expression 
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5.1 Abstract 
It is well established that vitamin D plays a key role in calcium absorption and 
the prevention of ill-health, with blood 25(OH)D concentration used as the 
identifier of a person’s vitamin D status. However, the literature identifies the 
VDR as the main mediator of the vitamin D system. Therefore, the aim of this 
study is to investigate whether baseline 25(OH)D concentration is linked to 
cellular VDR expression, and subsequently whether these important 
metabolites are associated with age and CRF (a reliable surrogate for physical 
fitness).  
Thirty-five male adults participated in this study (age 44 ± 17 y, body mass 
82.5 ± 11.4 kg, height 1.79 ± 0.08 m, BMI 25.7 ± 3.1 kg·m-2). The participants 
were separated into three groups based on their age: young (18-30 y; n=12), 
young/mid (31-45 y; n=11), and older adults (60-75 y; n=12). CRF and peak 
power were assessed via a cycling V̇O2peak test, and baseline blood samples 
were collected and analysed for serum 25(OH)D concentration (LC-MS/MS) 
and T cell VDR expression (flow cytometry).  
As predicted and in line with the literature, CRF and peak power declined with 
age (P<0.001). Baseline 25(OH)D concentration was not influenced by age 
(P=0.774) or CRF (P=0.624). A correlation analysis was used, which reported 
no relationship between the two metabolites (P=0.793). Moreover, VDR 
expression declined with age (P=0.015), and a higher CRF was linked to a 
greater expression of VDR (P=0.048).  
The results indicate that intracellular VDR expression appears to be 
susceptible to influence by age and CRF, whereas the commonly reported 
measure of vitamin D metabolism and status: 25(OH)D concentration, is not.   
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5.2 Introduction 
Vitamin D3 is an important secosteroid hormone derived from direct sunlight 
exposure (UVB radiation) and food sources (Holick & Chen, 2008), playing an 
important role in most tissues and cells on a genome and transcription-wide 
level (M. J. Campbell, 2014; Carlberg, 2014). A low vitamin D status, assessed 
as 25-hydroxyvitamin D (25(OH)D), is associated with the development and 
prevalence of numerous age-related chronic diseases and conditions, as 
discussed in the literature review (Chapter 2). Observational studies have 
indicated that higher levels of physical activity are associated with higher 
circulating 25(OH)D concentrations, even after adjusting for UVB exposure 
(Kluczynski et al., 2011; Scragg & Camargo, 2008; Scragg et al., 1992). This 
suggests that independent of sun exposure, physical activity and exercise may 
directly influence 25(OH)D concentrations. This relationship between CRF and 
vitamin D status has been previously explored in a population living in the US, 
reporting that 25(OH)D concentrations are positively associated with CRF in 
men (Farrell, Cleaver, & Willis, 2011) and women (Farrell & Willis, 2012). 
However, since the UVB exposure is different according to latitude and thus 
country, this relationship may not stand in Scotland: a country with a 
remarkably low annual UVB exposure level. Furthermore, the effect of age on 
25(OH)D concentration was not explored.  
Although 25-hydroxyvitamin D3 (25(OH)D3), is used as the biomarker for 
vitamin D status, it is the biologically active form of vitamin D, 1,25(OH)2D3, 
and the VDR that provide the functional platform for vitamin D metabolism 
function (Haussler et al., 1998). Therefore, instead of debating the optimal 
systemic concentration/threshold level of 25(OH)D3 and 1,25(OH)2D3, it can 
be suggested that due to the human variance in vitamin D intake and predictors 
of vitamin D status (age, BMI, season, UVB exposure, location, training status) 
human individuals should be tested for vitamin D responsiveness. Since the 
action of vitamin D is through the transcription factor VDR (Carlberg & Molnar, 
2012), expression changes of VDR and target genes can serve as a direct 
measure for the functional outcome of vitamin D metabolism. It has been found 
that following a 24 h stimulation with 1,25(OH)2D3, more than 1,000 genes alter 
their mRNA expression (Heikkinen et al., 2011; Hossein-nezhad, Spira, & 
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Holick, 2013; Nurminen et al., 2015; Ramagopalan et al., 2010). This response 
relies on the ligand binding to the VDR, and subsequent binding of the ligand-
VDR-RXR complex to the VDRE on the DNA strand. The availability of 
unbound VDR to receive 1,25(OH)2D3 is thus imperative for this process to be 
functional and efficient. Therefore, focus on measuring baseline VDR and in 
response to stimuli may provide greater insight into the functional capacity of 
vitamin D metabolism, and the potential health benefits that can then be 
induced through vitamin D.  
It has previously been reported that VDR protein expression decreases in 
human skeletal muscle tissue as age advances (Bischoff-Ferrari, Borchers, et 
al., 2004). Whereas, in human systemic PBMCs it has been reported that there 
is no influence of age on baseline VDR levels, however this mixed sex cohort 
was limited to 50 years+ (Coleman et al., 2016). In addition, the measure of 
VDR levels reported differs between studies, whereby Bischoff-Ferrari et al. 
(2004) measured VDR protein levels, whereas Coleman et al. (2016) 
measured VDR mRNA expression. Pre- and post-transcriptional expression 
and regulation of receptors and proteins can be affected by age. In the current 
investigation, the age span extends from 18-45 and 60-75 years to evaluate 
whether VDR expression in PBMCs is lower in older adults compared to 
younger populations, in healthy active humans.  
The aim of this investigation was to determine whether age and the CRF of a 
healthy male population have an influence on vitamin D status and T cell VDR 
expression. A secondary aim is to determine whether there is a relationship 
between 25(OH)D and VDR at baseline.   
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5.3 Materials and methods 
5.3.1 Participants 
Thirty-five male adults participated in this study (see section 3.2.2: age 44 ± 
17 y, body mass 82.5 ± 11.4 kg, height 1.79 ± 0.08 m, BMI 25.7 ± 3.1 kg·m-2). 
The participants were separated into three groups based on their age (see 
section 3.2.2): young (18-30 y; n=12), young/mid (31-45 y; n=11), and older 
adults (60-75 y; n=12). Following consent and screening (see section 3.3), 
anthropometric measurements and BP were taken (see section 3.4 and 3.5).  
 
5.3.2 Blood sampling and analysis 
Baseline blood samples were collected via cannulation (see section 3.7.2), the 
number of participants sampled per month is displayed in Figure 16. Serum 
25(OH)D3 concentrations were quantified using liquid chromatography mass 
spectrometry (LC-MS/MS) (see section 3.9.2). Baseline T cell VDR expression 
was analysed via flow cytometry using PBMCs isolated from EDTA treated 
whole blood (see section 3.10).  
 
 
Figure 16 The number of participants sampled per month for the cohort 
(n=35).   
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5.3.3 Cardiorespiratory fitness assessment 
All participants completed a peak oxygen uptake (V̇O2peak) test (see section 
3.6) on a cycle ergometer as an assessment of CRF and peak power.  
 
5.3.4 Statistical analysis 
Data was analysed as outlined in section 3.11.  
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5.4 Results 
5.4.1 Participant characteristics 
Table 12 describes the characteristics of all the participants (n=35) within the 
study, and of each age group. One participant withdrew their data. Adherence 
to trials was reported as 100%. The post-hoc power calculation performed 
revealed that the study is statistically powered (P>0.95) based on a sample 
size of 35 with an effect size of 0.732 and Eta2 of 0.349.  
There were no significant differences between age groups for baseline 
characteristics except for diastolic BP (F(2,32)=7.447, P=0.002), whereby the 
young/mid group had a lower diastolic BP compared to the older group 
(P=0.001). Since there were no differences in body composition, as measured 
by body mass, BMI calculation, and waist and hip circumference, the groups 
can be appropriately compared in the analysis.  
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Table 12 ExVD study participant characteristics (n=35).  
 All (n=35) Young (n=12) Young/mid (n=11) Older (n=12) df F P value P value P value P value 
        Y v Y/M Y v O Y/M v O 
Age, y 44 ± 17 27 ± 2 38 ± 6 * 67 ± 4 †, ‡ 2, 32 284.735 <0.001 <0.001 <0.001 <0.001 
Height, m 1.79 ± 0.08 1.81 ± 0.06 1.77 ± 0.09 1.79 ± 0.09 2, 32 0.753 0.479 - - - 
Body mass, kg 82.5 ± 11.4 83.8 ± 13.0 80.9 ± 11.0 82.7 ± 10.8 2, 32 0.180 0.836 - - - 
BMI, kg·m-2 25.7 ± 3.1 25.6 ± 3.9 25.8 ± 2.5 25.9 ± 2.9 2, 32 0.030 0.970 - - - 
Waist circumference, 
cm 
89 ± 9 87 ± 10 87 ± 7 93 ± 10 2, 32 1.923 0.163 
- - - 
Hip circumference, 
cm 
95 ± 7 93 ± 9 94 ± 5 98 ± 6 2, 32 1.971 0.156 
- - - 
Waist-to-hip ratio 0.94 ± 0.06 0.93 ± 0.04 0.93 ± 0.05 0.95 ± 0.08 2, 32 0.320 0.728 - - - 
Resting HR, 
beats·min-1 
59 ± 9 58 ± 11 58 ± 5 61 ± 9 2, 32 0.493 0.615 
- - - 
Systolic BP, mmHg 122 ± 11 124 ± 10 119 ± 12 122 ± 11 2, 32 0.739 0.486 - - - 
Diastolic BP, mmHg 73 ± 8 73 ± 7 67 ± 5 78 ± 8 ‡ 2, 32 7.447 0.002 0.129 0.154 0.001 
All data is presented as mean ± SD. * represents a significant difference between young and young/mid (P<0.001); † represents a significant difference between 
young and older (P<0.001); ‡ represents a significant difference between young/mid and older (P<0.01).  
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5.4.2 Baseline 25-hydroxyvitamin D concentration and age 
The vitamin D status, determined by serum 25(OH)D concentration (ng∙ml-1, 
nmol∙L-1), of participants is shown in Table 13. There was no difference in 
vitamin D status between age groups (F(2,34)=0.258, P=0.774). Collectively, 
participants as a whole and in each age group, are defined as vitamin D 
deficient.  
 
Table 13 Systemic 25(OH)D concentration of participants (n=35).  
 All (n=35) Young (n=12) Young/mid (n=11) Older (n=12) 
25(OH)D, ng·ml-1 15.7 ± 6.4 15.1 ± 7.0 15.2 ± 5.6 16.8 ± 6.7 
25(OH)D, nmol·L-1 39.3 ± 15.9 37.7 ± 17.6 38.1 ± 14.0 42.0 ± 16.8 
Data shown as mean ± SD.  
 
Upon inspection, using the categories defined in the literature review (Chapter 
2), 40% of participants were severely deficient, 29% were deficient, and 31% 
were defined as insufficient (shown in Table 14). None of the participants had 
a vitamin D status in the sufficient category.  
 
Table 14 Categorical vitamin D status of participants (n=35).  
Category Concentration (ng·ml-1) N % 
Severely deficient <12 14 40 
Deficient 12-20 10 29 
Insufficient 20-30 11 31 
Sufficient >30 0 0 
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5.4.3 Baseline VDR expression and age 
As shown in Figure 17, age was found to influence baseline VDR expression 
in circulating T lymphocytes (F(2,34)=4.763, P=0.015), with older adults 
expressing less intracellular VDR compared to the younger cohort (P=0.014). 
There was no difference in VDR expression between the young/mid cohort and 
young (P=0.656) or older adults (P=0.113).  
 
 
Figure 17 VDR expression in circulating CD3+ T lymphocytes for each age 
group: young (n=12), young/mid (n=11), and older (n=12). Data presented as 
mean ± SD. * denotes a significant difference between the young and older 
cohort (P≤0.05).  
 
Figure 18 shows the correlations between baseline VDR expression of each 
T cell subset against age (n=35). There is a significant inverse relationship 
between VDR expression and age for CD3+ T cells (Figure 18 A; r=-0.39, 
P=0.022), CD4+ T cells (Figure 18 B; r=-0.39, P=0.020), and CD8+ T cells 
(Figure 18 C; r=-0.38, P=0.025). As age advances, there is a decline in density 
of the receptor within the cells.  
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Figure 18 Correlation between intracellular VDR expression and age in (A) 
CD3+ T cells (P<0.05), (B) CD4+ T cells (P<0.05), (C) CD8+ T cells (P<0.05). 
Each marker represents an individual participant’s data.   
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5.4.4 25-hydroxyvitamin D concentration and VDR expression 
As shown in Figure 19 there was no association between baseline 25(OH)D3 
concentration and T cell VDR expression (n=35, r=0.046, P=0.793).  
 
 
Figure 19 Correlation between baseline 25(OH)D3 concentration (ng∙ml-1) and 
CD3+ T cell VDR expression (geometric mean) at baseline (n=35). Each 
marker represents an individual participants’ data.  
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5.4.5 Influence of CRF 
The main outcome variables of the V̇O2peak test for all participants and each 
age group are shown in Table 15. Maximum HR (HRmax) recorded during the 
test differed between age groups (F(2,31)=13.041, P<0.001), with the older 
group reaching a lower HRmax compared to the young group (P<0.001) and the 
young/mid group (P=0.009). The respiratory exchange ratio (RER) achieved 
during the test was similar between groups (F(2,32)=0.2309, P=0.796), with a 
mean of 1.19 ± 0.05 (n=35), indicating participants performed to maximum 
capacity (Edvardsen, Hem, & Anderssen, 2014).  
Maximal V̇O2peak, expressed as both absolute and relative to body mass 
values, differed between age groups (F(2,32)=12.877, P<0.001; 
F(2,32)=10.894, P<0.001), whereby the older group had a lower CRF 
compared to the young (P<0.001; P=0.001) and young/mid groups (P=0.001; 
P=0.002).  
Similarly, for absolute and relative peak power, there was a significant 
difference between age groups (F(2,32)=9.335, P=0.001; F(2,32)=6.200, 
P=0.005), whereby the older group has a lower peak power output compared 
to the young (P=0.004; P=0.030) and young/mid groups (P=0.001; P=0.006). 
However, there were no significant differences between the young group and 
young/mid group for any of the maximal data variables.  
 
103 
 
Table 15 Cardiorespiratory fitness (CRF) outcomes (n=35).  
 
All 
(n=35) 
Young 
(n=12) 
Young/mid 
(n=11) 
Older 
(n=12) 
df F P value 
P value P value P value 
Y v Y/M Y v O Y/M v O 
Max RER 1.19 ± 0.05 1.20 ± 0.04 1.20 ± 0.06 1.19 ± 0.05  2,33 0.230 0.796 - - - 
HRmax, beats·min-1 175 ± 19 189 ± 10 178 ± 8 160 ± 20 *, † 2,33 13.041 <0.001 0.182 <0.001 0.009 
Absolute VȮ2peak, L·min-1 3.12 ± 0.64 3.49 ± 0.45 3.33 ± 0.63 2.54 ± 0.37 *, † 2,34 12.877 <0.001 0.706 <0.001 0.001 
Relative VȮ2peak, ml·kg-
1·min-1 
38.0 ± 8.2 42.1 ± 7.9 41.4 ± 7.2 30.9 ± 3.8 *, † 2,34 10.894 <0.001 0.966 0.001 0.002 
Absolute peak power, W 261 ± 60 282 ± 49 293 ± 61 212 ± 34 *, † 2,34 9.335 0.001 0.852 0.004 0.001 
Relative peak power, 
W·kg-1 
3.23 ± 0.88 3.45 ± 0.89 3.67 ± 0.85 2.61 ± 0.52 *, † 2,34 6.200 0.005 0.772 0.030 0.006 
All data is presented as mean ± SD. RER, respiratory exchange ratio; Y, young; Y/M, young/mid; O, older. * represents a significant difference between young 
and older; † represents a significant difference between young/mid and older (P≤0.05).  
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5.4.5.1 25-hydroxyvitamin D concentration and CRF 
There is no correlation between baseline 25(OH)D3 concentration and peak 
oxygen uptake (r=0.086, P=0.624), as shown in Figure 20.  
 
Figure 20 Correlation between 25(OH)D3 concentration and relative peak 
oxygen uptake (n=35). Each marker represents an individual participants’ 
data.  
 
There is no significant relationship between baseline 25(OH)D3 concentration 
and peak power output (r=0.145, P=0.407), as shown in Figure 21.  
 
Figure 21 Correlation between 25(OH)D3 concentration and relative peak 
power output (n=35). Each marker represents an individual participants’ data.   
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5.4.5.2 VDR expression and CRF 
There is a significant positive relationship between baseline VDR expression 
and peak oxygen uptake (r=0.336, P=0.048), as shown in Figure 22.  
 
Figure 22 Correlation between baseline CD3+ T cell VDR expression and 
relative peak oxygen uptake (n=35). Each marker represents an individual 
participants’ data.  
 
There is no correlation between baseline VDR expression and peak power 
output (r=0.195, P=0.263), as shown in Figure 23.  
 
Figure 23 Correlation between baseline CD3+ T cell VDR expression and 
relative peak power output (n=-35). Each marker represents an individual 
participants’ data.   
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5.4.5.3 CRF quartiles 
Table 16 presents characteristics of the population (n=35) divided into 
quartiles according to peak oxygen uptake (V̇O2peak) as a marker of CRF to 
determine what participant characteristics are associated with a lower or 
higher level of fitness. A higher value for V̇O2peak is associated with a younger 
population (P=0.005), with the top two quartiles expressing a lower age 
compared to the bottom two quartiles. A lower resting HR was also reported in 
the top two quartiles of CRF (P=0.026). Although, maximum HR did not 
statistically differ between quartiles (P=0.054). As expected, the higher the 
V̇O2peak score the greater peak power exerted (P<0.001).  
There was no association between V̇O2peak and 25(OH)D3 concentration 
(P=0.576), but there was with baseline VDR expression (P=0.033), with the 
top two quartiles linked to a higher expression.  
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Table 16 Characteristics of the population (n=35) divided into quartiles according to peak oxygen uptake.  
Quartiles Q1 Q2 Q3 Q4 ANOVA 
VO2peak (ml∙kg-1∙min-1) 23.7-31.1 31.1-38.4 38.4-45.8 45.8-53.2 df F P value 
N 8 12 6 9    
Age, y 58 ± 16 49 ± 20 32 ± 8 * 34 ± 9 * 3,34 5.253 0.005 
BMI, kg·m-2 27.8 ± 3.9 26.1 ± 2.2 23.9 ± 3.0 24.7 ± 2.7 3,34 2.648 0.066 
Resting HR, beats·min-1 67 ± 9 58 ± 7 57 ± 6 55 ± 9 * 3,34 3.551 0.026 
HRmax, beats·min-1 167 ± 24 169 ± 19 188 ± 8 184 ± 9 3,34 2.857 0.054 
Peak power, W∙kg-1 2.36 ± 0.50 2.81 ± 0.32 3.66 ± 0.53 * † 4.29 ± 0.58 * † 3,34 28.950 <0.001 
25(OH)D3 concentration, ng∙ml-1 14.5 ± 5.7 17 ± 6.9 13.2 ± 6.1 17.4 ± 6.8 3,34 0.672 0.576 
VDR expression, geomean 606 ± 258 721 ± 244 880 ± 299 * 853 ± 206 * 3,34 3.007 0.033 
Data presented as means ± SD. * denotes a significant difference to Q1 (P<0.05). † denotes a significant difference to Q2 (P<0.05). 
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5.4.5.4 Regression models 
A multiple linear regression was calculated to predict T cell VDR expression 
based on CRF variables determined by the cycle-based maximal oxygen 
uptake test, primarily V̇O2peak and peak power output. The results are displayed 
in Table 17.  
For CD3+ T cells, a significant regression equation was found (F(4,32)=3.436, 
P=0.044), with an R2 of 0.177. Specifically, V̇O2peak relative to body mass 
predicts CD3+ T cell VDR expression (P=0.026). Participants CD3+ VDR 
expression increased by 27.036 (geomean) for each measure (millilitre) of 
relative V̇O2peak (ml·kg-1·min-1).  
For CD4+ T cell, there was a non-significant regression equation reported.  
For CD8+ T cell, a significant regression equation was found (F(4,32)=4.353, 
P=0.021), with an R2 of 0.214. Post hoc analysis found absolute and relative 
V̇O2peak predicts CD8+ T cell VDR expression (P=0.038; P=0.011). Peak power 
did not predict VDR expression. Participants CD8+ VDR expression increased 
by 31.732 (geomean) for each measure (ml) of relative V̇O2peak (ml·kg-1·min-1), 
and by 276.141 (geomean) for each measure (L) of absolute V̇O2peak (L·min-
1).  
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Table 17 Multiple regression models between baseline T cell subset VDR 
expression and cardiorespiratory variables (relative and absolute measures).  
Independent 
variable 
Variables df R2 F P value 
CD3+ T cell 
VDR expression 
(regression) 2, 32 0.177 3.436 0.044 
 Absolute VȮ2peak, L·min-1    0.072 
 Relative VȮ2peak, ml·kg-1·min-1    0.026 
 Absolute peak power, W    0.420 
 Relative peak power, W·kg-1    0.126 
CD4+ T cell 
VDR expression 
(regression) 2, 32 0.167 3.200 0.054 
CD8+ T cell 
VDR expression 
(regression) 2, 32 0.214 4.353 0.021 
 Absolute VȮ2peak, L·min-1    0.038 
 Relative VȮ2peak, ml·kg-1·min-1    0.011 
 Absolute peak power, W    0.297 
 Relative peak power, W·kg-1    0.064 
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5.5 Discussion 
This is the first study to show that there is a link between the age and CRF of 
participants and their baseline VDR expression levels, whereby VDR 
expression declines with age and a higher CRF is related to a higher density 
of receptors in immune cells. There was a strikingly high percentage of 
participants that were vitamin D severely deficient (40 %), deficient (29 %) and 
insufficient (31 %), contributing to literature defining Scotland as a vitamin D 
deficient nation (Kelly et al., 2015; Weiss et al., 2016; Zgaga et al., 2011). 
However, despite the low vitamin D status, it was observed that there is no 
association between serum 25(OH)D concentrations and circulating 
lymphocyte VDR expression in healthy human males.  
The latter finding has been reported previously, whereby there was no 
relationship between serum concentrations of 25(OH)D or 1,25(OH)2D3 and 
intracellular VDR expression in human muscle tissue (Bischoff-Ferrari, 
Borchers, et al., 2004; Kinyamu et al., 1997). If the metabolites are not 
correlated, this may suggest that baseline expression of the VDR protein can 
be regulated by factors other than circulating 25(OH)D concentrations. This 
was observed in the current study, whereby VDR expression was associated 
with age and CRF whilst 25(OH)D concentrations were not.  
The decline in CRF with age is an established inverse relationship reported 
over the past few decades (Baur, Christophi, Cook, & Kales, 2012; Buskirk & 
Hodgson, 1987; Fitzgerald et al., 1997; Fleg et al., 2005; Hakola et al., 2011; 
Pollock et al., 1997; Wilson & Tanaka, 2000; Zimmerman et al., 2014), which 
the current study endorses. The findings of the current investigation observed 
no influence of age or CRF on baseline 25(OH)D3 concentration. The lack of 
influence of age on vitamin D status has been reported previously 
(Masoompour, Sadegholvaad, Larijani, & Ranjbar-Omrani, 2008). However, 
published investigations report a positive correlation to exist between serum 
25(OH)D3 concentration and CRF (Ardestani et al., 2011; Mowry, Costello, & 
Heelan, 2009). The contradicting results may be attributed to the nature of the 
physical activity or exercise, which may be performed outdoors and thus 
increasing exposure to UVB radiation, or indoors which may limit UVB 
exposure (Kluczynski et al., 2011). Therefore, the nature of physical activity 
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and exercise, which in turn increases CRF, may determine whether there is an 
association between CRF and 25(OH)D concentration, as UVB exposure may 
be surrogate for elevated 25(OH)D levels. As a result, the data surrounding 
vitamin D status and associations with lifestyle factors, such as physical 
activity and exercise, should be interpreted with caution. Although, it has been 
reported recently that vitamin D status is not influenced by indoor and outdoor 
activity (Wanner et al., 2015).  
In line with previous data (Bischoff-Ferrari, Borchers, et al., 2004), there is an 
established relationship between baseline VDR expression and age, with a 
lesser density of the receptor found in T cells as age advances. Although, 
Bischoff-Ferrari et al. (2004a) reported the decline with age in skeletal muscle 
cells, our decline was observed in systemic T cells. Since the VDR is found in 
numerous tissues within the body (Y. Wang, Zhu, & DeLuca, 2012), perhaps 
numerous cells types exhibit this age-induced influence on VDR. For example, 
an age-associated decline in the intestinal concentration of VDR has been 
reported in both rats (Horst, Goff, & Reinhardt, 1990) and humans (female) 
(Ebeling et al., 1992), with no change in serum markers of vitamin D 
(1,25(OH)2D3). Although, this has also been contradicted showing no 
difference in intestinal VDR between young and older women (Kinyamu et al., 
1997). A number of factors, such as sex, age, and calcium have been found to 
affect the expression of the VDR protein and the VDR gene in specific tissues 
(Y. Wang et al., 2012). Vitamin D status has been reported to influence VDR 
expression in the kidney (Healy, Zella, Prahl, & DeLuca, 2003) and bone (Zella, 
Kim, Shevde, & Pike, 2006), however not in the intestine. In addition, the cell 
isolation process can alter the gene transcription and expression (Ahn et al., 
2007), thereby potentially altering VDR protein and gene expression. 
Moreover, the regulation of VDR expression has been found to differ between 
murine and human blood cells (Janik et al., 2017). The difference between 
tissue and cell sources analysed for addressing VDR expression may explain 
the contradictory results in the literature. Ultimately, if age induces a decline in 
VDR expression in cells, it follows that there are less receptors available within 
the cell to receive and bind to the ligand, thus reducing the capacity of the 
heterodimer (VDR-RXR-ligand) complex forming and translocating to the 
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nucleus (as outlined in the literature review). Therefore, the genomic and 
transcriptional alterations induced by the vitamin D complex, may be 
compromised. However, findings should be noted as specific to the species 
and tissue type analysed and the analysis methods, as all findings may not be 
translated into other cell types, or from murine models to humans.  
In the current study, the VDR expression was measured in CD3, CD4 and CD8 
T lymphocytes to identify whether there was a difference between subsets. It 
was found that CD3 and CD8 T cell VDR expression was predicted by CRF 
whereas CD4 T cell VDR expression was not. In previous studies it has been 
reported that training status influences the lymphocyte repertoire composition 
of naïve and senescent CD4 and CD8 T cells at rest (Spielmann et al., 2011) 
and in response to exercise (Brown et al., 2014). A higher maximal aerobic 
capacity exhibits a lymphocyte profile with more naïve CD8 T cells and less 
senescent CD4 and CD8 T cells (Spielmann et al., 2011). In support of this, it 
has been repeatedly demonstrated that the CD8 T lymphocyte is more 
responsive to exercise than its CD4 counterpart (Anane et al., 2009; J. P. 
Campbell, Guy, Cosgrove, Florida-James, & Simpson, 2008; R. J. Simpson et 
al., 2008; R. J. Simpson, Florida-James, Cosgrove, et al., 2007), with 
mobilisation of the senescent lymphocytes in response to exercise allowing for 
egress into tissues and freeing up space for naïve cells to accumulate in their 
place (R. J. Simpson, 2011). Although, it is not known whether there is a 
differing expression of VDR in naïve and senescent cells, it has been reported 
that 25(OH)D3 concentrations are inversely associated with naïve T cells 
(Hwang et al., 2013). This suggests a link between vitamin D metabolism and 
the T cell pool composition. Furthermore, it has been found that in terms of the 
total lymphocyte population, the highest concentrations of VDR are found in 
CD8 lymphocytes (Veldman et al., 2000). Therefore, selective mobilisation of 
CD8 T cells with higher levels of VDR expression, may be beneficial for 
immune health. Further investigations are required in the area to aid 
understanding of the relationship between vitamin D metabolism and 
lymphocyte populations.  
It should also be taken into consideration that although people in Scotland 
whom do not consume vitamin D supplements are deficient in vitamin D at 
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baseline, 25(OH)D is always present and bioavailable in the circulation, shown 
through the mean recorded serum 25(OH)D concentration of 15.7 ± 6.4 ng·ml-
1 in the current investigation. Therefore, there is always capacity for the 
conversion of 25(OH)D3 to the ligand 1,25(OH)2D3 and thus binding to the VDR 
within a target cell. However, the VDR must be available for binding if the 
vitamin D metabolic pathway is to be efficiently fulfilled. Thus strategies to 
increase VDR expression may be more valuable than strategies solely to 
increase 25(OH)D concentrations considering the metabolites may be 
independent of one another.  
In summary, the findings show that baseline VDR expression declines with age 
and is positively associated with a higher CRF. There was no observed 
association between the two key systemic vitamin D metabolites at baseline: 
25(OH)D concentration and VDR expression and circulating 25(OH)D 
concentrations observed no relationship with either age or CRF.  
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Chapter 6: Effect of Exercise on T Cell VDR 
Expression 
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6.1 Abstract 
It has previously been reported that exercise can upregulate cellular VDR 
expression, however studies are limited to murine and in vitro models. This 
study aimed to determine whether a single bout of exercise upregulates VDR 
expression in a human population and explore whether age affects the 
response.  
As in Chapter 5, thirty-five male adults participated in this study (age 44 ± 17 
y, body mass 82.5 ± 11.4 kg, height 1.79 ± 0.08 m, BMI 25.7 ± 3.1 kg·m-2). The 
participants were separated into three groups based on their age: young (18-
30 y; n=12), young/mid (31-45 y; n=11), and older adults (60-75 y; n=12). 
Participants completed three trials: control, endurance exercise and resistance 
exercise, with blood samples collected pre- and post-exercise bout/control rest 
period (pre, 0 h, 1 h, 3 h). Systemic T cells (CD3+, CD4+, CD8+) were isolated 
from whole blood and analysed for VDR expression (flow cytometry).  
Both modalities of exercise, endurance (P<0.001) and resistance (P=0.001), 
induced an increase in VDR expression immediately upon cessation of the 
exercise, with the endurance bout promoting a greater increase in VDR 
expression compared to RE (P=0.048) The effect was acute, as VDR 
expression dropped to baseline level after 3 h post-exercise. The response 
was unaffected by age despite the difference in baseline VDR expression at 
rest (Chapter 5). Moreover, there was no correlation between change in T cells 
and change in VDR expression in response to exercise.  
The results indicate that a single bout of exercise is an effective way to 
increase intracellular VDR expression in immune cells. The upregulation in 
VDR protein expression may be independent of T cell mobilisation in response 
to exercise, and independent of age.   
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6.2 Introduction 
Vitamin D is classically regarded as a key regulator in bone health, playing a 
role in calcium and phosphate homeostasis. However, numerous tissues have 
now been identified in the literature as vitamin D active (Y. Wang et al., 2012) 
through the binding of the biologically active form of vitamin D, 1,25(OH)2D3, 
to its specific receptor, the VDR. This resulting complex translocates to the 
nucleus where it binds to VDREs in DNA and regulates the expression of target 
genes and thus their products (Pike & Meyer, 2010; Pike et al., 2012), which 
are involved in the pathophysiology of numerous diseases. Therefore, cellular 
expression of the VDR is vital for this pathway to function efficiently.  
Exercise has been shown to be an efficient stimulus to upregulate 25(OH)D 
concentrations in a human population (Sun et al., 2017). Emerging data are 
now suggestive that acute mechanical stress, i.e. exercise, can impact vitamin 
D metabolism at a cellular level, inducing an upregulation of the VDR (Aly et 
al., 2016; Makanae et al., 2015). To the best of our knowledge, the effects of 
exercise on VDR expression have not yet been investigated in a human 
population. Moreover, due to the differing findings surrounding exercise 
modality and fibre type recruitment (Ceglia et al., 2013; Makanae et al., 2015; 
Widegren et al., 2000), both endurance and resistance exercise will be 
included in the current investigation.  
For the purpose of the current investigation, PBMCs, specifically T cells, which 
are representatives of the innate and adaptive immune system, are most 
suited as they are obtained through less invasive procedures to the human 
participant and can be easily isolated for flow cytometry staining and analysis. 
Moreover, exercise activates T lymphocytes (Siedlik et al., 2017), and with the 
VDR found in activated T cells (Baeke, Korf, et al., 2010; Baeke, Takiishi, et 
al., 2010; Bhalla et al., 1983; Provvedini et al., 1983), this marks them as a 
strong contender to determine the effect exercise may have on vitamin D 
metabolism.  
The primary aim of this study was to investigate whether a single bout of 
endurance and resistance exercise can increase VDR expression in immune 
cells. The secondary aim was to examine if this response to exercise is 
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influenced by age. The tertiary aim was to explore the changes in T cell 
concentration in response to exercise, and whether this influences the 
exercise-induced increase in VDR expression. It was hypothesised that 
exercise will acutely upregulate VDR expression in T cells. Although, it is 
explorative as to whether both exercise modalities will induce alterations in 
VDR expression in a human population.   
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6.3 Materials and methods 
6.3.1 Participants 
Thirty-five male adults participated in this study (see section 3.2.2: age 44 ± 
17 y, body mass 82.5 ± 11.4 kg, height 1.79 ± 0.08 m, BMI 25.7 ± 3.1 kg·m-2). 
The participants were separated into three groups based on their age (see 
section 3.2.2): young (18-30 y; n=12), young/mid (31-45 y; n=11), and older 
adults (60-75 y; n=12). Participant characteristics are presented in Chapter 5 
(see section 5.4.1). Following the power analysis calculation (section 3.2.2.1), 
participants were recruited on a rolling basis over the projected 12 month time 
frame for the ExVD study. The number of participant trials per month and thus 
the month of blood sampling for each trial during the 12 month study time frame 
is displayed in Table 18.  
 
Table 18 The number of participant trials per month.  
Month Total trials CON EE RE 
January 8 3 3 2 
February 13 4 5 4 
March 3 1 0 2 
April 3 1 1 1 
May 14 5 5 4 
June 14 6 4 4 
July 5 1 2 2 
August 11 4 4 3 
September 9 2 4 3 
October 9 5 1 3 
November 8 1 3 4 
December 7 2 3 2 
Total 104 35 35 34 
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6.3.2 Preliminary measurements 
Participants performed a V̇O2peak test (see section 3.6, and CRF outcomes in 
section 5.4.5) to set the intensity of the endurance exercise (EE), and a 
familiarisation of the resistance exercise (RE) protocol to allow correct 
positioning of the participant on the dynamometer (1 set of 4 repetitions of the 
RE protocol was performed, see section 6.3.3.3).  
 
6.3.3 Trials 
Participants were randomly assigned to a continuous moderate intensity EE 
trial or a RE trial, adapted from Makanae et al. (2015), or a control trial as 
shown in Figure 24. Randomisation was performed by an online generator 
that creates random permutations of treatments for situations where 
participants (n=36) were to receive all of the “treatments” (trials: CON, EE, RE) 
in random order (SEED number 22520, performed on 04/04/2017). For each 
visit, participants arrived to the laboratory between 7.30-8.30am in a fasted 
state (10 h). A baseline blood sample was collected via cannulation (see 
section 3.7.2), with the randomly assigned exercise performed promptly after, 
or a 1 h rest period during the control trial. Blood samples were collected 
immediately post-, 1 h post-, 3 h post-cessation of the exercise/rest period (Kim 
et al., 2005; Makanae et al., 2015) and were handled as previously described 
in sections 3.7 and 3.8. Participants remained seated and rested for the 3 
hours post-exercise/rest period. HR was continuously monitored (Polar, 
RS400, Finland) throughout each trial. Trials were separated by at least 7 days 
to allow recovery.  
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Figure 24 Schematic diagram of the protocol and time of blood sampling for 
each of the three trials: CON, EE, RE (top to bottom, respectively).  
 
6.3.3.1 CON trial 
During the control trial, participants remained seated for 1 h.  
 
6.3.3.2 EE trial 
The EE trial consisted of a continuous 60 min cycling bout on an electronically 
braked cycle ergometer (Lode, Corival CPET, Netherlands) at 55% V̇O2peak to 
correspond to an intensity below estimated lactate threshold in untrained 
males (Joyner & Coyle, 2008). The wattage set during the protocol was based 
on the workload (wattage) achieved at 55 % of V̇O2peak. Participants were 
instructed to maintain a pedalling rate between 70-80 rpm for the duration of 
the trial.  
 
6.3.3.3 RE trial 
The RE trial was designed to replicate the protocol utilised in the study by 
Makanae et al. (2015) and consisted of 5 sets of 10 repetitions of 3 s isometric 
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MVCs on an isokinetic dynamometer (HUMAC Norm Cybex, CSMi Medical 
Solutions, USA), with 7 s rest intervals between repetitions and 3 min recovery 
between sets. Participants were seated with dominant leg fixed, with a knee 
joint angle of 90° flexion (with straight leg representing anatomical zero), and 
ankle attached just superior to malleoli to a strain gauge. Since the duration of 
the RE protocol was 19 min, the participant rested for 41 min prior to the 
exercise. This ensured blood sampling time points were standardised.  
 
6.3.4 Experimental controls 
Participants were asked to complete a 24 h food diary for the day prior to the 
trials, and asked to abstain from consuming foods that are natural or fortified 
sources of vitamin D3 (Holick et al., 2011), with a list of food items provided to 
participants (Appendix 6). Participants were asked to maintain their habitual 
diet and activity in between trials, with trials separated by at least 7 days to 
allow for muscle recovery and vascular healing from blood collection. If 
participants reported they had been on a holiday outside of the UK to a sunny 
destination, they were not sampled for a minimum of 2 months post-holiday, to 
avoid any influence of increased UV exposure as a result of foreign holidays 
on vitamin D status and metabolism (Weiss et al., 2016). During the 12 months 
of data collection the weather conditions, in particular the statistical summary 
for ‘Sunshine’, was representative of the average for the UK (100% of the 
1981-2010 average) as reported by the Meteorological Office 
(www.metoffice.gov.uk/climate/uk/summaries/2017/annual).  
 
6.3.5 Blood sampling and analysis 
Baseline blood samples were collected via cannulation (see section 3.7.2). 
Upon collection, EDTA treated whole blood was analysed for full 
haematological profile (see section 3.8). All haematological data were adjusted 
to account for any changes in plasma volume (PVC) from baseline using the 
method outlined by Dill and Costill (Dill & Costill, 1974). This procedure is 
required to ensure that any changes in cells in response to trials in this study 
is a movement of cells in/out of the circulation, rather than a 
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concentration/dilution effect due to alterations in plasma levels. The PVC (%) 
during each trial is shown in Figure 25, and were analysed via paired samples 
t-tests, with all differences reported as highly significant (P<0.001).  
 
Figure 25 The change in plasma volume (%) during the three trials (n=35): 
CON (A), EE (B), and RE (C). * denotes a significant difference between 
changes in plasma volume (P≤0.05).  
 
Whole blood was collected at each time-point, with PBMCs subsequently 
isolated and CD3+, CD3+CD4+, and CD3+CD8+ T cell VDR expression was 
analysed via flow cytometry (see section 3.10). Absolute T cell subset 
concentration was calculated based on the haematological data. The 
correction factor for PVC (percentage change) was then applied to the T cell 
concentration data and the T cell VDR expression data (geomean). 
 
6.3.6 Statistical analysis 
Full statistical analysis is outlined in section 3.11.   
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6.4 Results 
6.4.1 Trial heart rate data 
The mean and maximum HR response to each trial is shown in Figure 26. 
There was no difference in HR between age groups during the CON trial rest 
period. There was a main effect of trial (CON, EE, RE) on the mean HR 
recorded (F(2,60)=463.090, P<0.001), with a trial by age group interaction 
(F(4,60)=4.169, P=0.005), whereby mean HR was higher in the young group 
compared to the older group (P=0.017) for both EE and RE. Similar results 
were found for maximum HR during the sessions, with a main effect of the trial 
(F(2,60)=369.925, P<0.001), and a trial by age group interaction 
(F(4,60)=4.086, P=0.005) reported, whereby maximum HR was higher in the 
young compared to the older cohort (P=0.001) for both EE and RE.  
 
Figure 26 Mean and maximal HR data for each trial for young (n=12), 
young/mid (n=11), older (n=12) adults. All data are presented as mean ± SD. 
* represents a significant within subject effect of the trial (P<0.001). † 
represents a significant difference between young and older (P≤0.05).   
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6.4.2 Exercise and VDR expression 
The intracellular T cell VDR expression is expressed as fold change, to allow 
for comparison between trials and age groups relative to the change as 
opposed to absolute value due to baseline VDR expression differences 
between the age groups (as seen in section 6.4.2). The change in VDR 
expression (CD3 T cells) in response to EE and RE compared to the CON trial 
is shown in Figure 27. There was a main effect of time (F(3,96)=21.128, 
P<0.001) on the response of VDR expression to exercise, with a significant 
interaction effect (trial*time) observed (F(6,192)=6.241, P<0.001). There was 
a significant effect of the trial/modality on VDR expression (F(2,64)=7.005, 
P=0.002), with EE inducing a greater increase in VDR expression compared 
to RE (P=0.048) and the CON (P=0.002). Moreover, RE upregulated VDR 
expression compared to the CON (P=0.047).  
 
Figure 27 Effect of endurance and resistance exercise on VDR expression 
(n=35). Data presented as mean ± SD. * denotes a significant main effect of 
time (P≤0.05). † denotes a significant main effect of the trial (P≤0.05). a 
represents a significant difference from PRE; b represents a significant 
difference from 0h (P≤0.05).  
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6.4.2.1 CD3+ T cells 
The change in CD3+ T cell VDR expression of each age group in response to 
the three trials is shown in Figure 28. There was no change in CD3+ T cell 
VDR expression during the 4 hour CON trial (Figure 28 A, F(3,93)=0.769, 
P=0.514).  
There was a significant main effect of the EE trial on VDR expression (Figure 
28 B, F(3,93)=16.639, P<0.001), with an increase at the 0 h time point 
(P<0.001) and the 1 h post-exercise time point, compared to baseline 
(P=0.002).  
There was a main effect of the RE trial on VDR expression (Figure 28 C, 
F(3,96)=7.401, P=0.001), with an increase immediately after exercise (0 h) 
compared to baseline (P<0.001) and then a decrease at the 1 h compared to 
0 h post-exercise time point (P=0.014).  
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Figure 28 Changes in T cell CD3+VDR+ expression, expressed as fold 
change during each trial for the (A) CON trial, (B) EE trial, (C) RE trial. Data 
presented as mean ± SD. * denotes a significant main effect of the trial 
(P<0.05).  † denotes a significant difference from PRE (P<0.05). ‡ denotes a 
significant difference from 0 h (P<0.05).  
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6.4.2.2 CD4+ T cells 
The change in CD4+ T cell VDR expression in response to each of the trials is 
shown in Figure 29. There was no change in receptor expression during the 
CON trial (Figure 29 A, F(3,93)=0.757, P=0.521).  
There was a main effect of the EE trial on CD4 T cell VDR expression (Figure 
29 B, F(3,90)=10.760, P<0.001), with an increase at the 0 h time point 
(P<0.001) and the 1 h post-exercise time point, compared to baseline 
(P=0.001).  
There was a main effect of the RE trial on CD4 T cell VDR expression (Figure 
29 C, F(3,96)=12.730, P<0.001), with an increase immediately after exercise 
(0 h) compared to baseline (P<0.001) and then a decrease at the 1 h compared 
to 0 h post-exercise time point (P=0.036).  
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Figure 29 Changes in T cell CD3+CD4+VDR+ expression, expressed as fold 
change during each trial for the (A) CON trial, (B) EE trial, (C) RE trial. Data 
presented as mean ± SD. * denotes a significant main effect of the trial 
(P≤0.05).  † represents a significant difference from PRE (P≤0.05). ‡ denotes 
a significant difference from 0 h (P≤0.05).  
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6.4.2.3 CD8+ T cells 
The change in CD8+ T cell VDR expression in response to each of the trials is 
shown in Figure 30. There was no effect of time on the CD8+ T cell VDR 
expression fold change during the CON trial (Figure 30 A, F(3,93)=0.473, 
P=0.686). There was a main effect of the EE trial, and the RE trial on CD8+ T 
cell VDR expression.  
There was a main effect of the EE trial on CD8 T cell VDR expression (Figure 
30 B, F(3,93)=8.329, P<0.001), with an increase at the 0 h time point 
(P=0.001) and the 1 h post-exercise time point (P<0.001), compared to 
baseline.  
Similarly, there was a main effect of the RE trial on CD8 T cell VDR expression 
(Figure 30 C, F(3,96)=6.437, P=0.001), with an increase immediately after 
exercise (P<0.001) and at the 1 h time point (P<0.001) compared to baseline.  
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Figure 30 Changes in T cell CD3+CD8+VDR+ expression, expressed as fold 
change during each trial for the (A) CON trial, (B) EE trial, (C) RE trial. Data 
presented as mean ± SD. * denotes a significant main effect of the trial 
(P≤0.05).  † represents a significant difference from PRE (P≤0.05).  
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6.4.3 Acute T cell response to exercise 
There was a main effect of time on the CD3+ T cell response to the three trials 
(F(3,93)=16.066, P<0.001), with a significant interaction effect (trial*time) 
observed (F(6,186)=13.493, P<0.001), whereby there was a difference 
between trials (CON, EE, RE) at the 0 h time point (F(2,100)=6.115, P=0.003), 
but not at the other time points. At the 0 h time point, CD3 T cell number was 
elevated in response to the EE bout compared to CON (P=0.002). However, 
there was no difference between the other trials.  
The CD3+, CD4+ and CD8+ T cell response to each trial is presented in Table 
19. There was an increase in T cell number in response to both EE and RE, 
which falls in line with the classic acute response to exercise that is well 
established in the literature. There was also a main effect of time during the 
CON trial in CD3+ and CD4+ T cells. There was no interaction effect (time*age 
group) during any of the trials, and thus no influence of age group.  
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Table 19 The T cell response to each trial (n=35).  
  Time points Main effect of time Interaction effect 
  PRE 0h 1h 3h df F P value df F P value 
CON CD3 1011 ± 479 1011 ± 502 1088 ± 496 1124 ± 529 3,96 3.468 0.043 6,96 0.517 0.704 
 CD4 554 ± 232 543 ± 242 587 ± 218 613 ± 247 3,96 3.436 0.039 6,96 0.414 0.794 
 CD8 355 ± 239 360 ± 250 384 ± 264 392 ± 275 3,96 2.327 0.106 6,96 0.597 0.732 
EE CD3 976 ± 506 1505 ± 913 891 ± 417 1001 ± 474 3,96 20.228 <0.001 6,96 0.977 0.409 
 CD4 526 ± 238 683 ± 363 491 ± 218 544 ± 246 3,96 8.326 <0.001 6,96 0.778 0.516 
 CD8 344 ± 257 611 ± 523 302 ± 185 351 ± 213 3,96 17.232 <0.001 6,96 0.493 0.656 
RE CD3 1012 ± 462 1204 ± 615 1027 ± 500 1106 ± 556 3,96 7.669 <0.001 6,96 1.621 0.168 
 CD4 544 ± 210 589 ± 242 547 ± 233 606 ± 264 3,96 2.895 0.039 6,96 0.857 0.529 
 CD8 349 ± 231 450 ± 311 356 ± 233 379 ± 254 3,96 13.912 <0.001 6,96 1.794 0.131 
All data is presented as mean ± SD.   
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6.4.4 Change in circulating T cells 
The change in circulating concentration of T cell subsets in response to a 
single bout of EE and RE is presented in Figure 31, showing the differences 
between age groups. This potentially represents the mobilisation of T cell 
subsets into the circulation and out of the circulation. There is a large increase 
of CD3, CD4, and CD8 T cells from pre- to immediately post-exercise (Figure 
31 A), followed by a large decrease from post-exercise to 1 h post-exercise 
(Figure 31 B).  
Although, when analysing the difference between age groups statistical 
significance was only observed for the egress of CD3 T cells in response to 
the EE (F(2,33)=5.140, P=0.012) and RE trials (F(2,33)=5.104, P=0.012), and 
CD4 T cells in response to the EE trial (F(2,33)=4.022, P=0.028). Following 
the EE bout, the younger cohort compared to the older cohort redistributed 
significantly more CD3 T cells (P=0.013) and CD4 T cells (P=0.027) from the 
circulation to surrounding tissues. In response to the RE bout, the egress of 
CD3 T cells was greater in the young compared to the young/mid (P=0.023) 
and older group (P=0.030). There was no significant difference between age 
groups in the CD8 T cell circulating concentration.  
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Figure 31 The change in circulating T cell subset concentration in response to 
exercise: (A) the increase immediately after exercise and (B) the decrease 1 
h after exercise in young (n=12), young/mid (n=11), older (n=12). * represents 
a significant difference between age groups (ANOVA: P≤0.05). † denotes a 
significance difference compared to young (post hoc analysis: P≤0.05).   
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6.4.5 VDR expression and acute T cell response 
Figure 32 A and B demonstrate the difference in cell concentration and VDR 
expression within the cells, respectively. There is a significant difference 
between ultimate cell number in circulation, and the density of the receptor 
within those cells, at the 0 h post-exercise (CD8+ T cells, P=0.036) and 1 h 
post-exercise (CD3+ T cells, P=0.003; CD4+ T cells, P=0.005; CD8+ T cells, 
P=0.006) time points during the EE trial, and the 3 h post-exercise time point 
during the RE trial (CD8+ T cells, P=0.031). The decline in cell number follows 
the biphasic response, with a substantial decrease 1 h after exercise 
cessation, however the VDR expression remains elevated, indicating that VDR 
expression is increased in T cells after exercise.  
To further explore this, the correlation analyses between the delta change in 
cell number and the delta change in VDR expression (geomean), from each 
time-point to the next, are presented in Table 20. There is no relationship 
between cell number in the circulation and the expression of the receptor in 
CD3 and CD4 T cells during the EE trial. There is a correlation for CD8 T cells 
from 1 h post- to 3 h post-exercise, whereby there is an increase in cell number 
but a decrease in VDR expression. There were no correlations between 
change in cell number and VDR expression during the RE trial.  
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Figure 32 Percentage change of T cells (solid bars) and T cell VDR expression 
(lines) during (A) EE (n=35) and (B) RE (n=35) trial. Data presented as mean 
± SEM. Significant differences between T cell concentration and VDR 
expression within the cells are denoted on the figures by: a CD3+ T cells; b 
CD4+ T cells; c CD8+ T cells (P<0.05).   
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Table 20 Correlations between delta change in cell number and delta change 
in VDR expression (n=35).  
   ∆ cell number ∆ VDR expression Correlation P value 
EE CD3 Pre-0h 545 ± 629 300 ± 332 -.145 0.406 
  0h-1h -631 ± 684 -155 ± 289 -.029 0.871 
  1h-3h 113 ± 236 -113 ± 240 .331 0.052 
 CD4 Pre-0h 158 ± 308 229 ± 284 0.558 0.558 
  0h-1h -192 ± 318 -96 ± 285 -.061 0.728 
  1h-3h 53 ± 128 -104 ± 230 .114 0.515 
 CD8 Pre-0h 267 ± 322 229 ± 358 -.212 0.221 
  0h-1h -309 ± 393 -74 ± 311 -.025 0.884 
  1h-3h 49 ± 107 -135 ± 273 .344 0.043 
RE CD3 Pre-0h 192 ± 279 137 ± 142 -.048 0.783 
  0h-1h -177 ± 274 -80 ± 227 .055 0.752 
  1h-3h 79 ± 227 -12 ± 366 -.095 0.587 
 CD4 Pre-0h 45 ± 134 105 ± 166 -.136 0.438 
  0h-1h -41 ± 142 -50 ± 154 .150 0.390 
  1h-3h 59 ± 146 -111 ± 185 .102 0.560 
 CD8 Pre-0h 101 ± 115 157 ± 189 -.046 0.794 
  0h-1h -94 ± 119 -21 ± 157 -.030 0.863 
  1h-3h 23 ± 74 -64 ± 370 -.126 0.472 
All data is presented as mean ± SD.   
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6.5 Discussion 
This is the first study to show that a single bout of endurance and resistance 
exercise can increase T cell VDR expression in male adults. The data shows 
that VDR expression increases in line with T cell elevations in circulation, which 
may be due to either 1) selective ingress of T cells with high levels of VDR 
expression, or 2) upregulation of VDR protein expression in circulating T cells. 
However, the changes in cell number in response to exercise are not 
correlated with the change in intracellular VDR expression, suggesting that the 
acute increase in VDR expression may be exercise-induced and not cell 
mobilisation-induced thus independent of the redistribution of T cells observed 
in response to exercise. Moreover, despite the decline in baseline VDR 
expression with age (found in Chapter 5), the response to exercise was not 
influenced by age.  
Previous studies have demonstrated that exercise can increase serum 
25(OH)D concentration in humans (Sun et al., 2017) and myocyte VDR 
expression in rats (Aly et al., 2016; Makanae et al., 2015), presenting a 
strategic intervention to favour metabolism of vitamin D. The current study 
demonstrated that an acute bout of both resistance and endurance exercise 
can upregulate VDR expression in systemic blood T cells from a human male 
population. In the study by Makanae et al. (2015), only resistance exercise 
augmented intramuscular VDR expression, suggesting the response may 
differ between species and/or cell type.  
It is well established that exercise induces alterations of blood lymphocytes, 
with an initial rise in lymphocyte count followed by an immediate decline post-
exercise in the recovery phase (Kruger & Mooren, 2007; Nieman, 1994; 
Nieman et al., 1991; M. Ross et al., 2016; R. J. Simpson, Florida-James, 
Cosgrove, et al., 2007). The current investigation observed this response with 
an increase in lymphocytes in response to both an acute bout of endurance 
and resistance exercise. The rise in lymphocytes is usually attributed to cell 
mobilisation and redistribution from tissues into the circulation, which can be 
induced by a trigger or stimuli such as exercise (McCarthy & Dale, 1988; R. J. 
Simpson, Florida-James, Cosgrove, et al., 2007; Witard et al., 2012). The lack 
of correlation between change in T cell concentration in the blood and VDR 
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expression in the T cells suggests that the upregulation in VDR expression 
may not be dependent on mobilisation of cells but an increase in the VDR 
protein within the cells.  
Since the current investigation was conducted in T cells, it is important to 
determine what the physiological role of the VDR is in T cells and thus the 
impact of the acute upregulation. A paracrine mode of action of vitamin D in 
the immune system is suggested by the regulated presence of both the 
activating enzyme, CYP27B1, and the VDR in immune cells. The effect of 
ligand-activated VDR on key genes involved in the immune system, also points 
toward a physiological role for vitamin D in immune health. One approach to 
determine the role of VDR in the immune system is to study mice lacking the 
VDR: the VDR knock out (KO) mouse. These mice exhibit impaired bone 
formation (Kato et al., 1999) but no abnormalities in the numbers and types of 
cells present (Mathieu et al., 2001). Specifically, the latter study observed 
equivalent distributions of T cells (CD4 and CD8) in peripheral blood and in 
other lymphoid organs (bone marrow, spleen, thymus, lymph node) of wild-
type mice and the VDR KO mice. There is also no effect of VDR deficiency on 
the number of naïve and or memory CD4 cells. Similarly, it was reported that 
relatively small changes in CD4 T cells do not explain the increased 
autoimmunity that develops in VDR KO mice. Taken together these data 
suggest that it is not the change in T cell number that impacts VDR expression 
and the genomic and non-genomic actions of the VDR. Therefore, it is 
reasonable to suggest that exercise-induced changes in VDR expression in T 
cells may not be attributable to alterations in T cell number and type per se, 
but potentially the quantity of receptors within the cells.  
The VDR has a relatively short half-life of 1.7 h in untreated T cells and 2.9 h 
in T cells treated with 25(OH)D (Kongsbak, von Essen, Boding, et al., 2014). 
The VDR is degraded in the cytosol and nucleus, with 1,25(OH)2D3 
upregulating the VDR by increasing VDR mRNA expression and/or stabilising 
the VDR at the protein level by protecting it from proteasomal degradation 
(Kongsbak, von Essen, Boding, et al., 2014). The acute increase in VDR 
protein expression observed in the current study in response to exercise may 
be short-term due to the short half-life of the VDR. If the exercise bout 
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increases intracellular VDR expression with an immediate decline during the 
hour after the exercise, this may suggest that the VDR begins to degrade upon 
cessation of the physical demand. Therefore, the benefit of exercise for vitamin 
D and VDR metabolism may be very short-term. It is currently unknown 
whether regular exercise training could increase the half-life of the VDR and/or 
the rate of expression, thereby raising baseline VDR expression.  
The response of VDR expression to an acute bout of exercise was found not 
to be influenced by age. Ageing is associated with an accumulation of 
senescent T cells. Immune cell senescence, simply the process of ageing of 
cells, occurs as a “consequence of chromosome telomere shortening in 
response to repeated antigenic stimulation and/or excessive exposure to 
oxidative stress” (R. J. Simpson, Florida-James, Whyte, et al., 2007). 
Senescent T cells do not follow the same path as younger cells, whereby they 
go through rounds of cell division and result in different phenotypes, they can 
no longer enter the cell division cycle, and thus become dysfunctional within 
the immune system. This may affect the T cell VDR response to exercise, as 
the biological ageing of cells can result in reduced expression of receptors and 
antigens, and thus intracellular VDR expression. Although biological ageing 
does not necessarily correspond with chronical ageing, older persons will likely 
have a greater accumulation of senescent cells (R. J. Simpson, Florida-James, 
Whyte, et al., 2007), which can then influence the baseline expression of key 
receptors, such as the VDR. It could also be hypothesised that this would then 
affect the response to exercise, however in the current study there was no 
effect of age on the response of T cell VDR expression to either modes of 
exercise. This may indicate that the response of cellular VDR metabolism 
responds to exercise regardless of chronological age of the individual. 
Therefore, although baseline VDR expression is lower in older adults (Chapter 
5), exercise is effective at inducing a substantial increase in the expression of 
receptors regardless of age.  
The current investigation incorporated the two exercise modalities, endurance 
and resistance, with the intent to recruit different skeletal muscle fibre types. 
The findings suggest that exercise modality appears to play a role in T cell 
VDR expression, with endurance exercise eliciting a greater effect compared 
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to a resistance exercise bout. This may be intensity or duration dependent, 
since the exercise bouts differed in both parameters, possibly presenting a 
different mechanical load. Both exercise protocols were designed to mimic 
those employed in the murine model by Makanae et al. (2015), however were 
altered to be reproducible by a human population. The HR zones differed 
during the exercise bouts, with the endurance bout ranging between 62-86 % 
HRpeak, and the resistance bout ranging between 50-81 % HRpeak. Therefore, 
the differing response could be attributed to the higher HR zone during the 
endurance bout, combined with the longer duration. In addition, only one leg 
was exercised in the RE trial, therefore reduced muscle recruitment compared 
to the EE trial. Therefore, the muscle fibre type and muscle mass recruited 
during exercise-induced muscle contraction could account for the difference in 
VDR expression observed between endurance and resistance exercise 
modality. Supplementation with vitamin D has previously been shown to 
increase myocyte VDR expression in type II fibres and not type I fibres (Ceglia 
et al., 2013). However, this contradicts our finding that endurance exercise, 
which is more focussed on type I fibre recruitment (Gollnick, Piehl, & Saltin, 
1974), augments the increase in VDR compared to a more type II fibre based 
resistance protocol. It could also be argued that the participants are all 
recreationally active individuals that partake in different sports and activities 
and thus are not trained cyclists, therefore the muscle recruitment pattern and 
utilisation of aerobic and anaerobic systems may differ between participants, 
thereby affecting the response to the RE and EE trials. Moreover, it must be 
taken into consideration that these studies measure localised (to contracting 
skeletal muscle) metabolism, whereas the current investigation utilised a non-
localised systemic model, which may account for the differing outcomes.  
In summary, we have demonstrated that an acute bout of resistance and 
endurance exercise acutely increased T cell VDR expression in healthy males 
immediately upon cessation of the exercise bout, with the effect lost at 3 h 
post-exercise. The VDR response to exercise was found in circulating CD3 T 
cells, and the two subsets: CD4 and CD8 T cells. In contrast to the hypothesis, 
there was no observed influence of age on the response. These results 
suggest that exercise could be an efﬁcient way to increase systemic cellular 
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VDR expression in a human population, although only on a short-term basis. 
Furthermore, as discussed, there may be an influence of cell mobilisation in 
response to exercise that may contribute to the increase in VDR expression 
observed. Interestingly, there was no correlation between the change in 
circulating cell number and VDR expression thereby concluding that exercise 
may have the capacity to increase intracellular VDR expression independent 
of T cell redistribution and mobilisation.   
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7.1 Main findings 
This thesis project was designed to address the main aim of exploring the role 
of exercise and ageing on vitamin D metabolism, investigating the 
relationships between physical activity and CRF, and vitamin D status and the 
key mediator of vitamin D metabolism: VDR.  
 
The four aims of the thesis were:  
I. To evaluate the vitamin D status of older adults in Scotland and 
determine whether there is a link with physical activity levels.  
II. Investigate whether vitamin D status is influenced by age and 
associated with CRF.  
III. Determine whether there is a relationship between vitamin D status 
and baseline VDR expression, and investigate the role of age and 
CRF on VDR expression.  
IV. Explore the effects of acute exercise on VDR expression, and 
identify if this response is influenced by age.  
 
The main findings of this thesis are:  
• There is a high prevalence of severe deficiency (26 % and 40 %), 
deficiency (64 % and 29 %) and insufficiency (10 % and 31 %) in adults 
living in Scotland reporting an overall deficient vitamin D status of 14.5 
± 3.9 ng·ml-1 and 15.7 ± 6.4 ng·ml-1 (Chapters 4 and 5, respectively).  
• There was an influence of season on 25(OH)D concentrations, with 
vitamin D status lower in winter compared to summer months (Chapter 
4).  
• Older adults drastically underestimate sedentary behaviour by as much 
as 7 h, underestimate LPA to a lesser degree, and overestimate MPA. 
Surprisingly, there was an inverse correlation between VPA and 
25(OH)D concentration (Chapter 4).  
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• Baseline 25(OH)D concentration was not influenced by age or CRF, 
even though CRF was lower in older adults (Chapter 5). These data 
suggest that vitamin D status is likely dependent on environmental 
factors (UVB exposure) and dietary sources, as opposed to an 
individual’s modifiable (CRF) and non-modifiable (age) characteristics.  
• There is no observed relationship between the two measured key 
systemic vitamin D metabolites at baseline: circulating 25(OH)D 
concentration and T cell VDR expression (Chapter 5).  
• Baseline circulating T cell VDR expression is associated with both CRF 
and age, with lower expression observed in older adults compared to 
younger populations, and a higher CRF associated with a greater 
density of receptors in the cells (Chapter 5).  
• An acute bout of endurance and resistance exercise acutely increased 
circulating T cell VDR expression in healthy males (Chapter 6). Despite 
the difference in VDR expression at rest (Chapter 5), the short-term 
response to exercise was unaffected by age.  
• There was a classic acute response of T cells to both endurance and 
resistance exercise bouts and although not entirely conclusive, the data 
suggests that VDR expression was upregulated in response to exercise 
independent of T lymphocyte mobilisation and translocation (Chapter 
6).  
 
7.2 General discussion 
The main aim of this thesis was to investigate the influence of physical 
activity/exercise and age on vitamin D metabolism. The research questions in 
this thesis recognised that vitamin D plays a role in prevention of ill-health 
(Autier et al., 2014), primarily through the action of the VDR. However, it has 
been reported that there is a decline in vitamin D status (25(OH)D 
concentration) (Baker, Peacock, & Nordin, 1980; Maggio et al., 2005) and VDR 
expression with increasing age (Bischoff-Ferrari, Borchers, et al., 2004). This 
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presents an issue as age advances, and an avenue for intervention to improve 
vitamin D metabolism and promote ‘healthy ageing’.  
To the best of our knowledge, this is the first study to show in a human 
population that there is a decline in resting systemic lymphocyte VDR 
expression with age, and exercise alone can increase VDR expression in 
these cells, independent of age. Furthermore, we show that there is no 
association between vitamin D status and VDR expression, therefore age 
appears to alter vitamin D metabolism at the cellular level and not the 
circulating blood marker level. Moreover, a higher CRF predicts a higher 
expression of the VDR, suggesting aerobic fitness serves as a protective 
mechanism to beneficially influence vitamin D metabolism.  
In Scotland, the “normal” baseline 25(OH)D concentration is far below the level 
classified as “sufficient” (>30 ng·ml-1) (Holick, 2009; Holick et al., 2011), with a 
strikingly low vitamin D status reported by several Scotland-based studies: 
14.4 ng·ml-1 (Zgaga et al., 2011) and 12.7 ng·ml-1 (Weiss et al., 2016). Our 
data is in line with these reports, with a mean 25(OH)D concentration of 14.5 
ng·ml-1 (VDS study) and 15.7 ng·ml-1 (ExVD study). Although an individual may 
be classified as vitamin D deficient or insufficient, there is a constant, albeit 
low, quantity of 25(OH)D compounds circulating in the blood (the findings are 
stated above). Therefore, there is a constant baseline capacity to convert 
25(OH)D to the active form, 1,25(OH)2D3, and thus a supply of the ligand 
available to enter target cells and find an available receptor. Vitamin D-induced 
benefits are modulated by the intracellular binding of 1,25(OH)2D3 to the VDR 
and the translocation of this complex to the nucleus to bind to the VDRE (Pike 
et al., 2012). It could be suggested that the availability of VDR needs to be 
proportional to the number of 1,25(OH)2D3 for the metabolic pathway to 
operate efficiently. Therefore, adequate VDRs in the cell that are available to 
receive the ligand, may be equally or more important as 25(OH)D 
concentration when determining the role of vitamin D in health and disease. 
Moreover, this thesis reports that there is no association between 25(OH)D 
concentration and VDR expression, therefore VDR expression in cells may be 
independent of “vitamin D status”. Strategies to improve vitamin D metabolism 
currently identify supplementation with vitamin D as a solution to increase 
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25(OH)D availability (Autier et al., 2012) and thus potentially alleviate skeletal 
and non-skeletal disorders. However, future studies should consider the 
pathway as a whole when determining whether low 25(OH)D or impaired 
vitamin D metabolism is the cause or result of ill health.  
Serum 25(OH)D concentration is measured as the main marker of vitamin D 
status (Holick, 2009) due to its close relationship with vitamin D3 exposure 
(through dietary intake or dermal synthesis), and its relatively long half-life of 
around 15 days (K. S. Jones et al., 2014). However, since it is the biologically 
active form of vitamin D, 1,25(OH)2D3, that enters the cell and binds to VDR, it 
may be thought to be the ideal measure to determine vitamin D status. In terms 
of the pathway, although an adequate supply of 1,25(OH)2D3 to target cells is 
vital to progress towards VDR-induced gene activity, the relatively short half-
life of this metabolite (4-15 hours) (Zehnder et al., 2001) renders it an 
unreliable and useless marker of vitamin D status and metabolism. In addition, 
the efficacy of tissues to exert VDR-induced biological effects will be 
dependent upon the ability of the cell to internalise 1,25(OH)2D3. Cells express 
membrane-bound proteins, such as megalin, that play a facilitating role in the 
endocytosis of the 1,25(OH)2D3-DBP complex to the cytoplasm (Abboud et al., 
2013; Rowling, Kemmis, Taffany, & Welsh, 2006). In addition, circulating levels 
of 1,25(OH)2D3 are a thousand fold less than 25(OH)D (Metzger et al., 2013). 
Taken together, 25(OH)D may be effectively used to help with the association 
of vitamin D deficiency and several disorders (Holick, 2006), but the VDR 
provides a better indication of the capacity to alter gene transcription. 
Measuring different metabolites may also be more relevant depending on the 
tissue type.  
The antibody to the VDR used in our study does not have specific binding to 
unoccupied (“available”) VDR and thus binds to both occupied and unoccupied 
VDR, reported in other study’s (Bischoff-Ferrari, Borchers, et al., 2004). The 
unoccupied VDR may be a more sensitive measure to determine VDR 
available for binding to the ligand. It is therefore important to consider these 
limiting factors to the vitamin D metabolic pathway, particularly when reporting 
VDR expression as a marker of vitamin D metabolism-responsiveness. 
Nonetheless, this is the first study to employ flow cytometry analysis of 
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intracellular VDR protein expression in human primary cells. Therefore, in 
conjunction with the study by Bendix et al. (2015), it could be used to inform 
methods of future investigations and experiments.  
This thesis reports that baseline 25(OH)D concentration is not influenced by 
age, however VDR expression significantly declines with age. Currently, it is 
not known whether low 25(OH)D concentration or another factor associated 
with ageing leads to decreased stimulation and expression of the VDR. In light 
of the results of this thesis, it could be suggested that low 25(OH)D 
concentrations do not influence VDR expression, in agreement with other 
studies (Bischoff-Ferrari, Borchers, et al., 2004; Kinyamu et al., 1997). This 
points towards other factors being responsible for disrupting cellular VDR 
expression in older persons. It should be noted that the VDR expression 
reported in this thesis is specific to circulating T lymphocytes, however it does 
represent a human cell model. This is similar to that reported in human skeletal 
muscle cells (Bischoff-Ferrari, Borchers, et al., 2004), whereby the authors 
reported decreased VDR expression with older age. These findings lead us to 
propose that measuring VDR expression responsiveness during investigative 
trials, in addition to the classically measured vitamin D status, is important for 
public health. Determining what exercise protocols yield the most effective 
increase of VDR expression may inform the design/approach of strategies and 
interventions aimed at improving the vitamin D endocrine system.  
Although this may specifically benefit older populations, adults of all ages are 
defined as vitamin D deficient in Scotland. Therefore, perhaps people that 
reside in Scotland have a relatively low VDR expression at baseline compared 
to populations living at different latitudes. This is currently unknown and 
speculative. However, as a result there would be differing latitude-induced 
UVB exposure and thus skin synthesis of vitamin D contributing 25(OH)D 
concentrations, and since increasing 25(OH)D concentration through 
supplementation increases VDR expression (Ceglia et al., 2013), it follows that 
this may also occur in response to sunlight-induced increases in 25(OH)D 
concentration. Taking this into consideration, public health strategies to 
improve vitamin D health in adults that reside in Scotland should target all 
ages.  
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This thesis also reports that CRF is associated with, and predicts, baseline 
VDR expression in circulating T lymphocytes, but has no relationship with 
25(OH)D concentration. This latter finding contradicts previous publications, 
whereby serum 25(OH)D concentrations are associated with V̇O2max (Mowry 
et al., 2009) and predict V̇O2max (Ardestani et al., 2011) in healthy adults. 
However, the latter studies were conducted in the US with reported baseline 
serum 25(OH)D concentrations of 34 ng·ml-1 and 46 ng·ml-1, which are 
substantially higher than that reported in our populations living in Scotland: 
14.5 and 15.7 ng·ml-1. The UV Index differs between countries/latitudes, 
dependent on climate and weather and seasonal variations, therefore 
influencing vitamin D status (O'Neill et al., 2016). For that reason, the reports 
are specific to the country/location. Scotland is a region of low UVB radiation 
due to the high northern latitude (55°-59° North), with the prevalent cloud cover 
and poor weather conditions limiting sunlight-induced vitamin D skin synthesis 
(Rhodes et al., 2010). This relationship appeared in our findings and is in line 
with other studies in the UK (Hirani, 2013; Hypponen & Power, 2007; Kelly et 
al., 2015; Zgaga et al., 2011), whereby there appears to be an influence of 
season on 25(OH)D concentration, with vitamin D deficiency more prevalent 
in winter compared to summer months.  
There is also an influence of season and weather on physical activity levels 
(Tucker & Gilliland, 2007), therefore CRF may decline in winter months. 
Although even in light of the influence that season likely has on these two 
factors, there was no association between baseline 25(OH)D concentration 
and CRF in the current investigations. Interestingly, it has been reported in an 
investigation conducted in the US, that increasing physical activity can 
increase circulating vitamin D independent of whether the activity is performed 
outdoors or indoors (Wanner et al., 2015). Thereby implying that factors other 
than sun exposure may be responsible for the higher 25(OH)D concentrations. 
It has also been reported that physically active people are active both indoors 
and outdoors regardless of season (Touvier et al., 2015). This suggests that 
physical activity may influence vitamin D metabolism, not only via sun 
exposure during such activities. In order to confirm, this would require both 
factors, physical activity and UVB exposure, to be investigated simultaneously. 
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This has been identified and supported as a future direction by other studies 
(K. Brock et al., 2010), with the feasibility of objectively measuring both 
physical activity and UV exposure through an app currently being investigated 
by researchers (Hacker et al., 2018).  
If a higher CRF predicts a greater expression of VDR in cells, then methods to 
improve CRF may be a strategic approach in order to acquire the benefits 
associated with VDR-induced alterations in gene expression and protein 
synthesis. Particularly in older adults, since they have a lower CRF compared 
to younger populations. This concept was explored, whereby we investigated 
the responsiveness of VDR expression to a single bout of exercise, since 
regular exercise is associated with higher levels of CRF (Toth, Goran, Ades, 
Howard, & Poehlman, 1993). This study aimed to uncover the short-term 
response to exercise, thereby determining 1) whether exercise can increase 
VDR expression in humans, and 2) if there is a response, what is the duration 
of the effect? Previous reports in murine models have observed elevations in 
muscle tissue VDR expression in response to strenuous exercise (Aly et al., 
2016; Makanae et al., 2015). To our knowledge, this is the first study 
conducted in humans showing that a single bout of exercise increases 
intracellular VDR expression. Following both an endurance and a resistance 
exercise protocol, VDR expression was immediately increased and remained 
elevated for 1 hour upon cessation of the exercise bout. VDR expression then 
declined to baseline levels after 3 hours, indicating a short-term response. The 
two bouts of exercise do differ with regards to work load and muscle mass 
recruited, therefore are perhaps not entirely comparable (as discussed in the 
Thesis Limitations).  
Interestingly, although there is a lower baseline expression of VDR in older 
compared to younger individuals, age did not attenuate the responsiveness of 
cellular VDR expression to a bout of exercise. The biphasic pattern observed 
followed the same pattern regardless of the age group: 18-30 y, 31-45 y, 60-
75 y. Taken together these results suggest that exercise could be an efﬁcient 
way to increase systemic cellular VDR expression in all ages of a human adult 
male population.   
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7.3 Thesis limitations and future directions 
There were a number of limitations in this thesis as outlined and discussed 
below. Limitations within research studies often present future directions. 
Where this is the case, suggestions for future work have been proposed.  
The exercise bouts aimed to recruit the two muscle fibre types therefore 
inducing a different mechanical stress and metabolic demand. However, the 
duration and muscle recruitment of the two bouts were not matched and thus 
pose a limiting ability to compare the two types of exercise. Therefore, it cannot 
be concluded that either exercise modality induces a more pronounced 
response compared to the other. Future investigations should match bouts for 
workload and effort. Moreover, there are many different exercise modalities, 
which may alter the response of the vitamin D endocrine system. The protocols 
adopted in this thesis were designed to mimic those used by Makanae et al. 
(2015) in a murine model study. Ideally going forward for public health, focus 
should be directed towards protocols that the public are likely to engage in, in 
order to optimise the use of exercise as a strategy to improve vitamin D 
metabolic capacity. There is research on the affective responses and 
‘enjoyment’ of specific exercise protocols, however these differ depending on 
the population. For example, high intensity interval training (HIIT) has received 
much attention over the past decade as a protocol to promote enjoyment and 
adherence to exercise (Heisz, Tejada, Paolucci, & Muir, 2016), yet still 
receives mixed feedback (Biddle & Batterham, 2015). Therefore, consideration 
of the population recruited (sex, health status, age, BMI, physical ability) and 
the potential compliance out-with a supervised/controlled circumstance (i.e. 
laboratory-based studies) should be at the forefront of future investigations in 
humans (Courneya, 2010).  
In this thesis, T cells were used in the experiments, which represents a non-
localised response to mechanical stress. T cells were used in the study as they 
are easily obtainable through a less invasive procedure, systemic blood 
collection, compared to muscle biopsy procedures, which would provide 
myocytes. In order to accompany and compliment the results of the findings of 
this thesis, it would be ideal to investigate VDR expression in myocytes as this 
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represents localised metabolism induced by exercise, particularly in the 
working muscles.  
In the ExVD study it was found that an acute bout of exercise can increase 
VDR expression, however the effect was lost after 3 hours. Going forward it is 
of interest to determine whether a higher exercise load can elevate VDR to a 
higher degree, and/or for a longer duration. Moreover, if it is important to raise 
resting VDR expression in cells, then going forward it is of interest to 
investigate whether regular exercise can induce an adaptive response in cells 
to express VDR at a higher concentration. It may be that exercise only induces 
an acute response and thus exercise bouts must be repeated at regular 
intervals in order to benefit. Furthermore, since CRF is positively associated 
with VDR expression, using CRF as a measure of adaptation to regular 
exercise, and/or intentionally aiming to increase CRF through exercise 
training, may prove to be a source for elevated VDR expression and vitamin D 
endocrine metabolic capacity.  
 
7.4 Conclusions and implications 
As described in the Introduction and outlined in the Literature Review of this 
thesis, vitamin D deficiency is a worldwide epidemic, with Scotland being a 
prime example of a nation with low vitamin D concentrations, regardless of 
characteristics and lifestyle. The data in this thesis contributes to this 
consensus, as all individuals, whom did not consume vitamin D supplements 
or UVB treatment, were classified as vitamin D insufficient, deficient and 
severely deficient. Most tissues and cells of the body express key vitamin D 
metabolites and components, specifically the VDR, that mediate the vitamin D 
endocrine system and its functions: both genomic, mediated through the VDR 
transcriptional effects inside the cell nucleus, and non-genomic actions, rapid 
VDR-induced signalling. Another epidemic sweeping the UK and Scotland is a 
rise in sedentary behaviour and decline in physical activity levels.  
This thesis has shown that there is a link between vitamin D metabolism and 
physical fitness and capacity, with the association residing with VDR 
expression as opposed to 25(OH)D3 concentration (vitamin D status). The 
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findings are suggestive that a higher CRF is linked to a greater expression of 
VDR, but unfortunately VDR expression declines with age.  
One of the main findings of this thesis is that exercise can acutely increase 
VDR expression in circulating T cells, suggesting exercise may be an effective 
strategy to alter the vitamin D endocrine system providing a potential platform 
to influence the pathophysiological development of chronic diseases. 
However, much research is required into the mechanisms involved and if this 
is a relationship and/or response seen in other cell types.  
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